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Stroke is the third leading cause of death and disability both locally and 
internationally. Despite the enormous availability of scientific literatures on brain 
ischemia, currently, only intravenous recombinant tissue-type plasminogen activator 
(rt-PA, Alteplase) thrombolytic treatment and antiplatelet therapy are approved 
pharmacological managements which induce the degradation of the arterial thrombus 
and restoration of vessel patency and blood flow to improve clinical prognosis. In the 
present study, experimental brain ischemia was modeled with intraluminal suture 
technique induced middle cerebral artery occlusion in rats (MCAo). Stroke can be 
temporally classified into varying phases where pharmacological intervention plays 
an important mediating role in the early phase and physiotherapy in addition to 
medication are proven clinical approach for managing brain ischemia later.  
 
Studies showed that in early phases of MCAo, cell death advances via a continuum 
between apoptotic and non-apoptotic modes that hinged on cellular energy level. In 
the current acute phase study, concomitant administration of both z-VAD-fmk and 
3-AB yielded better outcome with bigger infarct volume reduction in comparison with 
single inhibitor administration following MCAo. In addition, combinatorial treatment 
remained effective even when administered at 24hr post MCAo. Although there was 
no general correlation between intracellular ATP level and infarct size, only treatment 
xiii 
 
with PARP inhibitors had showed that intracellular ATP level was inversely related to 
the size of infarct. 
 
Although physiotherapy has been clinically proven, its molecular basis has not been 
well elucidated. The present chronic phase study demonstrated that eight weeks of 
moderate forced treadmill post-ischemic exercise were able to reduce secondary 
damages, and achieved better clinical outcome following brain ischemia via 
multi-modal neuroprotective and angiogenic (in turn supporting neuroregeneration) 
mechanisms. The elevated level of activated caspase-3 seen in the MCAo rats was 
reduced subsequent to post-ischemic exercise when TGF-β1 was further increased and 
smad7 was reduced concomitantly in the ipsilateral cortices of the MCAo-runner rats 
suggesting an anti-caspase-dependent-apoptosis property of TGF-β1’s role in 
neuroprotection. Paradoxically, up-regulated positive TUNEL staining within the 
ipsilateral cortices of the MCAo-runner rats may be taken as an indication as the 
body’s effort to modulate imminent cell death via apoptotic pathways which will be 
less prone to inflammatory events. 
 
In addition to neuroprotection, neuroregeneration after ischemic insults is pivotal for a 
more favorable prognosis. For neuroregeneration to happen, increase in angiogenic 
and erythropoietic activities are needed to form new and effective oxygen delivery 
vascular structures. Interestingly, distinct Pecam-1 immunoreactivities were seen with 
marginal PDGFB increased in sham-runner rats. However, opposite observations 
xiv 
 
could be observed in the ipsilateral cortices of the MCAo-runner rats with 
up-regulated PDGFB expressions that were not reciprocated by strong Pecam-1 
immunoreactivities. Thus suggested that brain ischemia may produce or remove 
another unidentified factor that may form either inhibitive or necessary condition for 
the angiogenic property of PDGFB to work. With changes to the 
angiogenic/erythropoietic factors and vasculatures, antioxidants’ profiles were also 
dissimilar in the rats possibly reflecting the differential conditions. 
 
In its essence, the present study has shown that combinatorial administration of both 
z-VAD-fmk and 3-AB was better than if the inhibitors were given individually in the 
acute phase stroke. The current data from the chronic phase of brain ischemia 
experiments also showed that post-ischemic exercises could induce endogenous 
factors that may confer neuroprotection and possibly neuroregeneration.
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1.1  Epidemiology of Stroke 
 
Stroke is the third leading cause of death and disability both locally and internationally. 
Approximately 11% of all deaths in Singapore are contributed by stroke related deaths; 
these are predominantly elderly patients and remain a priority for the health of the nation 
(Venketasubramanian et al., 2005). Although the incidence of stroke is reducing with 
improved public health measures, the prevalence is increasing within the aging 
population. In addition, although stroke is a clinical term used to describe a sudden 
cerebrovascular accident causing major physical disability, a large number of events are 
silent and are a recognized cause of multi-infarct dementia associated with progressive 
cognitive decline and dependency (Caplan and Schoene, 1978; Fields, 1986). The true 
burden on the community is incalculable, and set to increase.  
 
1.2  Clinical Classification of Brain ischemia 
 
Stroke can be broadly divided into two major categories – hemorrhagic and ischemic. In 
Singapore, approximately 75% of all strokes are of ischemic origin which is the interest 
of this thesis. Ischemic stroke can be further dichotomized into thrombotic and embolic 
cerebral ischemia. Ischemic stroke occurs when a blood vessel leading to the brain is 
occluded, thus resulting in a reduction of cerebral perfusion. Within minutes of reduced 
cerebral perfusion, brain infarction that is characterized by an irreversibly necrotic core 
formed within an area of hypoperfused brain tissue will develop. The hypoperfused 
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regions are viable tissue of varying degree and are termed as the ischemic penumbra 
(Astrup et al., 1981; Heiss et al., 1994; Heiss, 2000) which represents the target for most 
therapeutic interests and interventions. Clinical interpretation of normal cerebral blood 
flow in grey matter and white matter are in the range 60–70 ml/100 g/min and 20–30 
ml/100 g/min respectively. When the flow rate went below a threshold of 10–12 ml/100 
g/min, it is called absolute ischemia and develops irreversible neuronal structural damage 
(ischemic core) (Hossmann, 1994). 
 
Temporally, stroke can be stratified into the following phases: hyper-acute, acute, 
sub-acute and chronic brain ischemia. In human, the four phases for stroke are defined as 
between symptomatic onset and six hours for hyper-acute phase, within 24hr to 
approximately seven days post-stroke for acute phase (Page et al., 2005; Bader et al., 
2006), one week to three months post-stroke for sub-acute phase (Page et al., 2001; Page 
et al., 2002; Kalra et al., 2007) and more than three months post-stroke for chronic phase 
(Page et al., 2004; Nudo et al., 2007). Understanding the mechanisms of these various and 
distinct phases are pivotal in delivering an effective rehabilitation intervention because 
cellular events that are triggered by insults to the brain during the acute and sub-acute 
phases are likely to be independent of the processes in the chronic phases. 
 
The regions of brain infarction are characterized by a necrotic core, in which all cell death 
occurs rapidly. This core of irreversible damage is surrounded by an ischemic penumbra 
in which neurons die over days to weeks (Schellinger et al., 2001a; 2001b) likely through 
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apoptotic processes and the potential area of developing therapeutic interventions (Rami 
et al., 2008). Apoptosis and necrosis have long been recognized and documented as two 
distinct forms of cell death where apoptosis is an energy requiring programmed process 
and necrosis is presumably an unregulated mode (Wyllie et al., 1980). Not only apoptosis 
and necrosis are considered biochemically and morphologically different, they hold 
different implications for the surrounding tissues as well. 
 
1.3  Types of Experimental Brain Ischemia Rodent Model 
 
Extensive studies have shown that apoptosis and necrosis occurred in brain of the 
experimental cerebral ischemic rodent model following middle cerebral artery occlusion 
(MCAo), where apoptosis occurs surrounding the necrotic core, in the penumbra region 
(Ferrer and Planas, 2003). Most in vivo rodent models of experimental brain ischemia 
that are used today were developed between the late 1970s and early 1980s. They are 
generally divided into two categories, global and focal ischemia. MCAo is a focal 
ischemic model, was first introduced by Kozuimi and coworkers (Kozuimi et al., 1986) 
and subsequently modified by Longa and co-workers (Longa et al., 1989) and many 
others to reduce subarachnoid haemorrhage (SAH) by blunting the end of the nylon 
suture and premature reperfusion by coating the suture with poly-L-lysine or silicone 
(Belayev et al., 1996; Schmid-Elsaesser et al., 1998). MCAo model can be further defined 
by period of occlusion. In temporary MCAo, vascular occlusion is induced up to three 
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hours followed by prolonged reperfusion, while in permanent MCAo vascular occlusion 
is maintained throughout the experiment. 
 
1.4  Clinical Relevance of Middle Cerebral Artery Occlusion (MCAo) Rodent 
Model 
 
In permanent ischemic model, there is significant variation in the extent of the different 
infarcted regions documented with the different strains of rodents such as 
Sprague-Dawley rats, spontaneously hypertensive rats, and Wistar rats (Brint et al., 1988; 
Buchan et al., 1992; Markgraf et al., 1993; Back et al., 1995). At the same time, infarction 
can be first observed between the third to the twelfth hour following MCAo. This wide 
time range further supports the existence of fundamental difference in each strain’s 
properties. Sprague-Dawley rats was seen with an earlier circumscribed area of infarct as 
compared to Wistar rats, which possibly be due to the less uniform lesion in the latter 
(Peter, 1999). 
 
As in human, permanent MCAo in rodents produce core ischemic cell death in striatum 
that progress into the other regions of neocortex, entorhinal cortex and medial 
caudate-putamen which make up the penumbra (Bolander et al., 1989; Nagasawa et al., 
1989; Memezawa et al., 1992; Belayev et al., 1997). The infarcted core area in the 
striatum is presented with a necrotic character that occurs rapidly upon ischemic insult 
(Garcia et al., 1995; Li et al., 1995b) and the devastation in this core region has reached a 
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irreversible point that render most administered neuroprotective agents ineffective 
(Mohamed et al., 1985; Buchan et al., 1991; Minematsu et al., 1993; Yrjanheikki et al., 
1999; Sydserff et al., 2002). At the other end of the spectrum, the infarcted area in 
penumbra contains a greater degree of delayed apoptotic cell death than in striatal 
infarction (Garcia et al., 1995; Li et al., 1995a; 1995b; Linnik et al., 1995). This delayed 
progression of cell death in the penumbra (cortex) following MCAo presents an 
opportunity for this model to be employed in identification of new targets for 
neuroprotective therapies (Gladstone et al., 2003; Cheng et al., 2004). 
 
However, studies using positron emission tomography (PET) scans showed that blood 
flow rates varies widely in terms of space and time within the penumbral region in 
different MCAo models resulting in modeling inconsistency (Nagasawa et al., 1989; 
Heiss et al., 1994; Zhao et al., 1994; Belayev et al., 1997). Modification of the MCAo 
model with occlusion of the MCA together with ipsilateral common carotid artery (CCA) 
reduces cerebral blood flow (CBF) leading to the core and periphery of the MCA territory 
and has been reported to successfully produce more consistent infarct volumes (Chen et 
al., 1986; Ginsberg and Busto, 1989; Buchan et al., 1992; Avendano et al., 1995; Soriano 
et al., 1997). Pan-necrosis, occurs during the final stage of infarct development in focal 
ischemia, refers to the complete loss of cellular elements approximately seven days 
following ischemic insult. In this stage, the neuronal death is found together with glial 




1.5  Post-Ischemic Cellular Events and Responses in the Central Nervous 
System (CNS) 
 
Brain ischemia elicits an array of cellular response and activates a convoluted cellular 
signaling. The normal physiological function of nervous system is orchestrated by 
different cell types with differing roles. The neurons are the functional cells whereas the 
astrocytes, microglia and oligodendrocytes play the supporting role in the brain. In the 
event of an ischemic incident onset, neuronal cell can be degenerated by energy failure 
caused by rapid loss of blood supply, or by the activation of calcium (Ca2+) - dependent 
pathways (Mattson, 2000). When blood supply to the brain is impeded in stroke, neuronal 
cells in the core lesion die immediately from oxygen and glucose starvation, mainly 
necrosis. Necrotic neuronal cell death within the core ischemic region can trigger immune 
responses that lead to microglial activation and infiltration of peripheral inflammatory 
cells usually with a negative connotation (Siesjo and Siesjo, 1996; Dirnagl et al., 1999). 
These inflammatory cells can release a variety of cytotoxic agents including more 
cytokines and more reactive oxygen species (ROS) in response to ischemia which may 





1.6  Intracellular Adenosine-5'-Triphosphate (ATP) Level Following Brain 
Ischemia 
 
At the immediate site of the ischemic region during an acute phase of a stroke, lower 
blood flow rate trigger necrosis as a result of an energy failure, or drastic decrease in 
intracellular (adenosine-5'-triphosphate) ATP levels (Eguchi et al., 1997; Leist et al., 
1997). Intracellular ATP levels are fundamentally decided by three parameters: material 
supply (glucose uptake), ATP synthesis (mostly in the mitochondria) and consumption. 
Poly (ADP-ribose) polymerase (PARP) is a deoxyribonucleic acid (DNA) repair enzyme 
that is primarily activated by DNA strand breaks. Berger et al. (1986) proposed a 
“suicide” concept whereby PARP overactivation occurs when there was massive level of 
DNA damage, leading to intracellular ATP depletion in an attempt to restore 
nicotinamide adenine dinucleotide (NAD+), is implicated for participation in DNA 
damage-induced necrotic 
Transforming Growth Factor-β1 (TGF-β1) is a member of super-family of 
multifunctional cytokines orchestrates various critical physiological processes, including 
proliferation, differentiation, growth inhibition, and apoptosis (Schuster and Krieglstein, 
2002). TGF-β isoforms (TGF-β1, 2 and 3) elicit their cell type-specific responses through 
death (Ha and Snyder, 1999). 
 
1.7  Roles of Transforming Growth Factor-β1 (TGF-β1) and Sma and Mad 




the ligand induced formation of a heteromeric receptor complex between the 
serine/threonine kinases TGF-β receptor type I (TGFBR-I) and TGFBR-II: the type II 
receptor binds TGF-β by its own, then recruits the type I receptor, allowing the 
transphosphorylation-mediated activation of TGFBR-I. The TGFBR-I then interact and 
phosphorylate smad protein transcription factor, smad2 and smad3, which form 
heterotrimeric complexes with smad4 and translocate into the nucleus to regulate key 
target gene transcription cascade (Shi and Massague, 2003; ten Dijke and Hill, 2004). 
smad7, an inhibitory smad, acts by occupying ligand-activated TGFBR-I and interfering 
with the phosphorylation of smad2 and smad3 in a negative feedback loop preventing 
over-stimulation of the cell by TGF-β. Up-regulation of smad7 has been associated with 
an inhibition 
TGF-b1 mRNA and protein have been shown to increase and have also demonstrated 
neuroprotective activity (Ruocco et al., 1999; Zhu et al., 2002) following experimental 
hypoxia (Klempt et al., 1992), global (Zhu et al., 2000) or focal (Ata et al., 1999) 
ischemia, and in cultured neurons after various stimuli (Ren and Flanders, 1996). The 
neuroprotective mechanism of this cytokine to antagonize neuronal apoptosis has been 
coupled to the up-regulation of B-cell leukemia/lymphoma 2 (Bcl-2) and Bcl-xl (Prehn et 
al., 1994), and the inhibition of caspase-3 activation (Zhu et al., 2001). It was proposed 
that a mechanistic loop, involving Bcl-2 and caspase-3, where inhibition of caspase-3 
activation by TGF-β1 is mediated through the up-regulation of Bcl-2. And because of 
suppressed caspase-3 activation, the cleavage of Bcl-2, a substrate of caspase-3, could in 




turn be reduced. In view of this point, reduced activation of caspase-3 by TGF-β1 may 
contribute to up-regulation of Bcl-2 expression. Besides the classic receptor-activated 
smad signaling, increasing studies have demonstrated that TGF-β1 activates other 
pathways such as mitogen-activated protein kinase (MAPK) and 
phosphatidylinositol-3-OH kinase (PI3k)/Akt signaling pathways (Xiao et al., 2002; Yu et 
al., 2002). And It has been demonstrated recently that TGF-β1 inactivates the 
pro-apoptotic protein Bcl
The cytoprotective effect of TGF-β1 produced in the central nervous system (CNS) 
following various insults may be consistent with the low numbers of apoptotic microglia 
found in in vivo models of CNS inflammatory diseases (Pender et al., 1991), as abnormal 
overactivation and resultant death of microglial cells may cause more neurotoxicity in 
various neurodegenerative diseases (Gebicke-Haerter et al., 1996). Microglia are 
functionally equivalent to peripheral macrophages in the CNS (Giulian, 1987). Activated 
microglia which secrete bioactive molecules, such as reactive oxygen or nitrogen species 
and inflammatory cytotoxins, have been closely associated with various 
neurodegenerative diseases such as stroke, trauma, Alzheimer’s disease (AD), multiple 
sclerosis, and human immuno-deficiency virus (HIV)-associated dementia (Ransohoff et 
al., 1996; Gonzalez-Scarano and Baltuch, 1999). Sustained overproduction of those 
molecules via microglia over-activation would cause severe damage to both the normal 
-2-associated death promoter (Bad) via activation of 
mitogen-activated protein kinase (MAPK)/extracellular-signal regulated kinase (Erk)1,2 




and pathological brain region. Nonetheless, the role of TGF-β1 in relation to 
anti-inflammatory and anti-apoptotic functions in the CNS remains controversial as it is 
extremely dependent on the cell type, the pathological stimuli and the experimental 
conditions (De Luca et al., 1996) 
 
In the smad signaling pathway, smad7 expression is increased in response to TGF-β, bone 
morphogenic protein (BMP), and activin, providing a mechanism for negative feedback 
regulation (Massague´ and Chen, 2000). Interestingly, smad7 expression can also be 
induced by interferon-γ (IFN-γ) and by tumor necrosis factor- α (TNF-α), which suggest 
that smad7 may fulfill other cellular functions independent of its inhibitory role (Ulloa et 
al., 1999; Bitzer et al., 2000). Overexpression of smad7 has also been reported, in several 
studies which pronounce TGF-β1 as pro-apoptotic, to sensitize various cell types to many 
forms of cell death via a yet defined mechanism (Landstrom et al., 2000; Lallemand et al., 
2001), where smad7 could possibly be involved in the activation of the Jun N-terminal 
kinase (JNK) signaling pathway, which appears to play a critical role in mediating the 
apoptotic function of smad7 (Maire et al., 2005). 
 
1.8  Roles of Erythropoietin (EPO) and Erythropoietin Receptor (EPOR) in 
Brain Ischemia 
 
During hypoxia and ischemia, expressions of erythropoietin (EPO) and its receptor 
(EPOR) are enhanced as a result of hypoxia inducible factor-1α (HIF-1α) accumulation. 
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Human erythropoietin (HuEPO), a glycoprotein growth factor, is the main regulator of 
erythropoiesis. The HuEPO gene was cloned in the early 1980s: a recombinant human 
form of erythropoietin (rHuEPO) was subsequently developed. EPO, increases red cell 
mass to improve tissue oxygenation, is produced by the kidney and the liver (in fetuses) 
in response to hypoxic and ischemic insults to stimulate erythropoiesis (Jewell et al., 
2001; Sirén et al., 2001a). 
 
EPO has also been shown to exert neuroprotective effects against neurological injury in 
several experimental models both in vitro and in vivo (Grasso et al., 2001). EPO may 
protect neurons from glutamate toxicity by activation of calcium channels, increasing the 
activity of antioxidant enzymes in neurons, modulation of angiogenesis in the ischemic 
brain, and by anti-apoptotic effects via the activation of janus kinase-2 (JAK2) and 
nuclear factor κB (NF-κB) signaling pathways (Digicaylioglu and Lipton, 2001; Chong et 
al., 2002) 
 
Treatment with rHuEPO in hypoxic and ischemic animal experimentation have shown 
significantly reduced delayed neuronal death in the Cornu Ammonis 1 (CA1) area of the 
hippocampus (Zhang et al., 2006) and prevented cognition impairment in the passive 
avoidance test (Catania et al., 2002). The “Göttingen EPO-Stroke-Trial” which took place 
in 1998 is the first clinical trial that suggested rHuEPO, in addition to erythropoiesis, has 
therapeutic advantages that can alleviate ischemic and traumatic CNS damages and these 
findings were supported by subsequent clinical trial. 
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Jelkmann (2005) with his elegant review has dichotomized the effects of EPO to be direct 
and indirect. Indirectly, EPO improves sensory, cognitive and endocrine functions of the 
CNS through its erythropoiesis-stimulating effect, because it increases the oxygen supply 
to the brain. The alleviation of anaemia in patients suffering from renal insufficiency or 
malignancy ameliorates attention difficulties and psychomotor slowing and may cure 
from depressing fatigue. The direct effects of EPO are independent of erythropoiesis. 
Both EPO and its receptor (EPOR) are expressed in the CNS where EPO prevents 
hypoxia- and glutamate-induced neuronal cell death. 
 
There is increasing evidence that EPO has a protective function in cerebral ischemia. 
Enthusiasm for rHuEPO as a potential neuroprotective therapeutic must be tempered, 
however, by the knowledge it also enlarges circulating red cell mass and increases platelet 
aggregability. When using rHuEPO for treatment, high EPO plasma levels associated 
with increases in blood viscosity, however, may counteract beneficial effects of EPO in 
brain ischemia (Wiessner et al., 2001). Therefore, production of endogenous EPO from 
brain and endothelial cells are particularly important for neuroprotection as only low 
levels of rHuEPO appear to be able to cross the blood-brain barrier (BBB) when 




1.9  Roles of Hypoxia Inducible Factor-1 (HIF-1) in Brain Ischemia 
 
HIF-1 is a wide spectrum transcription factor that encodes for various proteins that 
mediate molecular responses to reduced oxygen availability (Stroka et al., 2001; Shao et 
al., 2005). HIF-1 protein is a heterodimer consisting of a α- and β-subunit. The HIF-1β 
subunit is expressed constitutively in the nucleus, whereas the HIF-1α subunit expresses 
variably under normoxic and hypoxic conditions. During normoxia, HIF-1α subunit is 
subjected to ubiquitination and proteasomal degradation (Salceda and Caro, 1997; Huang 
et al., 1998). However, these processes are inhibited under hypoxic conditions to allow 
accumulation of HIF-1α subunit which then translocate into the nucleus from the 
cytoplasm and form heterodimerization of the HIF-1α and HIF-1β subunits (Jiang et al., 
1996; Jewell et al., 2001). This complex, together with its transcriptional co-activators, 
will then bind to the hypoxia response elements of various HIF-1 target genes such as 
vascular endothelial growth factor (VEGF) and EPO (Ratcliffe et al., 1998; Semenza et 
al., 2001; Fandrey et al., 2006) to elicit an appropriate response. 
 
1.10  Roles of Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor 
(VEGFR) in Brain Ischemia 
 
VEGF is a major family of angiogenic growth factor that induces vascularisation 
(Carmeliet and Storkebaum, 2002), currently consisting of various isoforms such as 
VEGF-A, VEGF-B, VEGF-C, VEGF-D, and PLGF (Katoh and Katoh, 2006; Ladomery 
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et al., 2007). Among the different isoforms, VEGF-A is the best described and often 
referred to as VEGF. VEGF ligand binds to the vascular endothelial growth factor 
receptors (VEGFR), a tyrosine kinase receptor, to elicit several intracellular signaling 
pathways to promote cell proliferation and induce cell survival (Takahashi et al., 1999; 
Kilic et al., 2006). VEGFR are dichotomized into VEGFR-1 and VEGFR-2 with 
VEGFR-2 being the primary transducer of VEGF signals. VEGF expression level is 
increased following a variety of brain insults. Although VEGF is expressed largely by 
neurons and astrocytes following experimental seizure (Nicoletti et al., 2008), under 
hypoxic conditions VEGF is secreted mostly by astrocytes (Chow et al., 2001). During 
seizure VEGFR expression has been observed in endothelial cells of blood vessels, 
astrocytes and neurons where VEGFR-2 is overexpressed by neurons following epileptic 
insult (Croll et al., 2004a; 2004b; Rigau et al., 2007). In the case of hypoxia, VEGFR-2 
expression was found to co-localise with the endothelial cells of blood vessels, astrocytes, 
and neurons at 48hr post-stroke and persist up to ten days (Kovacs et al., 1996; Kilic et al., 
2006). Neo-vascularisation may take place following ischemic insult via VEGF. 
However, neo-angiogenesis usually refers to newly formed capillaries which were 
“leaky” and poorly perfused (Greenberg et al., 2008; Karamysheva, 2008). On top of its 
angiogenic property, VEGF signals have been documented to play a neuroprotective and 
neurotrophic roles and exert direct effects on different cell types such as neurons, 




1.11  Roles of Platelet-derived Growth Factors (PDGF) and PDGF Receptor 
(PDGFR) in Brain Ischemia 
 
Platelet-derived growth factors (PDGFs) consist of four different ligands denoted as 
PDGFA, PDGFB, PDGFC and PDGFD (Fredriksson et al., 2004; Reigstad et al., 2005). 
PDGF is expressed as an inactive monomeric form, and is then activated proteolytically 
to form homodimeric or heterodimeric complexes. Among all the known ligands, only 
PDGF-A and PDGFB has been observed in a hetero-configuration. Active PDGF ligands 
interact with two distinct, but related structurally, membrane bound receptor tyrosine 
kinases, PDGF receptor A (PDGFRA) and PDGF receptor B (PDGFRB) (Fredriksson et 
al., 2004; Reigstad et al., 2005). This ligand-receptor interaction induces either 
homodimerization or heterodimerization with the two types of receptor to give a total of 
three distinct permutations. Each PDGFR has been shown to have different affinity with 
different PDGF ligands (Heldin and Westermark, 1999; Li et al., 2000; Bergsten et al., 
2001; LaRochelle et al., 2001), where PDGF-BB has a greater binding affinity for 
PDGFRB. Similar to VEGF and VEGFR, PDGFB and its receptor, PDGFRB displayed a 
complementary role in the maturation process of newly formed blood vessels (Folkman 
and D’Amore, 1996; Lindahl et al., 1997; Yancopoulos et al., 2000). In the CNS, PDGFB 
and its receptor, PDGFRB were found to be expressed strongly in neurons (Sasahara et 
al., 1991; Smits et al., 1991). Following cerebral ischemia, expression of the ligand has 
been up-regulated in neurons and macrophages, and expression of its receptor has been 
observed in neurons, astrocytes and macrophages which suggest an additional role to the 
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angiogenic maturation; possibly neuroprotection (Iihara et al., 1994; Cheng and Mattson, 
1995; Iihara et al., 1996; Krupinski et al., 1997; Kaneko et al., 1998). 
 
1.12 Roles of Antioxidants in Brain Ischemia 
 
Reactive oxygen species (ROS) or free radicals are generated via aerobic metabolism, 
although with short half-life, have been implicated in the pathophysiology of many 
neurologic disorders and brain dysfunctions such as stroke (Kontos, 1985; Siesjö et al., 
1989; Chan, 1994). For example free radicals can alter the structural and functional 
integrity of cells by lipid peroxidation, thus making CNS especially susceptible (Dringen, 
2000; Adibhatla and Hatcher, 2006), which eventually lead to cell death by either 
necrosis or apoptosis. This malice against the individual cell by the ROS is scavenged and 
controlled by a variety of antioxidant enzymes such as superoxide dismutase (SOD), 
catalase and glutathione peroxidase (GPx). Acting at different point in a cascade of 
defense, SOD, GPx and catalase have been found to inhibit the formation of hydroxyl 
radical (•OH) and peroxynitrite (OONO-), via converting OONO- to hydrogen peroxide 
(H2O2) and then into water and oxygen molecules (Crack et al., 2003). SOD reduces 
superoxide (•O2-) to H2O2, whereby H2O2 is converted into water at the expense of 
glutathione (GSH) by either GPx or catalase. There are three subtypes of SODs, 
copper/zinc SOD (Cu/ZnSOD, SOD1), manganese SOD (Mn-SOD, SOD2), and 
extracellular SOD (ECSOD, SOD3), where Cu/ZnSOD have been shown to be more 
crucial in brain ischemia (Kondo et al., 1997a; 1997b; Chan et al., 1998; Kawase et 
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al.,1999). GPx enzymes belong to a family of selenoproteins includes various isoforms of 
varying substrate specificity (Ursini et al., 1995; Brigelius-Flohe, 1999), cytosolic GPx1 
being the predominantly expressed isoform (Ho et al., 1997; De Haan et al., 1998; Lei 
and Cheng, 2005) and have shown to be very important for the antioxidative defense of 
brain cells (Zhang et al., 2000; Crack et al., 2001; Flentjar et al., 2002). Albeit sharing the 
same role of detoxification of H2O2
Although with wide inter-individual variability, both hyper-acute phase and acute phase 
of brain ischemia characteristically develop from the initial symptoms of neurologic 
impairment which is then followed by further deterioration of the neurologic impairment 
before realizing clinical stability with or without medical intervention. Pharmacological 
interventions during the early phase (hyper-acute phase and acute phase) are aimed to be 
administered within a therapeutic window of three hours upon confirmed 
non-hemorrhagic stroke onset (Clark and Madden, 2009). Currently, the goals of arterial 
thrombus degradation and restoration of vessel patency and blood flow to improve 
 with GPx in the brain (Dringen and Hamprecht, 
1997; Dringen et al., 1999; Baud et al., 2004; Liddell et al., 2004), catalase has been 
documented with lower activity in brain than in kidney or liver (Ho et al., 1997). Even 
with a rigorous multi-layer of antioxidant enzyme activities, oxidative stress can still 
occur when the level of antioxidant enzyme activities are overwhelmed by the excessive 
production of the free radicals during brain ischemic insult. 
 




clinical prognosis are achieved with intravenous recombinant tissue-type plasminogen 
activator (rt-PA, Alteplase) thrombolytic treatment and antiplatelet therapy. After going 
through the hyper-acute phase and acute phase of stroke, the subject enters the sub-acute 
phase and chronic phase of brain ischemia when signs of recovery in neurological 
functions are evident. Usually, 95% of the subjects will reach their optimal recovery by 
the third month (Jorgensen et al., 1995). The goals of pharmacological interventions in 
these phases are to prevent a recurrence of similar ischemic insult thus differ much in 
intentions as opposed to the acute phase. However the pharmacological interventions are 
commonly combined with implementation of physical rehabilitation such as physical, 
occupational, and speech therapy to improve neurological function. This comprehensive 
program is to help a person to attain as close as possible to a pre-stroke level of 
functioning allowing independence for the activities of daily routine (Dobkin, 2004). 
 
1.14 Pharmacological Intervention in Acute Phase of MCAo 
 
3-Aminobenzamide (3-AB), a poly (ADP-ribose) polymerase (PARP) inhibitor, has been 
shown to be effective in reducing neuronal death in cortical cultures and infarct size 
following MCAo in rats (Ding et al., 2001). However another study showed that PARP 
inhibition had increased caspase-3-like activity (Cole and Perez-Polo, 2002) which 




In the apoptotic penumbra, caspases play an essential role in apoptosis (Cohen, 1997; 
Nicholson and Thornberry, 1997). Though three major apoptotic pathways have been 
proposed (mitochondrial, death receptors mediated and endoplasmic reticulum (ER) 
initiated pathways) (Danial and Korsmeyer, 2004), all these mechanisms converge to 
caspase-3 activation and nuclear fragmentation as the final step. 
 
All caspases are synthesized as proenzymes activated by proteolytic cleavage at Asp-X 
sites and contain a conserved pentapeptide QACXG sequence. Caspases are essential for 
apoptosis to proceed (Cohen, 1997; Nicholson and Thornberry, 1997). Among the family 
of capases, caspase-3 holds a pivotal position in the downstream of the cascade pathway. 
Caspase-3 is activated via the proteolytic processing of its inactive zymogen into 
activated p17 and p12 subunits. 
 
PARP is a DNA repair enzyme, a substrate of caspase-3 as well, is primarily activated by 
DNA strand breaks. Berger et al. (1986) proposed a “suicide” concept whereby PARP 
overactivation occurs when there is massive level of DNA damage, leads to cellular ATP 
depletion, is implicated for participation in DNA damage-induced necrotic 
Carbobenzoxy-Val-Ala-Asp-fluoromethylketone (z-VAD-fmk) a broad spectrum 
irreversible caspase inhibitor can modulate apoptotic cell death. In some cell lines, 
caspase inhibition has been shown to increase cell survival (Endres et al., 1998), whereas 





other cells show an increased level of death by switching the mode of death to necrosis 
(Lemaire et al., 1998; Vercammen et al., 1998; Ruemmele et al., 1999). Thus caspase 
inhibition may not prevent cell death, instead induce a switch from apoptosis to necrosis.  
 
Traces of apoptosis have been observed in the pro-necrotic core of MCAo animals (Choi, 
1996; Guegan and Sola, 2000). This has led to the controversial theory that cell death 
advances via a number of hybrid pathways among a continuum between the two extremes 
(Roy and Sapolsky, 1999) called aponecrosis or necrapoptosis (Formigli et al., 2000). The 
cellular energy producing factory, the mitochondria, is now increasingly being implicated 
in the cell’s decision to live or die (Murphy et al., 1999) and may even influence the 
mode of cell death chosen (i.e. apoptosis or necrosis), depending on their functional state 
(Tsujimoto, 1997). Leist et al. (1997) have shown in their experiment that ATP level is a 
determinant of cell death by apoptosis or necrosis. 
 
Attempts in using pan-caspase inhibitor, z-VAD-fmk, has been explored and shown 
promising results in reducing infarct size when administered into ischemic rodents 
(Endres et al., 1998), but caspase inactivation has also been proposed to be crucial for the 
switch mechanism from apoptosis to necrosis (Melino et al., 1997; Lemaire et al., 1998). 
While another group in a separate study successfully employed 3-AB, a PARP enzyme 
inhibitor in reducing the brain injury volume (Cole and Perez-Polo, 2002) using rat 
pheochromocytoma PC12 cells subjected to H2O2 injury. However, blocking the 
depletion of both NAD+ and ATP by PARP allow energy-dependent apoptosis to occur 
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(Berger et al., 1986). Currently there is no report on brain ischemia using MCAo rodent 
model with concomitant dosages of pan-caspase inhibitor and PARP inhibitor with 
reference to ATP availability. 
 
1.15 Effects of Pre- and Post-ischemic Exercise as Physical Rehabilitation in 
Brain Ischemia 
 
The lead time from ischemic injury to cognitive and functional recovery requires a 
prolonged course of interventions; however the current pharmacological intervention has 
only a short therapeutic window within the hyper-acute and acute phase of stroke onset. 
Therefore, rehabilitation through physical therapy forms a complementary long-term 
program for stroke management into the latter phases of stroke. 
 
More recently, both human and animal studies have shown that exercises can also 
produce beneficial effects endogenously necessary to maintain a healthy and functional 
ageing brain (Larson et al., 2006; Cotman et al., 2007). These broad spectrums of positive 
effects were outcomes of induced neurogenesis (Pereira et al., 2007) and reduced 
neurodegenerative processes (Ang et al., 2004) sustained by increased cerebral blood 
volume (CBV) (Pereira et al., 2007) to meet the increased demand in cellular metabolism. 
Studies have shown forced treadmill exercise may ameliorate neurologic impairment by 
impeding neuronal loss, through suppression of the ischemia-induced increases in 
apoptosis following various brain insults. These studies suggest the possibility that 
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treadmill exercise aids the recovery from CNS sequelae following stroke (Ang et al., 
2003; Sim et al., 2005). Although it has been demonstrated that exercise training has an 
anti-apoptotic effect on post ischemic brain tissues, the mechanisms responsible for this 
effect are still largely unclear. 
 
Previously it was shown that pre-ischemic forced treadmill exercise has neuroprotective 
effect and reduced infarct volume in rats following MCAo. At the molecular level, 
reverse transcription polymerase chain reaction revealed that the treadmill exercise prior 
to MCAo increased gene expression for nerve growth factor (NGF). In addition, treadmill 
exercise showed a significantly higher number of cholinergic neurons, which 
constitutively expressed p75, in the horizontal diagonal band of Broca (HDB). The 
findings suggested that neuroprotection after physical exercise may be a result of an 
increase in an endogenous neurotrophic factor, NGF and the proliferation of its receptive 
cholinergic neurons (Ang et al., 2003). In another study, forced treadmill exercise 
preconditioning was shown to induce angiogenesis with newly established microvessel 
bed that could increase neuronal tolerance to ischemic insults with an adequate blood 
flow into the area during reperfusion and possibly establishing a collateral circulation 
(Ding et al., 2004). 
 
At the other end of the spectrum with more clinical relevance, post-ischemic exercise 
study has shown forced treadmill exercise to significantly suppress the ischemia-induced 
caspase-3 expression and terminal deoxynucleotidyl transferase dUTP nick end labeling 
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(TUNEL) positive cells in gerbils. And in the same experiment, ischemia-induced 
short-term memory impairment was improved following the exercise regime (Sim et al., 
2005). However, there is no consensus in data concerning effects of exercise on cerebral 
ischemia in both humans and animals studies. These dissimilarities may be due to the 
differences in severity of insults and the distinct types and intensities of physical activities 
protocols being endorsed (Risedal et al., 1999; Ramsden et al., 2003). Currently, there is 
no data that look at the effects of post-ischemic exercises on the expression of 
antioxidants such as Cu/ZnSOD, GPx1 and catalase, and growth factors such as TGF-β1, 
EPO and PDGF which influence apoptosis, erythropoiesis and angiogenesis following 
brain ischemia. 
 
1.16 Aims and Scope of the Project 
 
The objectives of this study are to employ the well established MCAo rodent model 
(Longa et al., 1989) to study the effects of pharmacological intervention in the acute 
phase of stroke and the effects of post-ischemic exercise in the chronic phase of stroke. 
 
1.16.1 Pharmacological intervention in the acute phase of stroke 
 
Pharmacological interventions during the early phase (hyper-acute phase and acute phase) 
are usually administered within a therapeutic window of three hours upon confirmed 
non-hemorrhagic stroke onset (Clark and Madden, 2009). Currently, only rt-PA for 
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thrombolytic treatment and antiplatelet therapy are approved intravenous medications for 
the goals of arterial thrombus degradation and restoration of vessel patency and blood 
flow to improve clinical prognosis. In numerous publications on the topic of preventing 
cell damage or death following experimental hypoxia or ischemia, both pan-caspase 
inhibitor (z-VAD-fmk) and non-selective PARP inhibitor (3-AB) have showed potential 
in provision of alternative remedy in addition to the traditional thrombolytic treatment. As 
stroke presents a multi-pathway cell death mode which lead to infarcted brain, therapy of 
brain ischemic may not have to be restricted to single indication. However, there is no 
data at present looking at the effects of combinatorial treatment on experimental MCAo 
with combined administration of z-VAD-fmk and 3-AB. Thus,  
 
“Hypothesis 1 states that combined inhibitors administration of both z-VAD-fmk and 
3-AB can yield better outcome with bigger infarct volume reduction in comparison with 
single inhibitor administration following acute phase of experimental MCAo.” 
 
To prove the hypothesis 1, the study aims to 
1) compare the effects of single and combined inhibitors administration of both 
pan-caspase inhibitor, z-VAD-fmk and non-selective PARP inhibitor, 3-AB in the infarct 
volume reduction post-MCAo,  
2) ascertain the possible benefit of combined inhibitors treatment up to 24hr after MCAo,  




1.16.2 Post-ischemic exercise in the chronic phase of stroke 
 
As the recovery from stroke require an extended duration therefore a long term 
management plan, physiotherapy has often been prescribed as a complementary 
therapeutic program in addition to pharmacological remedy. Lee and coworkers (Lee et 
al., 2006) have shown that under pathological conditions, increased physical exercises can 
reduce expression of activated caspase-3 that is pivotal in apoptotic mechanism. 
Moreover, various studies have shown that increased physical activities can up-regulate 
endogenous neurotrophic factors with functions that have been known to be able to 
decrease caspase-3 activation (Wu et al., 2008; Nguyen et al., 2009; Stranahan et al., 
2009). In order to reinstate orders subsequent to brain ischemia, the program must be able 
to reduce apoptosis and enhance angiogenesis which in turn will create a favorable 
environment for neurogenesis. However, at present there is no data looking at the overall 
effects of eight weeks of moderate post-ischemic exercise on mediation of apoptosis and 
angiogenic potential via TGF-β1-signaling, VEGF/PDGF system, EPO/EPOR system and 
antioxidant enzyme activities. Thus, 
 
“Hypothesis 2 states that eight weeks of moderate post-ischemic exercises increase 
anti-apoptotic activities of TGF-β1-signaling” 
To prove hypothesis 2, the study aims to 
1) determine the effects of eight weeks of moderate exercise on: 
a. TGF-β1 and smad7 expression in both hippocampus and cortex. 
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b. correlation between changes in TGF-β signaling and apoptotic 
markers/TUNEL in both hippocampus and cortex. 
2) ascertain the effects of eight weeks of moderate post-ischemic exercise on:  
a. TGF-β1 and smad7 expression in ischemic cortex. 
b. correlation between changes in TGF-β signaling and apoptotic 
markers/TUNEL in ischemic cortex. 
 
“Hypothesis 3 states that eight weeks of moderate exercises increase angiogenesis in 
non-ischemia and ischemia via VEGF/PDGF system” 
To prove hypothesis 3, the study aims to 
1) determine the effects of eight weeks of moderate exercise on HIF-1α, VEGF, 
VEGFRB, PDGFB and PDGFRB expression in both hippocampus and cortex. 
2) ascertain the effects of eight weeks of moderate post-ischemic exercise on expression 
of HIF-1α, VEGF, VEGFRB, PDGFB, PDGFRB and angiogenesis in ischemic cortex. 
 
“Hypothesis 4 states that eight weeks of moderate post-ischemic exercises increase 
erythropoetic potential via EPO/EPOR system” 
To prove hypothesis 4, the study aims to 
1) determine the effects of eight weeks of moderate exercise on EPO and EPOR 
expression in both hippocampus and cortex. 
2) ascertain the effects of eight weeks of moderate post-ischemic exercise on EPO and 
EPOR in ischemic cortex. 
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“Hypothesis 5 states that eight weeks of moderate post-ischemic exercises reduce 
secondary damages by moderating antioxidant enzyme activities” 
To prove hypothesis 5, the study aims to 
1) determine the effects of eight weeks of moderate exercise on enzyme activities of 
Cu/ZnSOD, GPx1 and catalase in both hippocampus and cortex. 
2) ascertain the effects of eight weeks of moderate post-ischemic exercise on enzyme 
















2.1  Animals 
 
One hundred and fifty eight male Sprague-Dawley rats (200 to 250g approximately 6 
weeks old) obtained from the University Laboratory Animal Centre were used in the 
study. All experiments were carried out in accordance with the guidelines set by the 
Institutional Animal Care and Use Committee (IACUC), National University of 
Singapore (NUS) and all efforts were made to minimize the number of rats used and their 
suffering. Animals were age-matched and divided into various groups for the different 
purposes in both early and late phases of experimental MCAo. All the rats were housed in 
individual cages in order to fulfill strict solitary confinement requirement. This was to 
minimize other possible confounding factors such as environmental and social interaction 
influences. 
 
2.1.1 Acute phase grouping 
 
In this experiment, the study was sub-divided into two phases. For the first phase of the 
study, the rodents were randomly divided into four groups (n=10): a) sham group, b) 
untreated MCAo control group, c) pan-caspase inhibitor group and d) PARP inhibitor 
group. The untreated MCAo control group was administered intraperitoneally with saline 
30min post-MCAo. The rats were administered intraperitoneally with 1mg/kg, 3mg/kg 
and 5mg/kg z-VAD-fmk (#V-116, Sigma, St Louis, MO, USA) 30min post-MCAo for 
the pan-caspase inhibitor group. Intraperitoneal injection of 10mg/kg, 30mg/kg and 
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50mg/kg 3-AB (#A0788, Sigma, St Louis, MO, USA) were given 30min post-MCAo for 
the PARP inhibitor group. Rats were euthanized 48hr following MCAo. For the second 
phase combined inhibitors treatment study, the concentration of pan-caspase inhibitor and 
PARP inhibitor used in combination were based on the dosages that yielded the highest 
infarct size reduction from the earlier study. Temporal profile of pharmacological 
intervention at 30min, 6hr, and 24hr post-MCAo were analyzed. The rats were sacrificed 
at 48hr post-MCAo. These timings were selected based on the activities of PARP, 
caspase-8 and caspase-3 following permanent MCAo (LaPlaca, 1999; Velier et al., 1999; 
Harrison et al., 2001). 
 
2.1.2 Chronic phase grouping 
 
In this experiment, the rats were randomly assigned to four individual groups: a) sham 
group, b) sham-runner group, c) MCAo group, and d) MCAo-runner group. The animals 
in both sham-runner group and MCAo-runner group are subjected to one week 
familiarization with the treadmill plus eight weeks of forced treadmill exercise following 
a one week interval post-surgery. The sham rats and MCAo rats were exposed to the same 
set up daily for the duration that the runners were trained on the treadmill. Earlier studies 
had shown that rats subjected to moderate post-ischemic exercise are able to achieve 





2.2  Surgical Procedure 
 
Animals were anesthetized with 0.2ml/100g cocktail of ketamine and xylazine (75 mg/kg 
+ 10 mg/kg) mixture before surgery or sacrifice. The femoral artery was cannulated for 
monitoring of blood pressure (ML 785 Powerlab 8SP, ADInstrument, AOC, USA) and 
rectal temperature (Homeothermic Blanket System, Harvard Apparatus Inc., MA, USA) 
was monitored and maintained at 37°C. MCAo was carried out as described by Longa et 
al. (1989) with modifications (Fig. 1). A ventral midline incision was made and the 
carotid arteries were exposed. The pterygopalatine artery (PPA) was identified and 
ligated. A 4/0 suture with the tip blunted by heating was inserted via a hole created on 
external carotid artery (ECA), with temporarily clipped common carotid artery (CCA), 
and then via the internal carotid artery (ICA) which continue till the junction of anterior 
and middle cerebral artery. The suture was left in the animal till sacrifice. For the 
sham-operated rats, no vessel occlusion was carried out after exposure of the arteries. 
Within a 24 hrs period after the MCAo procedure, the number of sham and MCAo rats 
that did not survive was recorded. 
 





(Adapted from Lourbopoulos et al. 2008) 
Fig. 1. Schematic diagram and photograph of intraluminal suture technique MCAo. 
Shown here is (A) an example of 4/0 polypropylene monofilament suture and (B) the 
operating field of the ventral midline incision with the carotid arteries exposed and ligated 






2.3   Neurological Evaluation and Weight Changes 
 
The individual weight and neurological status of the rats from the sham (n=4), 
sham-runner (n=4), MCAo (n=4) and MCAo-runner (n=4) rats were assessed weekly 
over a ten weeks period after the MCAo surgery using a scoring system detailed by 
Menzies and colleagues (1992). A scale of 0 to 4 was used to evaluate the rats after 
recovery from anesthesia (Table 1). The test consisted of the following steps: rats were 
held by the tail and the forelimbs posture was noted. Normal rats extended both forelimbs 
towards the floor and were given a score of 0. If the contralateral forelimb to the stroke 
side was noted to be flexed during suspension, the rat was given a score of 1. The rats 
were then placed on an absorbent surface and pulled by the tail. If there were signs that 
the contralateral forelimb grip was decreased, the rat was given a score of 2. The rats 
were then placed on the floor but still held by the tail. The rat that showed signs of 
moving towards the stroke side but could also move in other directions was given a score 
of 3. Rats that consistently moved in circles towards the stroke side were given a score of 
4. This neurological test was consecutively repeated three times for each rat and the 
highest score was recorded. 
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Table 1: Neurological examination score chart 
Description Score 
When suspended by the tail, both forelimbs of the rat extended 
symmetrically towards the floor. 
 
0 
The contralateral forelimb is consistently flexed towards the body.  
1 
Decreased grip of the contralateral forelimb when pulled by the tail. 
This is done on an absorbent surface. 
 
2 
Established a tendency to move in circles towards the paralytic side 
though they appear to have the abilities to move in all directions.  
 
3 
Consistently moves in circles towards the paralytic side.  
4 
(Adapted from Menzies et al., 1992) 
 
2.4  Infarct Size Analysis 
 
The rats for the acute phase experiment were reanesthesized with ketamine + xylazine 
mixture and decapitated. The brain were removed and then coronally sectioned into slices 
with 1mm thickness using a brain matrix (Harvard Apparatus Inc., MA, USA). The brain 
slices were then incubated with 0.1% solution of 2,3,5-triphenyltetrazolium chloride 
(TTC) (Sigma, catalog number T4375) at 37°C for 30min, and then fixed by immersion 
in 4% paraformaldehyde. TTC stains viable brain tissue purple and, while infarcted tissue 
36 
 
remains unstained (Fig. 2). The TTC stained brain slices were photographed and the 
digitized images of infarct area were analyzed and quantified using an image processing 
software package (Scion Image for Windows, Version 4.0.2). The infarct volume were 
then calculated and corrected for edema based on a formula suggested by Swanson et al. 
(1990).  
 
True infarct volume = [right hemisphere area - (left hemisphere area - infarct area)] × 
thickness of the section  
 
Data were presented as mean ± SEM. Statistical comparisons are made with 
one-way analysis of variance (ANOVA), Newman-Keuls Multiple Comparison Test, 






Fig. 2. Brain sections with TTC staining. The MCAo models (n=4) revealed that areas of 
infarction were restricted only to the territories supplied by the left MCA. These infarcted 
regions were represented by the unstained tissue, while the unaffected areas were stained 
purple.  
(c - cortex and h - hippocampus) 
 















2.5  Intracellular ATP Level Determination 
 
The cellular ATP levels of the rats for the acute phase experiment were quantified using a 
luciferin/luciferase-based assay. The whole brain was removed to create a tissue 
suspension and tissues were lysed with ATP releasing buffer (Sigma). ATP content was 
measured with ATP assay kit (#119108 ATP Assay Kit, Calbiochem, CA, USA) and a 
luminometer (BD Monolight™ 3096 Microplate Luminometer) according to 
manufacturer’s instruction manual. 
 
2.6  Treadmill Exercise 
 
After surgery, the sham-operated or MCAo rats for the chronic phase experiment were 
randomly assigned to either non-runner or runner group and were given a week of resting 
period before being placed in initial exercise regime, which was designed to allow the 
animals to be familiarize with the treadmill machine (Panlab S.L., LE 8710R, Barcelona, 
Spain) (Fig. 3). In the week of familiarization, the rats began with 10min of running at the 
speed of 15cm/sec at 0 degree inclination and progressively increased to 30min session at 
the same speed, with daily increased duration of 5min interval (Table 2A). Subsequently 
the rats from the runner groups were being forced to run on a treadmill machine for 
45min, once a day, five days per week, for the following eight consecutive weeks. The 
exercise workload consisted of running at the speed 25cm/sec for the first 5min, 35cm/sec 
for the next 35min, and then back to 25cm/sec for the last 5min with 0 degree inclination 
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(Table 2B). Animals in the non-runner groups were left on the treadmill for 45min and 
were not made to run. A dose–response correlation between exercise duration/intensity 
and beneficial effects has been reported, whereby the best outcomes were associated with 
moderate exercise (Shen et al., 2001). Running distances covered in the present study 
were well above the threshold level of 500m/day which was considered as moderate 
exercise regime and reported to be needed for up-regulation of some key gene products 
believed to mediate effects of exercise on the brain (Shen et al., 2001). All the runners 




Table 2A: Treadmill exercise familiarization program 
Week 0 Speed (cm/s) Duration (min) 
Day 1 15 10 
Day 2 15 15 
Day 3 15 20 
Day 4 15 25 
Day 5 15 30 
 
Table 2B: Treadmill moderate exercise regime 
Week 1 to 8 Speed (cm/sec) Duration (min) 
Day 1 25    35    25 5    35    5 
Day 2 25    35    25 5    35    5 
Day 3 25    35    25 5    35    5 
Day 4 25    35    25 5    35    5 






Fig. 3. Photographs showing the five lanes motorized treadmill. This treadmill adapted 
for adult rats was used in the experiment. Note the metal grid at the rear end (green 
arrow) of the treadmill served to enforce running with adjustable strength of electric 
shock. 
 
2.7  Real Time-Polymerase Chain Reaction (RT-PCR)  
 
The ipsilateral and contralateral cortices and hippocampi were harvested from rats ten 
weeks after the onset of global ischemia and allowed wash-out period two days after 
completion of the last treadmill exercise. RNA was extracted from the snap-frozen tissue 
using RNeasy Lipid Tissue Midi Kit (Qiagen, GmbH, Germany). The total RNA was 
quantified with ND-1000 spectrophotometer (Nanodrop, Fisher Thermo, Wilmingyon, 
DE, USA). For reverse transcription, 1μg of RNA was incubated at 70°C for 10min. 
Single-stranded cDNA was synthesized from the RNA by adding reaction mixture 
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containing 4μl of MgCl2 (24mM), 2μl of reverse transcriptase 10X buffer, 2μl of dNTP 
mixture (10mM), 0.5μl of Recominabant RNasin® inhibitor, 15U of AMV reverse 
transcriptase (high concentration), 0.5μg of Oligo (dT)15 primers, 1μg of RNA and 
nuclease free water (Promega, Madison, WI, USA) in total volume of 20μl. The reaction 
mixture was incubated for 1hr at 42°C and the reaction was terminated by heating for 
5min at 95°C. Finally, reaction mixture was incubated at 0°C. The samples were store at 
-20°C for subsequent PCR analysis. Quantitative real time-PCR was carried out on a 
Light Cycler 2.0 instrument (Roche Diagnostics, Indianapolis, IN) using QuantiTect® 
SYBR® Green RT-PCR kit (Qiagen, Valencia, CA, USA) according to the 
manufacturer’s instructions. An aliquot of 1μl of the reverse transcription products 
(cDNA) was added to the reaction mixture of 10μl containing RNase free water and 
SYBR Green. Reaction mixture was pre-incubated at 85°C for 10min, PCR was 
completed with 50 cycles of denaturation at 95°C for 15sec, annealing at 63°C for 10sec 
and elongation at 72°C for PCR product size per 25sec. Specific forward and reverese 
primers and amplicon size for each gene are provided in Table 3. β-actin was adopted as 
the internal control and for normalizing the quantities in each sample. Gene expression 
was quantified using 2-ˆˆct method. Data were analyzed by unpaired t-test or One Way 
ANOVA Tukey’s test was presented as mean ± standard errors. Statistical significance is 
accepted at P<0.05. 
(Refer to Appendix 3 for essential reagents used for quantitative real time PCR) 
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Table 3: List of primer sequences 







TGF-b1 TGG ACC GCA ACA ACG 
CCA TCT ATG AGA AAA 
CC 
TGG AGC TGA AGC AAT 
AGT TGG TAT CCA GGG 
CT 
426 
CTG TCT GTG GAT GAC 
CTG GC 
TGFBR-II CTG GTG GTT GAG CCA 
GAA GC 
303 
Smad2 AAA ATG TCG TCC ATC 
TGC C 
GAG CTC ATG ATG GTC 
GTG AA 
431 
Smad7 ATG DTG TGC CTT CCT 
CCG CT 
CGT CCA CGG CTG CTG 
CAT AA 
494 
HIF-1α TCA AGT CAG CAA CGT 
GGA AG 
TAT CGA GGC TGT GTC 
GAC TG 
198 
VEGF CGG GCC CAC CAG CTC 
TGA ACA 
GGG CGG CTG CTC CAA 
GGT CA 
121 
VEGFR2 ATT TGG CAC CAC ACT 
TTC TAC 
TCA CGC ACG ATT TCC 
CTC TCA G 
379 
PDGFB CTG CCT CTC TGC TGC 
TAC CT 
GAT GAG CTT TCC GAC 
TCG AC 
206 
PDGFRB TGT TCG TGC TAT TGC 
TCC TG 
TCA GCA CAC TGG AGA 
AGG TG 
201 
EPO GAT CGC CCG GCT AGA 
GGA AAA AG 
TCG CAA CCC AGT CCA 
TCT TGT GT 
305 
EPOR CTG GTG GAC AAC ATC 
GCT CTG 
GGT CTG CTG ACC TCA 
CTT GTG 
226 
β-actin GTA TGT CGT GGA GTC 
TAC TGG 
CAT CAT ACT TGG CAG 




2.8  Western Blot Analysis 
 
For Western blotting, the ipsilateral and contralateral cortices and hippocampi were 
harvested from rats ten weeks after the onset of global ischemia and allowed wash-out 
period two days after completion of the last treadmill exercise. The specimens were 
homogenised in 1X RIPA lysis buffer with complete protease inhibitor cocktail (Santa 
Cruz Biotechnology Inc., CA, USA). The protein concentrations were determined by 
BCA (bicinchoninic acid) protein assay kit (Pierce, Thermo Scientific, IL, USA). 75μg of 
each sample homogenate was loaded onto a 10%, 12% or 15% SDS-PAGE gel and 
separated using Mini Protein II apparatus (Bio-Rad, CA, USA) for about 2hr at 100V. 
Proteins were subsequently electroblotted onto a PVDF membrane (Bio-Rad 
Laboratories) for 50min at 23V. The membrane was then blocked for one hour at room 
temperature with 5% dried milk in PBS with 1% Tween 20 (PBST), followed by 
overnight incubation with primary antibody at 4°C. The primary antibodies used were 
listed in table 4. After washing with PBST for three times (15min each time), the 
membrane was incubated with appropriate species-specific horseradish 
peroxidase-conjugated secondary antibody: goat anti-rabbit immunoglobulin G (sc-2004, 
1:1000; Santa Cruz Biotechnology Inc., CA, USA) or goat anti-mouse immunoglobulin G 
(sc-2005, 1:1000; Santa Cruz Biotechnology Inc., CA, USA). The membrane was then 
washed with PBST for three times (15min each time). Protein expression was detected 
with an enhanced chemiluminescence detection system (ECL+Plus; Amersham 
Pharmacia Biotech, Piscataway, NJ). Protein bands were quantified by densitometry 
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method and ImageQuant™ 350 (GE Healthcare UK Limited, Bucks, UK). All samples 
were normalized against the same value of expression for the housekeeping β-actin.  
 
The data were presented as relative expression, with sham-operated brain. Data were 
analyzed by unpaired t-test or One Way ANOVA Tukey’s test was presented as mean ± 
standard errors. Statistical significance is accepted at P<0.05 
 
















Table 4: List of primary antibodies and dilution factor 
Antibodies Dilution Manufacturer 
TGF-β1 1:2000 #3709 rabbit polyclonal antibody; Cell Signaling 
Technology Inc., MA, USA 
smad7 1:500 sc-11392 rabbit polyclonal antibody; Santa Cruz 
Biotechnology Inc., CA, USA 
Cleaved 
Caspase 3 
1:1000 #9661 rabbit polyclonal antibody; Cell Signaling 
Technology Inc., MA, USA 
PARP 1:1000 #9542 rabbit polyclonal antibody; Cell Signaling 
Technology Inc., MA, USA 
HIF-1α 1:1000 #3716 rabbit polyclonal antibody; Cell Signaling 
Technology Inc., MA, USA 
PDGF 1:1000 ab53716 rabbit polyclonal antibody; Abcam Inc., MA, USA 
EPO 1:500 sc-7956 rabbit polyclonal antibody; Santa Cruz 
Biotechnology Inc., CA, USA 
EPOR 1:1000 sc-697 rabbit polyclonal antibody; Santa Cruz 
Biotechnology Inc., CA, USA 
Cu/ZnSOD 1:250 ab13498 rabbit polyclonal antibody; Abcam Inc., MA, USA 
Catalase 1:1000 ab1877 rabbit polyclonal antibody; Abcam Inc., MA, USA 
GPx1 1:1000 ab59546 rabbit polyclonal antibody; Abcam Inc., MA, USA 
β-actin 1:1000 A5316 mouse monoclonal antibody (clone 74); 








2.9 Immunohistochemistry and Double Staining 
 
Rats from the four groups (sham, sham-runner, MCAo, and MCAo-runner) were 
anesthetized using ketamine + xylazine mixture. Transcardial perfusion was performed 
with Ringer’s solution (200 ml) and then 4% paraformaldehyde in 0.1M phosphate buffer 
(PB; pH 7.4; 200–300ml). Subsequently, the brain was removed, post fixed in the same 
fixative for an additional 4hr at 4°C, and then cryoprotected in 0.1M PB containing 15% 
sucrose overnight at 4°C. The brain was embedded in Lipshaw M-1 embedding matrix 
and treated with liquid nitrogen. Every fifth frozen section of 30μm, 2mm from the 
frontal pole was harvested and mounted onto gelatinized slides. Tissue sections were then 
washed three times (10min for each time) with PBS and blocked with 5% normal goat 
serum for 1hr to minimize nonspecific adsorption. The sections were then incubated with 
primary antibody such as anti-TGF-β1 (V) rabbit polyclonal antibody (sc146) (Santa Cruz 
Biotechnology Inc., CA, USA) (1:100), anti-Smad7 (H-79) rabbit polyclonal antibody 
(sc11392) (Santa Cruz Biotechnology Inc., CA, USA) (1:100), anti-Pecam-1 rabbit 
polyclonal antibody (sc-18892) (Santa Cruz Biotechnology Inc., CA, USA) (1:200), 
anti-EPO rabbit polyclonal antibody (sc-7956) (Santa Cruz Biotechnology Inc., CA, 
USA) (1:200) or anti-EPOR rabbit polyclonal antibody (sc-697) (Santa Cruz 
Biotechnology Inc., CA, USA) (1:200). All the sections incubated with various primary 
antibody listed above, with the exception of anti-Pecam-1 sections, were also 
co-incubated with anti-NeuN mouse monoclonal antibody (MAB377) [Chemicon 
(Millipore), MA, USA] (1:100) overnight at room temperature (25°C). Sections were then 
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washed three times (10min each time) with PBS and incubated with species-specific 
fluorescein labeled secondary antibodies: goat anti-rabbit immunoglobulin (IgG) Cy3 
conjugate (AP132C ) [Chemicon (Millipore), MA, USA] (1:200) and goat anti-mouse 
IgG, F(ab')2, FITC conjugate (AQ303F ) [Chemicon (Millipore), MA, USA] (1:200) for 
1hr at room temperature. After washing three times (10min for each time) with PBS, the 
slides were mounted and visualized by confocal microscopy (Olympus FV1000 inverted 
microscope IX81). 
 
(Refer to Appendix 5 for essential reagents used for immunohistochemistry) 
 
2.10 TUNEL Staining 
 
Rats from the four groups (sham, sham-runner, MCAo, and MCAo-runner) were 
anesthetized using ketamine + xylazine mixture. Transcardial perfusion was performed 
with Ringer’s solution (200 ml) and then 4% paraformaldehyde in 0.1M phosphate buffer 
(PB; pH 7.4; 200–300ml). Subsequently, the brain was removed, postfixed in the same 
fixative for an additional 4hr at 4°C, and then cryoprotected in 0.1M PB containing 15% 
sucrose overnight at 4°C. The brain was embedded in Lipshaw M-1 embedding matrix 
and treated with liquid nitrogen. Every fifth frozen section of 30μm, 2mm from the 
frontal pole was harvested and mounted onto gelatinized slides. Tissue sections were 
pretreated with 0.1% Triton X-100 in 0.1% sodium citrate for 2min on ice. The sections 
were then washed three times (10min each time) with PBS and incubated with anti-NeuN 
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mouse monoclonal antibody (MAB377) [Chemicon (Millipore), MA, USA] (1:100) 
overnight at room temperature (25°C). Sections were then washed three times (10min 
each time) with PBS and incubated with species-specific fluorescein labeled secondary 
antibodies: goat anti-mouse immunoglobulin IgG, Cy3 conjugate (AP124C) [Chemicon 
(Millipore), MA, USA] (1:200) for 1hr at room temperature. The sections were then 
washed three times (10min each time) with PBS and incubated with TUNEL reaction 
mixture from the in situ cell death detection kit [Roche Diagnostics Corporation (Roche 
Applied Science), IN, USA] that contains TdT and fluorescein-dUTP for 60min at 37°C 
in a humidified chamber in the dark. Subsequently, the tissue sections were washed three 
times (10min each time) with PBS before the cover slips were mounted. The label 
incorporated at the damaged sites of the DNA was visualized by confocal microscopy 
(Olympus FV1000 inverted microscope IX81). 
 
2.11 Statistical Analysis 
 
Data were presented as mean ± SEM. Statistical comparisons were made with upaired 
t-test and one-way ANOVA (Newman-Keuls/Tukey's Multiple Comparison Test) where 




Experimental markers assessed and quantified in this thesis are summarized in Table 5. 
Table 5: Summary of experimental markers addressed and quantified 
Acute phase of MCAo: Effects of combined treatment versus single modality with pan-caspase and PARP 
inhibitors 
 Inhibitor administration following  
Marker assessed 30min p.s. 6hr p.s. 24hr p.s.    
Infarct size z-VAD-fmk 
3-AB 
Combined 
Combined Combined    
ATP level z-VAD-fmk 
3-AB 
Combined 
Combined Combined    





WB, Combined WB, Combined    
 
Chronic phase of MCAo: Effects of post-ischemic exercises, ten weeks post-surgery 
Marker assessed Hippocampus Cortex 
TGF-β1 RT-PCR WB IHC (CA1, DG) RT-PCR WB IHC 
TGFBR-II RT-PCR   RT-PCR   
Smad7 RT-PCR WB IHC (CA1, DG) RT-PCR WB IHC 
Smad2 RT-PCR   RT-PCR   
Caspase-3 activation/ PARP 
cleavage 
    WB  
TUNEL      IHC 
       
HIF-1α RT-PCR WB  RT-PCR WB  
VEGF RT-PCR   RT-PCR   
VEGFR2 RT-PCR   RT-PCR   
PDGFB RT-PCR WB  RT-PCR WB  
PDGFRB RT-PCR   RT-PCR   
Pecam-1      IHC 
       
EPO  WB IHC (CA1, DG)  WB IHC 
EPOR  WB IHC (CA1, DG)  WB IHC 
       
Cu/Zn-SOD  WB   WB  
Catalase  WB   WB  
GPx1  WB   WB  
p.s., post-surgery; RT-PCR, Real Time Polymerase Chain Reaction; WB, Western Blot; ICH, Immunohistochemistry; 

























3.1  Effects of Pharmacological Intervention in Acute Phase of MCAo 
 
3.1.1  Effects of pan-caspase inhibition on infarct size 
 
To determine the optimized z-VAD-fmk concentration that showed the maximum infarct 
size reduction administered at 30min post-MCAo, rats were divided into three groups, 
receiving different concentration (1mg/kg, 3mg/kg and 5mg/kg) for the study. Fig. 4 
showed that of the three groups, rats injected with 1mg/kg (35.78% ± 1.95%) and 3mg/kg 
(24.13% ± 3.89%) z-VAD-fmk showed statistically significant reduction in the infarct 
size following MCAo. Whereas 5mg/kg (39.80% ± 2.69%) z-VAD-fmk group did not 







Fig. 4. Infarct size reduction following single inhibitor administration of pan-caspase 
inhibitor (z-VAD-fmk). Reduction of infarct sizes with single modality pan-caspase 
inhibitor (z-VAD-fmk) treatment following 48hr MCAo. Each group of animals (n=4) 
was treated with different doses of z-VAD-fmk, while the untreated control group was 
given saline. The infarct sizes were determined by TTC staining. Data were analysed by 











3.1.2  Effects of PARP inhibition on infarct size 
 
The 3-AB treated rats were also divided into three groups administered with either 
10mg/kg, 30mg/kg or 50mg/kg 30min post-MCAo. Only animals treated with 30mg/kg 
(26.98% ± 2.22%) 3-AB showed statistically significant reduction in the infarct size 
following MCAo (Fig. 5). The animals treated with 10mg/kg (39.99% ± 1.15%) and 
50mg/kg (38.14% ± 3.70%) 3-AB did not show significant reduction as compared with 






Fig. 5. Infarct size reduction following single inhibitor administration of PARP inhibitor 
(3-AB). Reduction of infarct sizes with single modality PARP inhibitor (3-AB) treatment 
following 48hr MCAo. Each group of animals (n=4) was treated with different doses of 
3-AB, while the untreated control group was given saline. The infarct sizes were 
determined by TTC staining. The infarct sizes were determined by TTC staining. Data 





3.1.3 Effects and temporal profile of combined inhibitors treatment on infarct 
size 
 
In the second phase of the study, most efficacious dosages of both pan-caspase and PARP 
inhibitors (3mg/kg z-VAD-fmk and 30mg/kg 3-AB) were used in the combined inhibitors 
treatment group after the MCAo. Fig. 6 showed that the concomitant administration of 
both inhibitors showed further reduction in the infarct size (7.228% ± 1.988%) at 30min 
post-MCAo as compared to brains of rats treated with specific inhibitor separately. The 
timing of the insult was prolonged from 30min to 6hr (21.02% ± 1.06%) and 24hr 
(24.40% ± 2,12%), before treatment intervention (Fig. 7). The combined inhibitors 







Fig. 6. Effects of single and combined inhibitors treatment on infarct size. Graph showing 
infarct sizes in ipsilateral brain, 48hr after MCAo in rats from various groups (n=4): 
untreated control; z-VAD-fmk; 3-AB; combined inhibitors treatment. The infarct sizes 
were determined by TTC staining and showed further reduction with combined inhibitors 
treatment. Data were analysed by One-way ANOVA, Newman-Keuls Multiple 






Fig. 7. Temporal profile of infarct sizes in rats with combined inhibitors treatment. Infarct 
sizes temporal profiles at 48hr after MCAo in rats treated with combined inhibitors 
(z-VAD-fmk and 3-AB) treatment (n=4). The infarct sizes were determined by TTC 
staining. Data were analysed by One-way ANOVA, Newman-Keuls Multiple 




3.1.4 Effects of pan-caspase and PARP inhibition on intracellular ATP level 
 
To quantify the intracellular ATP level, 33 rats were randomly divided into the following 
groups: sham-operated; untreated control; pan-caspase inhibitor (with the three varying 
dosages); PARP inhibitor (with the three varying dosages) and the combined inhibitors 
treatment (with three different time profiles) groups. They were used to analyze the 
intracellular ATP level in the lesioned cerebral cortex 48hr after MCAo. Fig. 8a showed 
that intracellular ATP level in sham-operated animals were measured at 1.01×10-2 ± 
9.87×10-4moles/mg, and the untreated control group were determined at 3.36×10-3 ± 
2.09×10-4moles/mg. Animals which received 1mg/kg (3.39×10-3 ± 1.23×10-4moles/mg), 
3mg/kg (3.94×10-3 ± 2.59×10-4moles/mg) and 5mg/kg (4.58×10-3 ± 7.97×10-4moles/mg) 
z-VAD-fmk did not raise the intracellular ATP level significantly. Rats administered with 
30mg/kg (7.56×10-3 ± 1.25×10-3moles/mg) and 50mg/kg (6.05×10-3 ± 
8.72×10-4moles/mg) of 3-AB were able to increase the intracellular ATP level 
significantly, but not the animal treated with 10mg/kg 3-AB (2.61×10-3 ± 
9.42×10-5moles/mg) (Fig. 8a). Fig. 8a further showed the temporal profile of the 
combinatorial administration of both inhibitors on the intracellular ATP level at 30min 
(5.21×10-3 ± 5.94×10-4moles/mg), 6hr (5.86×10-3 ± 5.67×10-4moles/mg) and 24hr 
(4.52×10-3 ± 2.72×10-4moles/mg). Combined inhibitors treated animals brought slight 
increase, though not statistically significant, in the intracellular ATP level as compared to 




The results showed that there were clear distinction between the sham-operated brain 
tissue and the saline controlled brain tissue intracellular ATP level. However, as depicted 
in Fig. 8b, only the animal treated with 3-AB, have shown that the intracellular ATP level 






Fig. 8a. Intracellular ATP level following single and combined inhibitors administration 
of pan-caspase inhibitor (z-VAD-fmk) and PARP inhibitor (3-AB). Intracellular ATP 
levels of lesioned cerebral cortices subjected to z-VAD-fmk, 3-AB and combined 
inhibitors treatments evaluated at 48hr following MCAo. Each group of rats (n=3) was 
treated with different doses of z-VAD-fmk and 3-AB, while the untreated control group 
was given 0.9% saline. Combined administration of z-VAD-fmk and 3-AB were given at 
different time intervals. Intracellular ATP level were determined using ATP assay kit and 
luminometer. Data were analysed by One-way ANOVA, Newman-Keuls Multiple 






Fig. 8b. Coefficient of determination for infarct size and intracellular ATP level for rats 
treated with 3-AB. Intracellular ATP level and size of infarct of brains (n=7) which were 
subjected to different doses of 3-AB measured at 48hr following MCAo. Linear 
regression analysis showed an inverse correlation between intracellular ATP level and 




3.1.5 Effects of pan-caspase and PARP inhibition on intracellular apoptotic 
markers 
 
Caspase-3 exists in cells as inactive 36kD proenzyme which are proteolytically cleaved 
into 19kD and 17kD fragment. PARP (116kD), a substrate for activated caspase-3, are 
cleaved into 89kD and 24kD fragments. Cleaved caspase-3 (active) and PARP cleavage 
are commonly used as apoptotic marker (Han et al., 2003). Fig. 9a to 9c show the protein 
expression changes in the lesioned cerebral cortices of rats with cleaved caspase-3 and 
PARP cleavage being absent in groups receiving 10mg/kg 3-AB, 3mg/kg z-VAD-fmk 
and 5mg/kg z-VAD-fmk treatments, while 30mg/kg, 50mg/kg 3-AB and 1mg/kg 
z-VAD-fmk treatments showed cleaved caspase-3 and PARP cleavage clearly. The 






Fig. 9a. Western blots of cleaved caspase-3 and cleaved PARP following MCAo. The 
various treatments were administered at 30min post-surgery unless otherwise stated as in 
the combined treatment groups. The lesioned cerebral cortices were excised for analysis 
48hr following MCAo. Western blot membranes were labeled with cleaved caspase-3 
antibody and cleaved PARP antibody, which were then developed with the ECL system. 







Fig. 9b. Western Blot analysis of PARP cleavage following MCAo. Each group of rats 
(n=3) was treated with different doses of 3-AB (PARP inhibitor), and control were given 
saline. Optimized doses of both inhibitors were administered concurrently in the 
combined inhibitors treatment group. 30 and 50mg/kg 3-AB and 1mg/kg z-VAD-fmk 
show cleaved caspase3 and PARP cleavage which suggests apoptosis process is present. 






Fig. 9c. Western Blot analysis of cleaved caspase-3 following MCAo. Each group of rats 
(n=3) is treated with different doses of z-VAD-fmk (pan caspase inhibitor), and control 
are given saline. Optimized doses of both inhibitors are administered concurrently in the 
combined inhibitors treatment group. 30 and 50mg/kg 3-AB and 1mg/kg z-VAD-fmk 
show cleaved caspase3 and PARP cleavage which suggests apoptosis process is present. 




3.2  Effects of Post-ischemic Exercise in Chronic Phase of MCAo 
 
3.2.1 Mortality rate  
 
Mortality rate within 24hr after surgery was 30% (12/36) for MCAO rats (consists of 
MCAo and MCAo-runner) and 0% (0/24) for the sham-operated rats (consists of sham 
and sham-runner) (Fig. 10). It was suggested by Venketasubramanian et al. (2005) that 
most of the death was due to the brain ischemia and not surgery.  
 













Fig. 10. Mortality rate within 24hr after sham-operation and experimental MCAo surgery. 
Mortality rate within 24hr after experimental MCAo surgery is 30% (12/36) for MCAo 
rats and 0% (0/24) for the sham-operated rats. It is apparent that the death is due to brain 




3.2.2 Estimation of path length run on the treadmill 
 
Both sham-runner rats and MCAo-runner rats were acclimatized to the treadmill machine 
(Panlab S.L., LE 8710R, Barcelona, Spain) progressively from 10 to 30min at the speed 
of 15cm/sec with 0 degree inclination, thus covered a total of 90 to 270m/day (Table 2A). 
Rats from the runner group were then subjected to the actual forced exercise program on 
the treadmill machine for 45min, once a day, five days per week, for eight consecutive 
weeks. The exercise workload consisted of running at the speed 25cm/sec for the first 
5min, 35cm/sec for the next 35min, and then back to 25cm/sec for the last 5min with 0 
degree inclination (Table 2B). The total distance covered at each session was 885m/day 
which was above the threshold of 500m/day indicated for any up-regulation of BDNF and 
activated cyclic adenosine monophosphate (cAMP) response element-binding protein 
(Shen et al., 2001). Both sham rats and MCAo rats were exposed to the same set-up with 
the treadmill turned off for the above duration thus did not cover any significant distance 




3.2.3 Weight changes 
 
The weights of all rats (n = 16) were observed to register a decline following surgery. The 
lost weights were presented in percentage instead of absolute value. One day 
post-operatively the weight changes were recorded with a drop of 5.57 ± 0.63%, 5.21 ± 
0.68%, 14.53 ± 1.07% and 13.97 ± 0.8% in sham, sham-runner, MCAo and 
MCAo-runner rats respectively (Fig. 11). Rats subjected to MCAo experienced weight 


































Fig. 11. Weight change (loss) 24hr post surgery. Weight change (loss) is evaluated with a 
reduction of 5.57 ± 0.63%, 5.21 ± 0.68%, 14.53 ± 1.07% and 13.97 ± 0.8% in sham, 
sham-runner, MCAo and MCAo-runner rats respectively. Weight loss is observed in all 
the groups, and the animal with MCAo registered higher weight loss. Data are analyzed 
with One-way ANOVA, Tukey's Multiple Comparison Test with ***p-value<0.001. 
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 week post-surgery, and without exception, all the rats 
registered weight gain across-the-board. The gained weights were presented in percentage. 
The weights gained were recorded as 121.8 ± 10.93%, 57.5 ± 8.45%, 124.7 ± 8.52% and 
68.34 ± 8.66% in sham, sham-runner, MCAo and MCAo-runner rats respectively (Fig. 
12). Interestingly, sham rats and MCAo rats, which were not subjected to forced treadmill 
exercise occlusion, experienced weight gain (in percentage) approximately 2.5 times 
more as compared to the rats which were subjected to forced treadmill exercise with 
p-value<0.001. However, no difference was seen between sedentary or runner groups 
regardless whether they were subjected to MCAo or sham-operations. 
 
 
Fig. 12. Weight change (gain) ten weeks post surgery. Sham, sham-runner, MCAo and 
MCAo-runner rats are observed with weight increased by 121.8 ± 10.93%, 57.5 ± 8.45%, 
124.7 ± 8.52% and 68.34 ± 8.66% respectively. The results show that exercise could 
reduce weight gain in animal with or without MCAo. Data are analyzed with One-way 
ANOVA, Tukey's Multiple Comparison Test with ***p-value<0.001. 
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3.2.4 Neurological scores 
 
All the rats were subjected to neurological evaluation following experimental MCAo for a 
total of ten weeks. The animals showed some signs of paralysis which included abnormal 
posture and hemiplegia and a reduction in spontaneous movements after MCAo. 
Typically, this was maximal during the 1
st 
week, and then gradually improved at varying 
degrees over the following nine weeks with or without any forced treadmill exercise. 
However, from 4th week onwards, MCAo-runner rats began to show some functional 
recovery, as reflected in the lower score, as compared the MCAo rats. And at the end of 
10th
Neurological Score for 10 weeks following MCAo























 week, the MCAo-runner rats showed distinct functional recovery in contrast with the 
MCAo rats (Fig. 13). 
 
 
Fig. 13. Neurological evaluation scores for MCAo (n=4) and MCAo-runner (n=4) rats ten 
weeks post-surgery (one week rest; one week treadmill familiarization; eight weeks 
moderate forced treadmill exercise). A lower score is indicative of better status for 
functional recovery. The data show that MCAo-runner rats can achieve a distinct 
improvement at week five as compared with the MCAo rats.
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3.2.5 TGF-β signaling in hippocampus 
 
All animals were sacrificed at ten weeks (included trainings and eight weeks of actual 
exercise regime) with two days wash-out period after the last run. 
 
3.2.5.1 Effects of exercise on TGF-β1, TGFBR-II, smad2 and smad7 mRNA and 
protein expression in hippocampus 
 
Following eight weeks of forced treadmill exercise, TGF-b1 and smad7 mRNA 
expressions were significantly increased by 1.40 ± 0.06 and 2.30 ± 0.45 fold respectively 
in the sham-runner rats as compared with the sham rats, p-value<0.05 (Fig. 14a and 
14d). TGFBR-II and smad2 mRNA expressions in the sham-runner rats flanked the 
mRNA expression levels in sham rats by 0.88 ± 0.08 and 1.35 ± 0.22 fold respectively 
following forced treadmill exercise, however, the changes were not statistically 




























































Fig. 14. mRNA expressions of TGF signaling in the hippocampus following eight weeks 
forced treadmill exercise. The brain homogenates are prepared from animals (n=4) 
sacrificed at ten weeks (whereby first two weeks are allocated for acclimatization and 
familiarization) and two days (as wash-out period for rats’ the last run). Changes in 
mRNA levels are evaluated by quantitative real-time PCR and the result show that forced 
exercise increases both (a) TGFb1 and (d) smad7 mRNAs by 1.40 ± 0.06 and 2.30 ± 0.45 
fold respectively in the sham-runner as compared with sham. However the exercise 
regime do not induce any significant changes to the (b) TGFBR2 and (c) smad2 mRNAs 
which are calculated at 0.88 ± 0.08 and 1.35 ± 0.22 fold respectively in the sham-runner. 
All data are analysed using unpaired t-test with *p-value<0.05. 
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Exposure to prolonged forced treadmill exercise produced increase in both TGF-β1 
and smad7 protein expression by 1.38 ± 0.05 and 1.54 ± 0.07 fold respectively in the 
sham-runner rats as compared with the sham rats, p-value<0.05 (Fig. 15a and 15b). 
However, this regimented exercise program did not register any significant change in 
both cleaved caspase-3 and cleaved PARP protein expression which was recorded at 0.99 
± 0.08 and 1.17 ± 0.10 fold respectively for the sham-runner rats as compared with the 




       
Fig. 15. Western blots and protein expressions of TGF signaling and capase-3 activity in 
the hippocampus following eight weeks forced treadmill exercise. The TGF-β1, smad7, 
cleaved caspase-3 and cleaved PARP antibodies detect the specific bands at 45kD, 51kD, 
17kD and 89kD respectively with β-actin (42kD) used for normalisation. Forced treadmill 
exercise increases both (a) TGF-β1 and (b) smad7 protein levels in the sham-runner by 
1.38 ± 0.05 and 1.54 ± 0.07 fold respectively as compared with the sham. These results 
suggest that forced exercise can have an effect on the hippocampal TGF signaling 
pathway. However, the experiment shows that forced exercise does not have any 
significant impact on caspase-dependent apoptosis. All data are analysed using unpaired 
t-test with *p-value<0.05. 
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3.2.5.2 Effects of exercise on TGF-β1 protein expression in the CA1 region 
 
These confocal images in Fig. 16 depicted the CA1 region (bregma -2.0 to -5.0mm ± 
0.5mm) immunostained with TGF-β1 and NeuN antibodies under different experimental 
conditions. Constitutively, punctated pattern of TGF-β1 expressions were found in the 
sham rats’ CA1s and the adjacent oriens layer and stratum radiatum (Fig. 16A to C). 
Following forced treadmill exercise, TGF-β1 expressions appeared diffused and present 
in more NeuN neurons within the CA1 of sham-runner rats when compared with the 
control rats (Fig. 16D to F). 
 
Subsequent to experimental brain ischemia, the TGF-β1 expressions in the MCAo rats 
were also presented in some NeuN neurons in the ipsilateral CA1s but seemingly subdued 
in the oriens layer and stratum radiatum (Fig. 16G to I), when compared with sham rats. 
Similarly, in the contralateral CA1s of the MCAo rats (Fig. 16J to L), more TGF-β1 
expression were co-localised with the CA1s’ neurons while the intensity of TGF-β1 
expression in the oriens layer and stratum radiatum, although with higher 
immunoreactivities than their counter sides, appeared to be lower than sham rats.  
 
The immunoreactivity profiles of the TGF-β1 expression in the MCAo-runner rats, when 
compared with the MCAo rats, remained relatively unchanged in the ipsilateral CA1’s 
neurons (Fig. 16M to O) following post-ischemic exercise. The ipsilateral CA1’s neurons 
in the MCAo-runner rats although shared similar regions of positive TGF-β1 expression 
77 
 
with sham-runner rats, the TGF-β1 immunoreactivities in the oriens layer and stratum 
radiatum from the ipsilateral hippocampi were less intense in the MCAo-runner rats than 
both sham-runner and MCAo rats. TGF-β1 expressions were also less intense in the 
contralateral hippocampi of the MCAo-runner rats (Fig. 16P to R) when compared with 





Fig. 16.  Double staining of TGF-β1 and NeuN in CA1. These brain sections are from 
either sham-operated or MCAo rats following eight weeks with or without forced 
treadmill exercise. The 30μm brain sections were prepared from both sedentary and 
exercised animals (n=4) sacrificed at ten weeks (whereby first two weeks were allocated 
for acclimatization and familiarization) and two days (as wash-out period for rats 
subjected to the last run) post-surgery with or without MCAo. These confocal images 
depict the CA1 region at bregma -2.0 to -5.0mm ± 0.5mm under different experimental 
conditions. The tissues were double stained with TGF-β1 (red) and NeuN (green). Sham 
rats are displayed in Panel A to C and sham-runner rats are presented in Panel D to F. The 
ipsilateral and contralateral CA1 of MCAo rats are shown in Panel G to I [MCAo(ipsi)] 
and Panel J to L [MCAo(contra)] respectively. The ipsilateral and contralateral CA1 of 
MCAo-runner rats are exhibited in Panel M to O [MCAo(ipsi)-runner] and Panel P to R 
[MCAo(contra)-runner] respectively. Immunoreactivities of TGF-β1 are shifted to NeuN 
positive neurons in the CA1s following either increased physical activity or brain 
ischemia. Forced exercise appear to reduce the intensity of TGF-β1 expressions in oriens 




3.2.5.3 Effects of exercise on TGF-β1 protein expression in the DG 
 
These confocal images in Fig. 17A to R depicted the DG from different experimental and 
control rats were immunostained with TGF-β1 and neuronal marker, NeuN antibodies. 
 
As in the case of the CA1 region, punctated staining patterns of TGF-β1 expression were 
observed in the DGs of the sham rats (Fig. 17A to C). Instead of repeating what was 
observed in the CA1, TGF-β1 expressions in the DGs were noticeably reduced as 
compared with the sedentary rats following eight weeks of regimented treadmill in the 
sham-runner rats (Fig. 17D to F). Therefore, may suggest that TGF-β1 had specific roles 
to fulfill within the hippocampus’ sub-structures. 
 
In both ipsilateral (Fig. 17G to I) and contralateral (Fig. 17J to L) hippocampi of the 
MCAo rats, TGF-β1 expression pattern appeared more diffused yet with comparable 
intensity to the sham rats following ischemic insults.  
 
Likened to the sham-operated scenarios, TGF-β1 staining patterns appeared subdued after 
post-ischemic exercise in both ipsilateral (Fig. 17M to O) and contralateral (Fig. 17P to 
R) hippocampi of the MCAo-runner rats as compared with the MCAo rats. These changes 
rendered the TGF-β1 staining patterns in MCAo-runner rats analogous to the observations 






Fig. 17. Double staining of TGF-β1 and NeuN in DG. Brain sections are prepared from 
either sham-operated or MCAo rats following eight weeks with or without forced 
treadmill exercise. These confocal images depict the DG at bregma -2.0 to -5.0mm ± 
0.5mm under different experimental conditions. The tissues were double stained with 
TGF-β1 (red) and NeuN (green). Intensity of TGF-β1 staining pattern was noticeably 
suppressed following increased physical activity in both sham-operated and MCAo rats. 
(D; G; J; M; P) 
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3.2.5.4 Effects of exercise on smad7 protein expression in the CA1 region 
 
These confocal images in Fig. 18 depicted the CA1 region immunostained with smad7 
and NeuN antibodies in various experimental conditions. Smad7 expression was hardly 
recognized in the sham rats’ CA1 regions (Fig. 18A to C). However, following eight 
weeks of regimented treadmill exercise smad7 was detected and found to be co-localised 
with NeuN immunoreactive neurons in the CA1 region of the sham-runner rats (Fig. 18D 
to F). In addition, smad7 expression was also seen in the oriens layer and stratum 
radiatum.  
 
In both ipsilateral (Fig. 18G to I) and contralateral (Fig. 18J to L) hippocampi of the 
MCAo rats, smad7 expressions were also detected and co-localised with NeuN positive 
neurons in the CA1 region, oriens layer and stratum radiatum.  
 
Post-ischemic exercise marginally reduced smad7 staining intensity in the ipsilateral 
CA1s of the MCAo-runner rats (Fig. 18M to O) as compared with the same region of the 
MCAo rats. There was no noticeable change in the smad7 expression in the contralateral 
CA1 of the MCAo-runner rats (Fig. 18P to R) in contrast with the MCAo rats. Therefore, 
the effects of post-ischemic exercise on smad7 expression in the CA1 appeared to be 






Fig. 18. Double staining of smad7 and NeuN in CA1. These brain sections are taken from 
either sham-operated or MCAo rats following eight weeks with or without forced 
treadmill exercise. These confocal images depict the CA1 region at bregma -2.0 to 
-5.0mm ± 0.5mm under different experimental conditions. The tissues were double 
stained with smad7 (red) and NeuN (green). Smad7 was increased following forced 
treadmill exercise and experimental brain ischemia (D; G; J; M; P). Interestingly, smad7 
expression was subdued in the ipsilateral CA1 region following post-ischemic exercise 




3.2.5.5 Effects of exercise on smad7 protein expression in the DG 
 
Immunostaining with smad7 and NeuN antibodies in DG under different experimental 
conditions were shown in Fig. 19A to R. Smad7 expressions in the DGs were scarce in 
the sham-operated rats (Fig. 19A to C). Following eight weeks of regimented treadmill 
exercise, forced exercised rats showed marginal smad7 expression being identified in the 
DG region and was also co-localised with NeuN positive neurons (Fig. 19D to F).  
 
Smad7 expression was detected in both ipsilateral (Fig. 19G to I) and contralateral (Fig. 
19J to L) hippocampi of the MCAo rats with marginal intensity that were co-localised 
with NeuN positive neurons and as well as extra neuronal structures.  
 
Post ischemic exercise did not alter the smad7 staining profile in the contralateral 
hippocampus (Fig. 19P to R) of the MCAo-runner rats when compared with sedentary 
rats. However, smad7 staining intensity in the ipsilateral hippocampus of the forced 
exercised rats (Fig. 19M to O) appeared to be slightly reduced as compared with the 






Fig. 19. Double staining of smad7 and NeuN in DG. Brain sections are prepared from 
either sham-operated or MCAo rats following eight weeks with or without forced 
treadmill exercise. These confocal images depict the DG at bregma -2.0 to -5.0mm ± 
0.5mm under different experimental conditions. The tissues were double stained with 
smad7 (red) and NeuN (green). Smad7 expression in the DG is marginally increased 
subsequent to prolonged running exercise and brain ischemia (D; G; J; M; P). However, 
when compared to the MCAo rats, smad7 expression appeared slightly suppressed 




3.2.6 TGF-β signaling and apoptosis in cortex 
 
All animals assigned to either exercise or sedentary groups were sacrificed at ten weeks 
post-surgery (includes the total time allocated for trainings and eight weeks of actual 
exercise regime for the runner groups), with two days wash-out period after the last run, 
with or without MCAo . 
 
3.2.6.1 Effects of exercise and brain ischemia on mRNA and protein expression in 
TGF-β signaling and caspase activity 
 
In Fig. 20a, following eight weeks of forced treadmill exercise, TGF-b1 mRNA 
expressions were determined at 1.07 ± 0.15 fold in the sham-runner rats thus were not set 
apart significantly from the sham rats. Under ischemic condition, TGF-b1 mRNA 
expressions in MCAo rats were also recorded with marginal up-regulations at 1.19 ± 0.04 
and 1.17 ± 0.04 in both ipsilateral and contralateral cortices respectively, but these 
differences were not statistically significant when compared with the sham rats. When 
forced exercise was introduced on top of ischemic insult, TGF-b1 mRNA expression was 
statistically increased by 2.53 ± 0.69 fold in the ipsilateral cortices of the MCAo-runner 
rats in contrast to MCAo rats, p-value<0.05. However, the contralateral cortices of the 
MCAo-runner rats remained comparable to the MCAo rats and the TGF-b1 mRNA 




As shown in Fig. 20b, TGFBR-II mRNA expressions in the sham-runner rats were 
recorded with a slight drop at 0.75 ± 0.04 fold after subjected to eight weeks of forced 
treadmill exercise. Under ischemic condition, TGFBR-II mRNA expressions were 
documented at 0.88 ± 0.06 and 1.01 ± 0.02 fold in both ipsilateral and contralateral 
cortices respectively of the MCAo rats. However, these adjustments when compared with 
the sham rats were not statistically significant. Following eight weeks of post-ischemic 
forced treadmill exercise, TGFBR-II mRNA expressions were further decreased to 0.59 ± 
0.06 and 0.78 ± 0.09 fold in the ipsilateral and contralateral cortices of the MCAo-runner 
rats but the changes were not statistically significant when compared with the MCAo rats. 
 
In Fig. 20c, smad2 mRNA expression was marginally increased by 1.24 ± 0.11 fold 
following eight weeks of forced treadmill exercise in the sham-runner rats. Smad2 mRNA 
expressions following experimental brain ischemia were also recorded with a small 
increment at 1.38 ± 0.13 and 1.37 ± 0.09 in both ipsilateral and contralateral cortices 
respectively of the MCAo rats. However, these alterations when compared with the sham 
animals were not statistically significant. Following eight weeks of post-ischemic forced 
treadmill exercise, smad2 mRNA expressions were documented with a marginal 
up-regulation at 1.24 ± 0.14 and 1.10 ± 0.04 in both the ipsilateral and contralateral 
cortices respectively of the MCAo-runner rats which were comparable to the MCAo rats. 
 
Smad7 mRNA expression in Fig. 20d showed the mRNA level was recorded at 0.98 ± 
0.14 fold following eight weeks of forced treadmill exercise in the sham-runner 
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rats. Smad7 mRNA expression were recorded with a slight increase at 1.15 ± 0.10 and 
1.34 ± 0.11 in both ipsilateral and contralateral cortices of the MCAo rats respectively 
following ischemic insults. Similar to the cases seen in smad2 mRNA expressions, these 
modifications in contrast to sham rats were not statistically significant. Smad7 mRNA 
expression, following eight weeks of post-ischemic forced treadmill exercise, in both the 
ipsilateral and contralateral cortices of the MCAo-runner rats, comparable to the MCAo 
rats, were documented at 0.73 ± 0.04 and 1.01 ± 0.10 respectively. All data were analysed 
with One way ANOVA, Tukey's Multiple Comparison Test. 
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Fig. 20. mRNA expressions of TGF signaling in the cortex. The brain homogenates were 
prepared from both sedentary and exercised animals (n=4) sacrificed at ten weeks 
(whereby first two weeks were allocated for acclimatization and familiarization) and two 
days (as wash-out period for rats subjected to the last run) post-surgery with or without 
MCAo. Changes in mRNAs levels were evaluated in sham, sham-runner, MCAo 
(ipsilateral cortex) [MCAo(ipsi)], MCAo (contralateral cortex) [MCAo(contra)], 
MCAo-runner (ipsilateral cortex) [MCAo(ipsi)-runner] and MCAo-runner (contralateral 
cortex) [MCAo(contra)-runner] rats. (a) The result showed that the presence of both brain 
ischemia and forced exercise [in MCAo(ipsi)-runner] can potentiate TGFb1 mRNA 
expression significantly by 2.53 ± 0.69 fold in the ipsilateral cortex as compared with the 
MCAo(ipsi) rats. (b) The experiment showed that the presence of both brain ischemia and 
forced exercise [in MCAo(ipsi)-runner, when compared with the MCAo(ipsi)] can further 
reduce cortical TGFBR2 mRNA expression to 0.59 ± 0.06 fold albeit not statistically 
significant. No change in (c) smad2 and (d) smad7 mRNA levels, which suggested that 
both brain ischemia and forced exercise did not have any influence on their gene 
expression. All data were analysed with One way ANOVA, Tukey's Multiple Comparison 




In Fig. 21a, eight weeks of forced treadmill exercise did not significantly increase 
TGF-β1 protein expression for the sham-runner rats and the TGF-β1 level was evaluated 
at 1.05 ± 0.05 fold which was not statistically significant when compared with the sham 
rats. Although TGF-β1 protein expression was up-regulated in both cortices of the MCAo 
rats at 1.28 ± 0.05 and 1.71 ± 0.08 fold for ipsilateral and contralateral cortices 
respectively, only the contralateral cortices showed significant increase when compared 
with the sham rats, p-value<0.05. TGF-β1 
Presented in Fig. 21b, s
protein expression seen in the ipsilateral 
cortices of the MCAo rats were further enhanced in the MCAo-runner rats following 
eight weeks of post-ischemic forced treadmill exercise documented at 1.55 ± 0.05 fold 
but the change was not statistically significant. The contralateral cortices of the 
MCAo-runner rats remained significantly up-regulated at 1.73 ± 0.12 fold and 
comparable to the increment seen in MCAo rats.  
 
mad7 protein expression showed a slight but not statistically 
significant upward trend subsequent to eight weeks of forced treadmill exercise in the 
sham-runner rats (1.18 ± 0.07) when compared with the sham rats. Demonstrably, smad7 
protein expression recorded an up-regulation in both ipsilateral and contralateral cortices 
of the MCAo rats by 1.50 ± 0.09 and 1.43 ± 0.10 fold respectively, and these upward 
trends were statistically significant when compared with the sham rats, p-value<0.01. 
Interestingly, smad7 protein levels in the ipsilateral cortices of the MCAo-runner rats 
were down-regulated (1.03 ± 0.07 fold) when compared with the same side in the MCAo 
rats, p-value<0.01. Otherwise smad7 protein expression, following eight weeks of 
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post-ischemic forced treadmill exercise, in the contralateral cortices of the MCAo-runner 
rats remained around 1.36 ± 0.08 fold as compared with the MCAo rats.  
 
Cleaved caspase-3 protein expressions displayed in Fig. 21c indicated that sham-runner 
rats were recorded at 1.06 ± 0.04 fold which was comparable to sham rats following eight 
weeks of forced treadmill exercise. In the ischemic brain, ipsilateral cortices of the MCAo 
rats recorded a significant increase in cleaved caspase-3 protein expression at 2.84 ± 0.27 
fold (p-value<0.01), while the contralateral cortices was noted at 1.18 ± 0.07 fold (not 
statistically significant) in contrast with the sham rats. This increased cleaved caspase-3 
protein levels observed in the ipsilateral cortex of the MCAo rats were down-regulated 
evidently following eight weeks of post-ischemic forced treadmill exercise to 0.94 ± 0.04 
fold as seen in the ipsilateral cortices of the MCAo-runner rats with p-value<0.01. The 
contralateral cortices of the MCAo-runner rats were recorded at 1.05 ± 0.04 fold which 
were comparable to the MCAo rats. 
 
As seen in Fig. 21d, cleaved PARP protein expression was recorded with a marginal 
increase at 1.10 ± 0.04 fold in the sham-runner rats subsequent to eight weeks of forced 
treadmill exercise but not statistically significant when compared with the sham rats. On 
the other hand, both ipsilateral and contralateral cortices of the MCAo rats recorded a 
significant up-regulation of cleaved PARP protein expression (1.50 ± 0.09 and 1.44 ± 
0.13 fold respectively) in contrast to the sham rats, p-value<0.05. Post-ischemic exercise 
brought down the cleaved PARP protein level to 1.13 ± 0.14 (p-value>0.05) and 0.73 ± 
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0.03 (p-value<0.05) in the ipsilateral and contralateral cortices of the MCAo-runner rats 
respectively when compared with the MCAo rats.  
 





Fig. 21. Western blots and protein expressions of TGF signaling and caspase-3 activity in 
the cortex. These brain tissues are taken from rats with or without eight weeks forced 
treadmill exercise under either sham-operated or MCAo conditions. The TGF-β1, smad7, 
cleaved caspase-3 and cleaved PARP antibodies detect the specific bands at 45kD, 51kD, 
17kD and 89kD respectively with β-actin (42kD) used for normalisation. (a) TGF-β1 was 
elevated significantly in MCAo(contra), by 1.71 ± 0.08 fold when compared with the 
sham. Post-ischemic exercise increased the TGF-β1 level in the ipsilateral cortices by 
1.55 ± 0.05 fold. (b) Smad7 can be increased in both ipsilateral and contralateral cortices 
with brain ischemia by 1.50 ± 0.09 and 1.43 ± 0.10 fold respectively in contrast with the 
sham-operated rats. And post-ischemic exercise could significantly reduce the protein 
expression by 1.03 ± 0.07 fold in the ipsilateral cortices when compared with the MCAo 
rats. (c) Caspase-3 activation was elevated in the ipsilateral cortices of the MCAo rats by 
2.84 ± 0.27 fold, and this elevation was down-regulated with post-ischemic exercise to 
0.94 ± 0.04 fold. (d) Increased cleaved PARP protein levels were recorded in both 
ipsilateral and contralateral cortices by 1.50 ± 0.09 and 1.44 ± 0.13 fold respectively in 
the animals with MCAo. PARP protein levels increment seen in ischemic cortices were 
reduced after post-ischemic exercise in both ipsilateral and contralateral cortices at 
varying degree. All data were analysed with One way ANOVA, Tukey's Multiple 




3.2.6.2 Effects of exercise and brain ischemia on TGF-β1 protein expression 
 
These confocal images in Fig. 22 depicted the parietal cortex (bregma -2.0 to -5.0mm ± 
0.5mm) under different experimental conditions. The tissues were double stained with 
TGF-β1 (red) and NeuN (green) antibodies. Sham rats are displayed in Fig. 22A to C and 
sham-runner rats are presented in Fig. 22D to F. The ipsilateral and contralateral cortices 
of the MCAo rats are shown in Fig. 22G to I and Fig. 22J to L respectively. The 
ipsilateral and contralateral cortices of MCAo-runner rats are exhibited in Fig. 22M to O 
and Fig. 22P to R respectively.  
 
Constitutively, punctated staining of cortical TGF-β1 expression was observed in the 
sham rats (Fig. 22A to C). In the sham-runner rats (Fig. 22D to F), the TGF-β1 expression 
following eight weeks of regimented treadmill exercise retained a punctated staining 
pattern albeit more diffused, and were present in some NeuN labeled neurons. At the 
same time, some TGF-β1 immunoreactive structures that resembled vasculatures were 
demarcated evidently by the punctated staining pattern of the TGF-β1 [Fig. 22D and F 
(refer to white arrow)].  
 
In the ipsilateral cortices of the MCAo rats (Fig. 22G to I), the immunoreactivity patterns 
of the TGF-β1 appeared to be diffused in the immediate periphery of the injury site and 
much coarse when further away the insulted region. Otherwise, TGF-β1s were found 
within some of the NeuN labeled neurons regardless of the distance from the insulted 
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area. In the contralateral cortices of the MCAo rats (Fig. 22J to L), TGF-β1 expressions 
were also detected in a punctated fashion comparable to the outer zone of the injury site 
in the ipsilateral cortices. 
 
TGF-β1 expression in the ipsilateral cortices of MCAo-runner rats (Fig. 22M to O) 
appeared to be reduced in staining intensity when compared to the MCAo rats. While the 
punctated TGF-β1 expression observed in the contralateral cortices of MCAo-runner rats 






Fig. 22. Double staining of TGF-β1 and NeuN in cortices. These brain sections are from 
sham-operated or MCAo rats following eight weeks with or without forced treadmill 
exercise. These confocal images depict the parietal cortex at bregma -2.0 to -5.0mm ± 
0.5mm under different experimental conditions. The tissues are double stained with 
TGF-β1 (red) and NeuN (green). TGF-β1 expressions appear to be more diffused 
comparing with sham rats following forced treadmill exercise. Experimental MCAo 
enhances TGF-β1 immunoreactivities in the ipsilateral cortices. However, forced exercise 
following brain ischemia, seem to reduce TGF-β1 immunoreactivities in the ipsilateral 




3.2.6.3 Effects of exercise and brain ischemia on staining profile of smad7 protein 
expression 
 
These confocal images in Fig. 23 depicted the parietal cortex (bregma -2.0 to -5.0mm ± 
0.5mm) under different experimental conditions. The tissues were double stained with 
smad7 (red) and NeuN (green). Sham rats are displayed in Fig. 23A to C and sham-runner 
rats are presented in Fig. 23D to F. The ipsilateral and contralateral cortices of MCAo rats 
are shown in Fig. 23G to I and Fig. 23J to L respectively. The ipsilateral and contralateral 
cortices of MCAo-runner rats are exhibited in Fig. 23M to O and Fig. 23P to R 
respectively.  
 
In sham rats (Fig. 23A to C), punctated staining patterns of smad7 were observed in the 
cortices. Following eight weeks of regimented treadmill exercise, the smad7 expressions 
in the sham-runner rats (Fig. 23D to F) were marginally increased and displayed an even 
staining pattern in some NeuN labeled neurons.  
 
In the ipsilateral and contralateral cortices of the MCAo rats (Fig. 23G to I and Fig. 23J to 
L), the distribution of the smad7 in the cortex was observed with punctated staining 
pattern. In the immediate periphery of the injury site (only ipsilateral cortex), some 




In the ipsilateral cortices of the MCAo-runner rats (Fig. 23M to O), the stainings of the 
smad7 in the cortices seemed less intense, but co-localisation of smad7 with NeuN 
neurons were more widespread than that of MCAo rats. The contralateral cortices of the 






Fig. 23. Double staining of smad7 and NeuN in cortices. Brain sections are taken from 
sham-operated or MCAo rats following eight weeks with or without forced treadmill 
exercise. These confocal images depict the parietal cortex at bregma -2.0 to -5.0mm ± 
0.5mm under different experimental conditions. The tissues are double stained with 
smad7 (red) and NeuN (green). Smad7 expressional intensities in sedentary 
sham-operated rats are slightly increased following forced exercise. Smad7 are evidently 
seen at the border of compromised cortical regions co-localised with NeuN positive 
neurons in MCAo rats with or without forced exercise. Interestingly, the width of the 
regions where smad7 are co-localised with NeuN neurons seem to be greater than before 




3.2.6.4 Effects of exercise and brain ischemia on TUNEL staining 
 
These confocal images in Fig. 24 display tissues from the parietal cortices (bregma -2.0 to 
-5.0mm ± 0.5mm) double stained with TUNEL (green) and NeuN (red) which were 
subjected to different experimental conditions. Respectively, sham and sham-runner rats 
are displayed in Fig. 24A to C and Fig. 24D to F. The ipsilateral and contralateral cortices 
of MCAo rats are shown in Fig. 24G to I and Fig. 24J to L respectively. The ipsilateral 
and contralateral cortices of MCAo-runner rats are exhibited in Fig. 24M to O and Fig. 
24P to R respectively.  
 
TUNEL staining was negative in sham rats (Fig. 24A to C) and sham-runner rats (Fig. 
24D to F), contralateral cortices of the MCAo rats (Fig. 24J to L) and contralateral 
cortices of the MCAo-runner rats (Fig. 24P to R). In the ipsilateral cortices of the MCAo 
rats (Fig. 24G to I), residing in the borders of ischemic regions, positive TUNEL staining 
was detected and co-localised with NeuN labeled neurons. Paradoxically, positive 
TUNEL staining co-localised with NeuN labeled neuron was more pronounced in the 
ipsilateral cortices of the MCAo-runner rats (Fig. 24M to O) in contrast to sedentary 






Fig. 24. Double staining of TUNEL and NeuN in cortices. The brain tissues are sectioned 
from either sham-operated or MCAo rats following eight weeks with or without forced 
treadmill exercise. These confocal images depict the parietal cortex at bregma -2.0 to 
-5.0mm ± 0.5mm under different experimental conditions. The tissues are double stained 
with TUNEL (green) and NeuN (red). Positive TUNEL staining is detected next to 
borders of the insulted cortices in the MCAo rats. Ironically, TUNEL stainings have their 
regional width augmented in the MCAo-runner rats following post-ischemic exercise 




3.2.7 Changes to expression profile of angiogenic factors in hippocampus 
following forced treadmill exercise 
 
All animals were sacrificed at ten weeks (includes trainings and eight weeks of actual 
exercise regime) with two days wash-out period after the last run. 
 
3.2.7.1 Effects of exercise on angiogenic factors’ mRNA and protein expression 
 
HIF-1α mRNA expression was recorded with an upward trend by 1.67 ± 0.42 fold 
following eight weeks of forced treadmill exercise in the sham-runner rats when 
compared with the sham rats however the difference was not statistically significant (Fig. 
25a). 
 
VEGF mRNA expression was documented at 1.38 ± 0.38 fold following eight weeks of 
forced treadmill exercise in the sham-runner rats in contrast to the sham rats but was not 
statistically significant (Fig. 25b).  
 
Prolonged forced treadmill exercise in the sham-runner rats, shown in Fig. 25c, 
increased VEGFR2 mRNA expression by 2.07 ± 0.91 fold as compared with the sham 




Following eight weeks of forced treadmill exercise in the sham-runner rats, PDGFB 
mRNA expressions were significantly increased by 1.53 ± 0.16 fold as compared with the 
sham rats, p-value<0.05 (Fig. 25d).  
 
PDGFRB mRNA expressions increased by 2.58 ± 0.35 fold following eight weeks of 
forced treadmill exercise in the sham-runner rats when compared with the sham rats, 
p-value<0.05 (Fig. 25e).  
110 
 














      


























     































Fig. 25. mRNA expressions of HIF-1α and angiogenic factors in the hippocampus. 
Changes in mRNA levels were evaluated by quantitative real-time PCR following eight 
weeks forced treadmill exercise. The increased of the HIF-1α, VEGF and VEGFR2 
mRNAs from the sham-runner rats in comparison to sedentary rats was not significant (a, 
b and c respectively). Significant up-regulation of PDGFB and PDGFRB mRNAs were 
recorded in the sham-runner rats at 1.53 ± 0.16 and 2.58 ± 0.35 folds respectively when 
compared with the sham rats (d and e respectively). All data were analysed using 





HIF-1α protein expressions were considerably up-regulated by 1.82 ± 0.24 fold following 
eight weeks of forced treadmill exercise in the sham-runner rats and when compared with 
the sham rats, *p-value<0.05 (Fig. 26a).  
 
PDGFB protein expressions were up-regulated by 1.30 ± 0.03 fold following eight weeks 
of forced treadmill exercise in the sham-runner rats as compared with the sham rats, 




Fig. 26. HIF-1α and PDGFB protein expressions in the hippocampus. The HIF-1α and 
PDGFB antibodies detect the band at 120kD and 25kD respectively with β-actin at 42kD 
as the housekeeping protein. Changes in HIF-1α (a) and PDGFB (b) protein levels were 
recorded with statistically significant increase at 1.82 ± 0.24 and 1.30 ± 0.03 fold 
respectively in the sham-runner rats when compared with the sham rats. All data were 
analysed using unpaired t-test with *p-value<0.05 and **p-value<0.01.
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3.2.8 Angiogenic factors and angiogenesis in cortex 
 
All animals assigned to either exercise or sedentary groups were sacrificed at ten weeks 
post-surgery (include the total time allocated for trainings and eight weeks of actual 
exercise regime for the runner groups), with two days wash-out period after the last run, 
with or without MCAo. 
 
3.2.8.1 Effects of exercise on angiogenic factors’ mRNA and protein expression 
 
The whole ipsilateral hemispheres of the cerebral cortices were used for the analysis of 
mRNA and protein expressions in all groups with additional examination of whole 
contralateral hemispheres for both MCAo and MCAo-runner rats. As shown in Fig. 27a, 
HIF-1α mRNA expressions showed a slight upward trend following eight weeks of forced 
treadmill exercise in the sham-runner rats (1.23 ± 0.08 fold) as compared with the sham 
rats. HIF-1α mRNA expression recorded a significant downward trend in both ipsilateral 
and contralateral cortices of the MCAo rats (0.46 ± 0.02 and 0.50 ± 0.05 fold 
respectively) in contrast to the sham rats, p-value<0.01. Eight weeks of post-ischemic 
forced treadmill exercise did not yield significant change to the HIF
Fig. 27b illustrated that neither prolonged forced exercise nor brain ischemia had any 
significant effect on 
-1α mRNA 
expression which remained comparable with MCAo rats. 
 
VEGF mRNA expression. VEGF mRNAs were calculated at 0.91 ± 
0.04 fold in the sham-runner rats and were worked out at 1.00 ± 0.28 and 0.88 ± 0.09 fold 
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in both ipsilateral and contralateral cortices of the MCAo rats respectively. These results 
from both groups were not statistically significant when compared with the sham rats. 
Following eight weeks of post-ischemic forced treadmill exercise, VEGF mRNA 
expressions in both ipsilateral and contralateral cortices of the MCAo-runner rats were 
evaluated at 0.61 ± 0.10 and 0.99 ± 0.17 fold respectively which were comparable to the 
MCAo rats. Even though there was marginal down-regulation seen in the ipsilateral 
cortices, the change was not statistically significant. 
 
VEGFR2 mRNA expressions (Fig. 27c) were calculated at 1.77 ± 0.35 fold following 
eight weeks of forced treadmill exercise in the sham-runner rats, and were recorded at 
1.06 ± 0.01 and 1.16 ± 0.003 fold in both ipsilateral and contralateral cortices of the 
MCAo rats respectively, however these observations were not statistically significant 
when compared with the sham rats. Subsequent to eight weeks of post-ischemic forced 
treadmill exercise, VEGFR2 mRNA expressions in both ipsilateral and contralateral 
cortices of the MCAo-runner rats were determined at 1.03 ± 0.14 and 1.05 ± 0.12 fold 
respectively which were comparable with the MCAo rats. 
 
PDGFB mRNA expressions were significantly increased by 1.46 ± 0.10 fold following 
eight weeks of forced treadmill exercise in the sham-runner rats as compared with the 
sham rats, p-value<0.01 (Fig. 27d). In the MCAo rats, PDGFB mRNA expression were 
evaluated at 1.59 ± 0.08 and 1.51 ± 0.06 fold in both ipsilateral and contralateral cortices 
respectively when compared with the sham rats, p-value<0.01. PDGFB mRNA 
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expression, following eight weeks of post-ischemic forced treadmill exercise, in both 
ipsilateral and contralateral cortices of the MCAo-runner rats were determined at 0.79 ± 
0.09 and 1.19 ± 0.02 fold. Notably, PDGFB mRNA expression in the ipsilateral cortices 
of the MCAo-runner rats were decreased when compared with the same cortices in the 
MCAo rats with p-value<0.01.  
 
Fig. 27e showed that PDGFRB mRNA expressions were calculated at 0.79 ± 0.11 fold 
following eight weeks of forced treadmill exercise in the sham-runner rats as compared 
with the sham rats. PDGFRB mRNA expression under ischemia (MCAo rats) were 
recorded at 1.60 ± 0.15 and 1.75 ± 0.27 fold in both ipsilateral and contralateral cortices 
respectively as compared with the sham rats. Although changes were observed following 
either forced exercise or brain ischemia, these alterations were not statistically significant 
when compared with the sham rats. PDGFRB mRNA expression, following eight weeks 
of post-ischemic forced treadmill exercise, in the ipsilateral cortices of the MCAo-runner 
rats were further increased by 2.82 ± 0.75 fold but remained at 1.68 ± 0.21 fold in 
contralateral cortices of the MCAo-runner rats. However, the change in the ipsilateral 
cortices was not statistically significant in contrast with the MCAo rats. 
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Fig. 27. mRNA expressions of HIF-1α and angiogenic factors in the cortex. Changes to 
mRNA levels in either whole ipsilateral or whole contralateral hemispheres of the 
cerebral cortices were evaluated by quantitative real-time PCR. (a) Long term forced 
exercise show increase HIF-1α mRNA expression in the sham-runner but the change is 
not statistically significant. Post-MCAo show that HIF-1α mRNA levels are 
down-regulated significantly by 0.46 ± 0.02 and 0.50 ± 0.05 fold in the ipsilateral and 
contralateral hemispheres respectively as compared to the sham. Post-ischemic exercise 
did not have any influence on the HIF-1α mRNA which remained at 0.40 ± 0.06 and 0.48 
± 0.04 fold in the ipsilateral and contralateral hemispheres respectively following 
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experimental ischemia. (b) The data showed that prolonged period of forced exercise did 
not have any effect on the expression of VEGF mRNA under both ischemic and 
non-ischemic conditions. (c) An upward trend was observed in the VEGFR2 mRNA 
expression following forced treadmill exercise (sham-runner) albeit non-significant. 
Experimental brain ischemia did not have any observable effect on the VEGFR2 mRNA 
and remained at post-MCAo’s level in the MCAo-runner rats. (d) Expression of PDGFB 
mRNA was up-regulated significantly after subjected to prolonged period of increased 
physical activities by 1.46 ± 0.10 fold and permanent ischemia by 1.59 ± 0.08 and 1.51 ± 
0.06 fold in both ipsilateral and contralateral hemispheres respectively. Post-ischemic 
exercise brought down the PDGFB mRNA levels in the ipsilateral cortices significantly to 
0.79 ± 0.09 fold as compared to the same cortices of the MCAo rats. (e) Upward trend of 
PDGFRB mRNA levels observed in the MCAo rats was not statistically significant. 
However PDGFRB mRNA expressions were further increased after post-ischemic 
exercise and the increase was statistically significant. Post-ischemic exercise did not 
produce any significant increase in PDGFRB mRNA expression. All data were analysed 





Illustrated in Fig. 28a, HIF-1α protein expressions following eight weeks of forced 
treadmill exercise in the sham-runner rats were calculated at 1.17 ± 0.05 fold which was 
not statistically significant as compared with the sham rats. Ipsilateral cortices of the 
MCAo rats worked out a considerable up-regulation of HIF-1α protein expression 
recorded at 1.51 ± 0.09 fold and with p-value<0.01 when compared with the sham rats. 
Though the contralateral cortices of the MCAo rats were determined at 1.22 ± 0.05 fold, 
the changes were not statistically significant in contrast with the sham rats. Following 
eight weeks of post-ischemic forced treadmill exercise, HIF
In Fig. 28b,
-1α protein expression in both 
ipsilateral and contralateral cortices of the MCAo-runner rats were measured at 1.55 ± 
0.08 and 0.90 ± 0.11 fold respectively which was not statistically significant when 
compared with the MCAo rats.  
 
 PDGFB protein expressions following eight weeks of forced treadmill 
exercise in the sham-runner rats were worked out at 1.20 ± 0.07 fold and this alteration 
was not statistically significant in contrast to the sham rats. PDGFB protein expressions in 
both ipsilateral and contralateral cortices of the MCAo rats were calculated at 0.77 ± 0.09 
and 1.17 ± 0.09 respectively was also not statistically significant when compared with the 
sham rats. PDGFB protein expressions, following eight weeks of post-ischemic forced 
treadmill exercise, in the ipsilateral cortices of the MCAo-runner rats were recorded with 
a significant increase by 1.43 ± 0.11 fold, while the contralateral cortices of the 
MCAo-runner rats were documented at 1.30 ± 0.12 fold. Interestingly, PDGFB protein 
expressions in the ipsilateral cortices of the MCAo-runner rats were increased when 
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compared with the same cortices in the MCAo rats, p-value<0.01. All data were analyzed 




Fig. 28. HIF-1α and PDGFB protein expressions in the cortex. The HIF-1α and PDGFB 
antibodies detect the band at 120kD and 25kD respectively with housekeeping β-actin at 
42kD. Changes to protein levels in either whole ipsilateral or whole contralateral 
hemispheres of the cerebral cortices were semi-quantified using Western blot. (a) An 
upward trend of the HIF-1α protein expression is documented in the sham-runner but the 
change is non-significant. Considerable increase in the level of HIF-1α protein expression 
is determined in the ipsilateral cortices of MCAo rats at 1.51 ± 0.09 fold, and 
post-ischemic exercise did not alter this elevation which remained at 1.55 ± 0.08 fold. (b) 
PDGFB protein level is increased significantly to 1.43 ± 0.11 fold in the ipsilateral 
cortices in the MCAo-runner rats when compared with ipsilateral cortices of the MCAo 
rats. All data were analysed with One way ANOVA, Tukey's Multiple Comparison Test 
with *p-value<0.05 and ** p-value<0.01.     
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3.2.8.2 Effects of forced treadmill exercise and brain ischemia on Pecam-1 
expression 
 
These confocal images in Fig. 29 depicted the parietal cortex (bregma -2.0 to -5.0mm ± 
0.5mm) under different experimental conditions. The tissues were double stained with 
Pecam-1 (green) and DAPI (blue). Sham rats are displayed in Fig. 29A to C and 
sham-runner rats are presented in Fig. 29D to F. The ipsilateral and contralateral cortices 
of MCAo rats are shown in Fig. 29G to I and Fig. 29J to L respectively. The ipsilateral 
and contralateral cortices of MCAo-runner rats are exhibited in Fig. 29M to O and Fig. 
29P to R respectively.  
 
Basal level of Pecam-1 was observed in sham rats (Fig. 29A to C). In comparison with 
the sedentary group, sham-runner rats displayed a striking increase in Pecam-1 
expressions (Fig. 29D to F). Following prolonged ischemic insult, Pecam-1 was observed 
in both cortices of the MCAo rats (Fig. 29G to I and Fig. 29J to L) comparable to the 
basal level seen in sham rats. An increase of Pecam-1 expression was noted in both 
cortices of the MCAo-runner rats (Fig. 29M to O and in Fig. 29P to R) over the sedentary 






Fig. 29. Double staining of Pecam-1 and DAPI in cortex. The brain sections are prepared 
from either sham-operated or MCAo rats following eight weeks with or without forced 
treadmill exercise. These confocal images depict the parietal cortex at bregma -2.0 to 
-5.0mm ± 0.5mm under different experimental conditions. The tissues were double 
stained with Pecam-1 (green) and DAPI (blue). In the sham-runner rats, Pecam-1 staining 
profile is very prominent as compared with the basal activity in the sham rats. 
Post-ischemic exercise is able to modestly increase the staining intensity in both 





3.2.9 Erythropoietic factors in hippocampus 
 
All animals were sacrificed at ten weeks (includes trainings and eight weeks of actual 
exercise regime) with two days wash-out period after the last run. 
 
3.2.9.1 Effects of exercise on erythropoietic factor’s protein expression 
 
Eight weeks of forced treadmill exercise (sham-runner rats) up-regulated EPO protein 
expression by 1.97 ± 0.30 fold as compared with the sham rats, p-value<0.05 (Fig. 30a).  
 
As illustrated in Fig. 30b, EPOR protein expression was increased by 1.63 ± 0.19 fold 
following eight weeks of forced treadmill exercise in the sham-runner rats in contrast to 






Fig. 30. EPO and EPOR protein expressions in the hippocampus. The EPO and EPOR 
antibodies detect the bands at 34kD and 71kD respectively with housekeeping β-actin at 
42kD. (a) EPO protein levels are up-regulated by 1.97 ± 0.30 fold and (b) EPOR protein 
expressions are significantly increased by 1.63 ± 0.19 fold in the sham-runner rats when 




3.2.9.2 Effects of exercise and ischemia on staining profile of erythropoietin (EPO) 
in the CA1 region 
 
These confocal images in Fig. 31 depicted the CA1 region (bregma -2.0 to -5.0mm ± 
0.5mm) under different experimental conditions. In the sham rats (Fig. 31A to C), there 
was hardly any EPO expression observed in the CA1 region. Following prolonged 
moderate exercise regime, punctated staining pattern of EPO was detected with some 
being co-localised with neurons (NeuN) in sham-runner rats’ CA1 region (Fig. 31D to F). 
 
Following the footsteps of sham-runner rats, EPO expressions of the MCAo rats were 
also fashioned in punctated patterns and were observed in some neurons (NeuN) residing 
in the CA1 region from the ipsilateral hippocampus (Fig. 31G to I). EPO staining in the 
ipsilateral CA1 region of the MCAo-runner rats (Fig. 31M to O) appeared to be increased 
both in number and intensity as compared with the ipsilateral region of the MCAo rats.  
 
In the contralateral hippocampi of the MCAo and MCAo-runner rats (Fig. 31J to L and 
Fig. 31P to R), punctated staining pattern of the EPO were markedly increased in the CA1 
and also extensively expressed in the oriens layer and stratum radiatum. Resembling the 
ipsilateral hippocampi of the MCAo rats, the contralateral CA1s of the MCAo-runner rats 





Fig. 31. Double staining of EPO and NeuN in CA1. These are brain sections from either 
sham-operated or MCAo rats following eight weeks with or without forced treadmill 
exercise. These confocal images depict CA1 region at bregma -2.0 to -5.0mm ± 0.5mm 
under different experimental conditions. The tissues were double stained with EPO (red) 
and NeuN (green). Sham rats’ CA1s display basal level of EPO expressions which are 
seen increase in sham-runner rats. The ipsilateral CA1s of both MCAo and MCAo-runner 
rats show subdued increment in contrast with their contralateral CA1s where the EPO 
immunoreactivities are notably higher, in addition, some are co-localised with NeuN 




3.2.9.3 Effects of exercise and ischemia on staining profile of EPO receptor (EPOR) 
in the CA1 region 
 
These confocal images in Fig. 32 depicted the CA1 (bregma -2.0 to -5.0mm ± 0.5mm) 
under different experimental conditions. In the sham rats (Fig. 32A to C), EPOR 
expressions were detected and with some being co-localised with CA1’s NeuN labeled 
neurons. In addition, EPOR expression was also detected in the oriens layer and stratum 
radiatum. Comparable stainings were seen in the sham-runner rats (Fig. 32D to F).  
 
In both sides of the MCAo rats’ hippocampus (Fig. 32G to I), EPOR immunoreactivity 
appeared to be reduced. EPOR staining in the CA1 region of the MCAo-runner rats (Fig. 
32M to O and Fig. 32P to R) was marginally higher when compared with the CA1 region 
of the MCAo rats. In the contralateral hippocampi of both MCAo and MCAo-runner rats 
(Fig. 32J to L and), punctated staining pattern of the EPOR were detected in the CA1 






Fig. 32. Double staining of EPOR and NeuN in CA1. Brain tissues are sectioned from 
either sham or MCAo rats following eight weeks with or without forced treadmill 
exercise. These confocal images depict CA1 region at bregma -2.0 to -5.0mm ± 0.5mm 
under different experimental conditions. The tissues were double stained with EPOR (red) 
and NeuN (green). EPOR expressions are comparable between sham and sham-runner 
rats. EPOR expressions appear to be down-regulated in both ipsilateral and contralateral 
CA1s of the MCAo rats. Forced running following ischemia seems to up-regulate the 




3.2.9.4 Effects of exercise and ischemia on staining profile of EPO in the DG 
 
These confocal images in Fig. 33 depicted the DG (bregma -2.0 to -5.0mm ± 0.5mm) 
under different experimental conditions. EPO expression was hardly detected in the DGs 
of the sham rats (Fig. 33A to C). However, subsequent to forced treadmill exercise, 
punctated expressions of EPO were unambiguously observed in the sham-runner rats’ 
DGs (Fig. 33D to F).  
 
In both ipsilateral and contralateral hippocampi of the MCAo and MCAo-runner rats (Fig. 
33G to I, Fig. 33J to L, Fig. 33M to O and Fig. 33P to R), instantly recognizable 
punctated staining pattern of EPO was spotted in a similar fashion as examined in the 
sham-runner rats. Interestingly, EPO was strongly expressed in the NeuN positive 






Fig. 33. Double staining of EPO and NeuN in DG. Brain sections are taken from either 
sham-operated or MCAo rats following eight weeks with or without forced treadmill 
exercise. These confocal images depict the DG at bregma -2.0 to -5.0mm ± 0.5mm under 
different experimental conditions. The tissues were double stained with EPO (red) and 
NeuN (green). EPO expression appear to be absent in the sham rats. The EPO expression 
is increased following both exercise and brain ischemia independently or in combination. 





3.2.9.5 Effects of exercise and ischemia on staining profile of EPOR in the DG 
 
These confocal images in Fig. 34 depicted the DG (bregma -2.0 to -5.0mm ± 0.5mm) 
under different experimental conditions. In the sham rats (Fig. 34A to C), EPOR 
expression was detected in the DG with some being co-localised with NeuN positive 
neurons. Eight weeks of regimented treadmill exercise appeared to marginally reduced 
EPOR immunoreactivities in DG of the sham-runner rats (Fig. 34D to F).  
 
Insulted ipsilateral side from MCAo (Fig. 34G to I) and MCAo-runner (Fig. 34M to O) 
rats demonstrated mild EPOR immunoreactivities in their DGs. Control contralateral side 
of the MCAo (Fig. 34J to L) and MCAo-runner DGs (Fig. 34P to R) showed marginally 






Fig. 34. Double staining of EPOR and NeuN in DG. Brain samples are sectioned from 
either sham or MCAo rats following eight weeks with or without forced treadmill 
exercise. These confocal images depict the DG at bregma -2.0 to -5.0mm ± 0.5mm under 
different experimental conditions. The tissues are double stained with EPOR (red) and 
NeuN (green). Expression of EPOR appears to be reduced following forced exercise. The 
EPOR expressions are seen to be higher in the contralateral than the ipsilateral DGs of 
both MCAo and MCAo-runner rats. 
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3.2.10 Erythropoietic factors in cortex 
 
All animals assigned to either exercise or sedentary groups were sacrificed at ten weeks 
post-surgery (includes the total time allocated for trainings and eight weeks of actual 
exercise regime for the runner groups), with two days wash-out period after the last run, 
with or without MCAo . 
 
3.2.10.1 Effects of exercise on erythropoietic factor’s protein expression 
 
Eight weeks of forced treadmill exercise produced a significant up-regulation of EPO 
protein expression in the cortices of sham-runner rats (1.42 ± 0.04 fold) as compared with 
the sham rats, p-value<0.05 (Fig. 35a).  
 
Ipsilateral cortices of the MCAo rats similarly recorded a significant increase in EPO 
protein
Subsequent to eight weeks of post-ischemic forced treadmill exercise, 
 expression by 1.36 ± 0.05 fold (p-value<0.05) in contrast to the sham rats. The 
alteration to the EPO protein levels was not statistically significant in contralateral 
cortices of MCAo rats which were calculated at 1.13 ± 0.08 fold when compared with the 
sham rats.  
 
EPO protein 
expression in both ipsilateral and contralateral cortices of the MCAo-runner rats were 
further increased by 1.76 ± 0.08 and 1.57 ± 0.11 fold respectively. However, only the 
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EPO protein expressions in the ipsilateral cortices of the MCAo-runner rats were 
significantly enhanced when compared with the same cortices in the MCAo rats with 
p-value<0.05. 
  
EPOR protein expression depicted in Fig. 35b, showed a significant increment following 
eight weeks of forced treadmill exercise in the sham-runner rats (1.28 ± 0.04 fold) as 
compared with the sham rats, p-value<0.05.  
 
Ensuing experimental brain ischemia, EPOR protein level was affected and calculated at 
1.21 ± 0.04 fold in the ipsilateral cortices of the MCAo rats however the differences were 
not statistically significant. On the other hand, the changes to the EPOR expression level 
in contralateral cortices of the MCAo rats registered a statistically significant 1.49 ± 0.04 
fold with p-value<0.01 when compared with the sham rats.  
 
Following eight weeks of post-ischemic forced treadmill exercise, EPOR protein level in 
ipsilateral cortices of the MCAo-runner rats displayed a statistically significant further 
increment by 2.19 ± 0.06 fold (p-value<0.01) and remained elevated in the contralateral 
cortices at 2.00 ± 0.11 fold in contrast to the MCAo rats.  
 





Fig. 35. EPO and EPOR protein expressions in the cortex. The EPO and EPOR antibodies 
detect the band at 34kD and 71kD with housekeeping β-actin at 42kD. Changes to protein 
levels in either whole ipsilateral or whole contralateral hemispheres of the cerebral 
cortices were semi-quantified using Western blot. (a) EPO protein level was significantly 
increased in the sham-runner rats by 1.42 ± 0.04 fold when compared with the sham rats. 
Experimental brain ischemia up-regulated the EPO level, only in the MCAo(ipsi), by 1.36 
± 0.05 fold. Post-ischemic exercise can further enhance the expression of EPO by 1.76 ± 
0.08 fold in the ipsilateral cortices in contrast with the same cortices from MCAo rats. (b) 
EPOR protein expression was augmented significantly in the sham-runner and 
MCAo(contra) by 1.28 ± 0.04 and 1.49 ± 0.04 fold respectively when comparing with the 
sedentary rats. Post-ischemic exercise further increased the EPOR level significantly in 
the ipsilateral cortices of MCAo-runner rats by 2.19 ± 0.06 fold. All data were analysed 





3.2.10.2 Effects of exercise and ischemia on staining profile of EPO 
 
These confocal images in Fig. 36 depicted the parietal cortex (bregma -2.0 to -5.0mm ± 
0.5mm) under different experimental conditions. The tissues were double stained with 
EPO (red) and NeuN (green). Sham rats are displayed in Fig. 36A to C and sham-runner 
rats are presented in Fig. 36D to F. The ipsilateral and contralateral cortices of MCAo rats 
are shown in Fig. 36G to I and Fig. 36J to L respectively. The ipsilateral and contralateral 
cortices of MCAo-runner rats are exhibited in Fig. 36M to O and Fig. 36P to R 
respectively.  
 
Fine punctated EPO immunoreactive stainings were evenly distributed over the cortex of 
the sham-operated rats (Fig. 36A to C). Subsequent to eight weeks of regimented 
treadmill exercise in the sham-runner rats, the EPO expression appeared to be marginally 
increased (Fig. 36D to F). Some degrees of co-localisation with NeuN neurons were also 
observed.  
 
Induced stroke caused increased in coarse granules of EPO immunoreactive products 
interspersed between fine immunoreactive specks, in both MCAo (Fig. 36G to I) and 
MCAo-runner (Fig. 36M to O) rats. Co-localisation of EPO in NeuN neurons appear 
more prominent in the MCAo (Fig. 36I and O) rats. In the contralateral cortices of the 
MCAo (Fig. 36J) and MCAo-runner (Fig. 36P) rats, EPO immunoreactivity was 





Fig. 36. Double staining of EPO and NeuN in cortex. These brain sections are prepared 
from either sham-operated or MCAo rats following eight weeks with or without forced 
treadmill exercise. These confocal images depict the parietal cortex at bregma -2.0 to 
-5.0mm ± 0.5mm under different experimental conditions. The tissues were double 
stained with EPO (red) and NeuN (green). EPO staining intensity appears to increase 
marginally in sham-runner rats as compared with the sham rats. Experimental brain 
ischemia, with or without forced exercise, enhanced the EPO staining in the appearance 
of coarse granules interspersed between fine immunoreactive specks in the ipsilateral 




3.2.10.3 Effects of exercise and ischemia on staining profile of EPOR 
 
These confocal images in Fig. 37 depicted the parietal cortex (bregma -2.0 to -5.0mm ± 
0.5mm) under different experimental conditions. The tissues were double stained with 
EPOR (red) and NeuN (green). Sham rats are displayed in Fig. 37A to C and sham-runner 
rats are presented in Fig. 37D to F. The ipsilateral and contralateral cortices of MCAo rats 
are shown in Fig. 37G to I and Fig. 37J to L respectively. The ipsilateral and contralateral 
cortices of MCAo-runner rats are exhibited in Fig. 37M to O and Fig. 37P to R 
respectively.  
 
EPOR expressions in punctated staining pattern were observed in sham rats (Fig. 37A to 
C). The EPOR expression pattern in the sham-runner rats (Fig. 37D to F) remained 
comparable to sham rats albeit higher in quantity.  
 
In the ipsilateral cortices of the MCAo (Fig. 37G to I) and MCAo-runner rats (Fig. 37M 
to O), EPOR-immunoreactivity was highly expressed in the periphery of the primary 
infarct zone. Though some EPOR was co-localised in NeuN neurons, much of them 
appeared to be localised in other cell types with astrocytic like processes. Running 
following MCAo, appeared to reduce the intensity as well as distribution of 
EPOR-immunoreactive products. The contralateral cortices of the MCAo rats (Fig. 37J to 
L) shared similar staining patterns with the sham rats, but the contralateral cortices of the 
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Fig. 37. Double staining of EPOR and NeuN in cortex. Sections of the brain are prepared 
from either sham or MCAo rats following eight weeks with or without forced treadmill 
exercise. These confocal images depict the parietal cortex at bregma -2.0 to -5.0mm ± 
0.5mm under different experimental conditions. The tissues were double stained with 
EPOR (red) and NeuN (green). Sham-runner share similar EPOR staining patterns as 
compared with sham. EPOR staining in the ipsilateral cortices of MCAo rats 
[MCAo(ipsi)] and MCAo-runner rats [MCAo(ipsi)-runner] outlined astrocytic-like 
processes at the periphery of infarct zone. Post-ischemic exercise appear to increase 
EPOR expressions in the contralateral cortices of MCAo-runner rats 




3.2.11 Antioxidants’ profile in hippocampus following forced treadmill exercise 
 
All animals were sacrificed at ten weeks (includes trainings and eight weeks of actual 
exercise regime) with two days wash-out period after the last run. 
 
3.2.11.1 Effects of exercise on antioxidants’ protein expression 
 
Eight weeks of forced treadmill exercise did not have any effect on the Cu/ZnSOD 
protein expressions in the sham-runner rats which were calculated at 1.00 ± 0.04 fold 
which was not statistically significant when compared with the sham rats (Fig. 38a).  
 
Catalase protein expressions in the sham-runner rats were determined at 1.05 ± 0.05 fold 
following eight weeks of forced treadmill exercise which was not statistically significant 
when compared with the sham rats (Fig. 38b).  
 
GPx1 protein expressions were increased by 1.26 ± 0.02 fold following eight weeks of 
forced treadmill exercise in the sham-runner rats in contrast to the sham rats, 






Fig. 38. Protein expressions of antioxidants in the hippocampus. The Cu/ZnSOD, catalase 
and GPx1 antibodies detect the bands at 19kD, 65kD and 22kD with housekeeping 
β-actin at 42kD. Increased physical activity did not give any boost to the hippocampal (a) 
Cu/ZnSOD and (b) catalase protein expressions in the sham-runner as compared with the 
sham rats. (c) Hippocampal GPx1 protein level was the only significantly up-regulated 
protein expression by 1.26 ± 0.02 fold in the sham-runner in contrast with the sham. All 




3.2.12 Antioxidants’ profile in cortex following forced treadmill exercise and brain 
ischemia 
 
All animals assigned to either exercise or sedentary groups were sacrificed at ten weeks 
post-surgery (includes the total time allocated for trainings and eight weeks of actual 
exercise regime for the runner groups), with two days wash-out period after the last run, 
with or without MCAo . 
 
3.2.12.1 Effects of exercise on antioxidants’ protein expression 
 
The whole ipsilateral hemispheres of the cerebral cortices were used for the analysis of 
protein expressions in all groups with additional examination of whole contralateral 
hemispheres for both MCAo and MCAo-runner rats. Cu/ZnSOD protein expression in the 
sham-runner rats showed up-regulation calculated at 1.19 ± 0.07 fold but was not 
statistically significant when compared with the sham rats (Fig. 39a). Conversely, rats 
that was exposed to brain ischemia, Cu/ZnSOD protein expressions recorded significant 
increment in both ipsilateral and contralateral cortices of the MCAo rats (1.65 ± 0.03 and 
1.76 ± 0.05 fold respectively) in contrast to the sham rats, p-value<0.01. Cu/ZnSOD 
protein expression, following eight weeks of post-ischemic forced treadmill exercise, in 
both ipsilateral and contralateral cortices of the MCAo-runner rats, comparable to MCAo 




Compared with the sham rats, eight weeks of forced treadmill exercise showed significant 
increase of catalase protein expression in the sham-runner rats by 1.32 ± 0.06 fold, 
p-value<0.05 (Fig. 39b). Similar to sham-runner rats, catalase protein expression recorded 
a considerable increase in the contralateral cortices of the MCAo rats at 1.32 ± 0.11 fold 
as compared with the sham rats, p-value<0.05. However, the ipsilateral cortices of the 
MCAo rats were determined only at 1.06 ± 0.08 fold which was not statistically 
significant as compared with the sham rats. Catalase protein expression, following eight 
weeks of post-ischemic forced treadmill exercise, in both ipsilateral and contralateral 
cortices of the MCAo-runner rats were documented at 1.19 ± 0.04 and 1.16 ± 0.01 fold 
respectively which were flat when compared with the MCAo rats. 
 
Shown in Fig. 39c, GPx1 protein expressions showed significant up-regulation in the 
sham-runner, both ipsilateral and contralateral cortices of the MCAo rats by 1.38 ± 0.03, 
2.87 ± 0.06 and 2.75 ± 0.08 fold respectively with p-value<0.01 when compared with the 
sham rats. GPx1 protein expression, following eight weeks of post-ischemic forced 
treadmill exercise, in both ipsilateral and contralateral cortices of the MCAo-runner rats 
were determined at 1.36 ± 0.02 and 1.33 ± 0.07 fold respectively. Interestingly, GPx1 
protein expressions in the ipsilateral cortices of the MCAo-runner rats were reduced when 
compared with the same cortices in the MCAo rats with p-value<0.01.  
 





Fig. 39. Protein expressions of antioxidants in the cortex. The Cu/ZnSOD, catalase and 
GPx1 antibodies detect the bands at 19kD, 65kD and 22kD with housekeeping β-actin at 
42kD. Changes to protein levels in either whole ipsilateral or whole contralateral 
hemispheres of the cerebral cortices were semi-quantified using Western blot. (a) 
Cu/ZnSOD protein expressions of the MCAo rats were significantly increased by 1.65 ± 
0.03 and 1.76 ± 0.05 fold in ipsilateral and contralateral hemispheres respectively. 
MCAo-runner rats are comparable to the sendentary rats with brain ischemia. (b) Forced 
treadmill exercise significantly increased catalase protein expression in the sham-runner 
by 1.32 ± 0.06 fold and experimental brain ischemia significantly enhanced catalase 
protein level in the contralateral cortex [MCAo(contra)] by 1.32 ± 0.11 fold when 
compared with sham. (c) Increased in physical activity and experimental brain ischemia 
can increase GPx1 protein level by 1.38 ± 0.03, 2.87 ± 0.06 and 2.75 ± 0.08 fold for 
sham-runner rats, MCAo(ipsi) and MCAo(contra) respectively in comparison with sham 
rats. Post-ischemic exercise significantly down-regulate GPx1 expression in 
MCAo(ipsi)-runner to 1.36 ± 0.02 fold as compared with the MCAo(ipsi). All data are 



























4.1 Effects of single modality and combined treatment on infarct volume and 
intracellular ATP level in acute phase following MCAo 
 
In the event of stroke, effective management of brain ischemia in the acute phase is 
usually achieved by pharmacological interventions with therapeutic windows shown 
clinically to be below three hours following ischemic onset (Clark and Madden, 2009). At 
present, only rt-PA for thrombolytic treatment and antiplatelet therapy are approved 
intravenous medications for the goals of arterial thrombus degradation and restoration of 
vessel patency and blood flow to achieve improved clinical prognosis. However, the 
treatment program fall short in offering direct help to the affected cells of the nervous 
system which is vulnerable and susceptible to cell damage and death when the blood flow 
rate fall under certain threshold. 
 
Cell death modes via apoptosis and necrosis have been shown to occur following MCAo, 
a focal cerebral ischemic model. They have long been recognized and documented as two 
distinct forms of cell death, either biochemically or morphologically, where apoptosis is 
an energy requiring programmed process and necrosis is presumably an unregulated 
mode (Wyllie et al., 1980). However, a body of evidence has shown that apoptosis and 
necrosis may not be mutually exclusive pathways, but may share some common events in 
the earlier cell death process, intracellular ATP level, and the downstream controller, 
which is the primary determinant for the switch between apoptosis and necrosis (Eguchi 
et al., 1997). In the present study, single modality treatment with both the pan-caspase 
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and PARP inhibitors, z-VAD-fmk and 3-AB respectively, have shown infarct size 
reduction following MCAo. Thus, the present data confirmed that both apoptosis and 
necrosis can occur together in the pronecrotic settings of ischemic model. This could also 
imply that the two cell death mode may be initiated by the same stimuli (Lee et al., 1999). 
 
Since the two neuroprotectants work via different pathways, it seems logical to administer 
them concurrently in treating a multi-cell-death-pathways ischemic injury. In the 
combined inhibitors treatment, the present data showed that it has reduced the infarct size 
further when administered with the same pharmacological intervention time course as in 
the single modality experiment. Though studies have shown that both apoptosis and 
necrosis can occur in a cell initiated by common stimuli (Bonfoco et al., 1995; Shimizu et 
al., 1996; Formigli et al., 2000; Papucci et al., 2004), the present data hinted that both 
apoptotic and necrotic outcomes can be regulated by different checkpoints as suggestive 
evidence has shown that combined inhibitors treatment can yield better outcome as 
compared to single inhibitor treatment. Although there is no data to suggest a general 
correlation between the infarct size and the intracellular ATP level, it has been observed 
that the intracellular ATP level of the animals which received the combined inhibitors 
treatment was kept above 4.52×10-3moles/mg tissue. This might imply that higher 
intracellular ATP level play an important role in maintaining the cell’s well being in the 
ischemic brain. Also in the present combined inhibitors experiment, we have shown that 
the longer the time taken for pharmacological intervention, the smaller the infarct size 
reduction. PARP activity has been shown in other studies to peak at the first 30 minutes 
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(LaPlaca, 1999), while initiator caspase-8 activation begins only at the sixth hour and 
executioner caspase-3 was observed 24hr following permanent MCAo (Velier et al., 
1999; Harrison et al., 2001). Therefore, this difference is mainly due to the peak PARP 
activity and not caspase activation. Interestingly, in the Western blot analysis, there was 
PARP cleavage independent of caspase-3 activation. This phenomenon was also noted in 
another study by Cole and Perez-Polo (2002). This might be due to the intracellular ATP 
level not being high enough for the cells to complete the apoptotic process. 
 
It has been suggested that intensity and duration, but not the type of insults, and 
intracellular ATP level can determine the switch between the two cell death modes 
(Bonfoco et al., 1995; Leist et al., 1997). Western blot analysis of the cleaved caspase-3 
and PARP revealed that there was caspase-3 activation and PARP cleavage at 30mg/kg 
and 50mg/kg 3-AB, but not in 10mg/kg 3-AB. The possible explanation is that the dosage 
of 10mg/kg 3-AB was not effective in handling the over-activated PARP which led to an 
inclination for necrotic death mode, and 30mg/kg 3-AB is the minimum dosage required, 
in the current study, to preserve the ATP pool (this is in agreement with data in the ATP 
level experiment in Fig. 8a). 1mg/kg z-VAD-fmk showed caspase-3 activation and PARP 
cleavage but not 3mg/kg and 5mg/kg z-VAD-fmk. In the present study, this could be 
explained that the minimum of 3mg/kg z-VAD-fmk is required to prevent apoptosis, but 
not ischemic damage via other cell death pathways. Although treatments with either 
3mg/kg or 5mg/kg z-VAD-fmk can effectively prevent executioner caspase activation, 
5mg/kg z-VAD-fmk treatment group showed higher intracellular ATP level with lower 
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yield of infarct size reduction. The higher intracellular ATP level for the 5mg/kg 
z-VAD-fmk treatment may be due the inhibition of the energy-requiring apoptotic 
pathway which reduces the utilization of the intracellular ATP. In recent years, more 
evidences have shown that caspases are not only important in apoptosis but they may 
have opposing roles in cellular survival (Los et al., 2001) and neuronal plasticity 
(Gulyaeva et al., 2003). Therefore, the 5mg/kg z-VAD-fmk treatment which yielded a 
lower infarct size reduction as compared to the 3mg/kg z-VAD-fmk treatment despite a 
higher intracellular ATP level may suggest the other possible role of caspases as an 
endogenous neuroprotecting factor following an ischemic insult. The data also 
demonstrate that z-VAD-fmk and 3-AB are not able to prevent cell death fully, and they 
switched the mode of cell death (Wallisser and Thies 1999; Los et al., 2002; Prabhakaran 
et al., 2004). 
 
The data show that there are clear distinction between the sham-operated brain tissue 
intracellular ATP level (1.01×10-2 ± 9.87×10-4moles/mg) and the untreated control brain 
tissue intracellular ATP level (3.36×10-3 ± 2.09×10-4moles/mg). Interestingly, the 
intracellular ATP level measured in the brain tissues of the animals under the single 
modality treatment showed that the 30mg/kg 3-AB treated animals have higher 
intracellular ATP level as compared to the 3mg/kg z-VAD-fmk treated animals, even 
though they have comparative infarct size reduction (26.98% ± 2.22% versus 24.13% ± 
3.89% respectively, p>0.05). This can be explained mechanistically, that the two 
neuroprotectants work differently to inhibit cell death. z-VAD-fmk inhibited the caspase 
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family and prevent the progression of apoptotic program, while allowing PARP to utilize 
the ATP pool to resynthesize NAD+
In conclusion, the study has shown that combined inhibitors treatment with z-VAD-fmk 
and 3-AB can achieve better infarct size reduction as compared to single modality 
treatment using the same chemical compounds. Though the combined inhibitors treatment 
can also further reduce infarct size with pharmacological intervention at 24hr post MCAo, 
it is the earlier intervention that gave the largest reduction in infarct size. Although there 
is no general correlation between intracellular ATP level and infarct size (as a 
consequence of the possible dual roles of caspases which complicate the results in the 
 (Prabhakaran et al., 2004). 3-AB, on the other hand, 
binds to PARP and preserves the ATP level by preventing the PARP (over-activation) 
from utilizing the ATP (Coppola et al., 1995). Although in vitro studies have shown that 
intracellular ATP level increment is positively correlated with cell survival (Izyumov et 
al., 2004), the present data have shown that there is no implied correlation between 
intracellular ATP level and infarct size. However in the 3-AB treated group, there 
appeared to be a trend that suggested higher intracellular ATP level is correlated with 
lower infarct size, and this fashion is not present in the other treatment groups. This 
comparison demonstrates that infarct size following ischemia could be either dependent 
or independent of the intracellular ATP level, depending on the conditions, and for this 
study on the types of inhibitors administered. Therefore, use of the intracellular ATP level 





pan-caspase treatment), in the case of the treatment with PARP inhibitors, there is a trend 
which showed that intracellular ATP level is inversely related to the size of infarct. More 
studies will be required to confirm the possible relationship between the intracellular ATP 
level and the infarct size following an ischemic insult which will have an important 
implication in clinical settings. 
 
4.2 Brain ischemia and exercise affect changes in body weight and neurological 
score 
 
As any form of surgical procedures is considered invasive, the weights of all rats were 
measured at 24hr post surgery. The measurements were compared in percentage, as 
opposed to absolute units of weight, because the present animal cohort was grouped by 
age and thus vary in sizes and weights. A universal decline in weights was observed 
across all groups following surgery. Interestingly, weight lost of animals either in MCAo 
or MCAo-runner rats, which were subjected to actual occlusion, exhibited a reduction 
approximately 2.5 fold more than the drop that had been seen in both sham or 
sham-runner rats with p-value<0.05. Therefore, the rats with insulted brain showed bigger 
weight reduction as compared with sham-operated rats. Generally, weight loss is not 
uncommon with human stroke patient which indicates poor nutritional status (Jönsson et 
al., 2008). The rats were then weighed again at tenth week post-surgery prior to sacrifice 
to ascertain if exercise or brain pathology may have any effect on weight gain. Without 
exception, all the rats registered weight gain across-the-board. However, notably, the 
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gained weight in either sham or MCAo rats, which were not placed on the forced 
treadmill exercise, acquired larger weight gain approximately 2.5 fold more than the 
gained mass seen in the rats that were subjected to forced treadmill exercise with 
p-value<0.05. Interestingly, there was no difference in regaining body weight seen 
between sham-operated rats and rats with actual occlusion. Therefore the results showed 
that the rats were able to gain weight and possibly maintained healthy nutritional status 
regardless of the status of brain pathology. In addition, perhaps expectedly, the prolonged 
exercise regime was able to have an effect on body weight in all conditions set in the 
present study. 
 
Sham-operated rats recovered quickly from the surgical procedures without any reported 
neurological deficits and accounted death. On the other hand, 30% mortality rate was 
accounted for in rats with actual experimental MCAO, thus suggested that the death was 
due to the ischemic brain insults and not the surgical procedures. Rats with experimental 
brain ischemia that survived were subjected to neurological evaluation for a total of ten 
weeks. These rats showed some signs of paralysis which included abnormal posture, 
hemiplegia and a reduction in spontaneous movements. Typically, these symptoms were 
maximal during the first
 
week, and then gradually improved over the following nine 
weeks with or without any forced exercise. Both MCAo and MCAo-runner rats showed 
indications of improving gait functions during the first week of resting period (resting 
period was set at one week and served as the buffering phase that allowed animals to heal 
wounds sustained from the invasive surgical procedures). However, from the fourth week 
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onwards (i.e. two weeks of post-ischemic forced treadmill exercise), MCAo-runner rats 
began to show slightly better functional recovery, as reflected by lower score achieved in 
the neurological examination, as compared to MCAo rats. And at the end of tenth week, 
rats that were subjected to forced treadmill running showed distinct functional recovery in 
contrast with sedentary rats. Running distances covered in the present study were 
considered as moderate regime reported to be effective for enhancing expressions of some 
key gene products believed to mediate favorable effects of exercise on the brain. 
Therefore, eight weeks of moderate forced treadmill exercise following MCAo was able 
to assist stroked rats to regain neurological outcomes earlier and better, which may have 
been linked to up-regulation of some key advantageous gene products, in comparison to 
sedentary animals with MCAo (Shen et al., 2001). 
 
4.3 Long term chronic exercise influences apoptosis in both sham-operated and 
ischemic brain with reference to caspase-3 activation and TUNEL 
 
As the recovery from stroke requires an extended duration therefore a long term 
management plan must be put in place to improve clinical outcomes. Physiotherapy has 
often been prescribed as a complementary therapeutic program on top of pharmacological 
means. Lee and coworkers (2006) have shown that under ischemic conditions, increased 
physical exercises can reduce expression of activated caspase-3. Moreover, various 
studies have shown that increased physical activities can up-regulate endogenous 
neurotrophic factors with effects that have been known to be able to decrease caspase-3 
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activation (Wu et al., 2008; Nguyen et al., 2009; Stranahan et al., 2009). Primarily, 
caspases are synthesized as proenzymes activated by proteolytic cleavage at Asp-X sites 
which contain a conserved pentapeptide QACXG sequence, and have been implicated in 
the progression of apoptotic activity (Cohen, 1997; Nicholson and Thornberry, 1997). 
Among the family of capases, caspase-3 holds a pivotal position as the executioner 
caspase in the downstream of the cascade pathway, and is activated via the proteolytic 
processing of its inactive zymogen into activated p17 and p12 subunits. Activated 
caspase-3 can cause breaks in DNA strand which is one of the hallmarks of apoptosis. 
The ailing cells with broken DNA strands then respond by activating their Poly 
(ADP-ribose) polymerase (PARP) which is a DNA repair enzyme. However, PARP being 
a substrate of caspase-3 can be cleaved and rendered inactive by activated caspase-3 
during apoptosis (Soldani and Scovassi, 2002). 
 
It was demonstrated in the present study that long term forced treadmill exercise, under 
sham-operated condition did not affect the level of both caspase-3 activation and PARP 
cleavage in the hippocampus and cortex. These observations suggested that the 
regimented exercise program designed for the study did not bring about any stress that 
may produce caspase-dependent apoptotic event under sham-operated condition. At the 
same time, TUNEL staining in the brains were also negative for the sham-runner rats. 
 
As the middle cerebral artery do not branch into the hippocampus, this section mainly 
cover on the effects of brain ischemia in the cerebral cortices which bear direct 
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implications following experimental MCAo. In the current permanent MCAo model, 
executioner caspase, caspase-3, was shown to be persistently elevated by 2.84 ± 0.27 fold 
in the ipsilateral cortices of the MCAo rats when compared to the sham rats. This 
relentless elevation of caspase-3 activation in the current animal model suggested 
occurrence of continuing evolvement of brain ischemic pathology even at the chronic 
phase. And the ongoing ischemic episodes were backed by positive TUNEL staining 
being detected in the ipsilateral cortices. This observation of increased activated 
caspase-3 was not repeated in the contralateral cortices within the same MCAo rats thus 
showed that the effect of surgery was localized to specific cortex.  
 
The cleavage of substrate PARP, has been shown to be cleaved in vitro by almost all 
caspases, while in vivo it is the targeted substrate of caspase-3 and -7 (Germain et al., 
1997), was shown to be increased in both ipsilateral and contralateral cortices by 1.50 ± 
0.09 and 1.44 ± 0.13 fold respectively in the MCAo rats. These observations suggested 
that the cleavage of PARP seen in the contralateral cortices was independent of caspase-3 
activation. This phenomenon of PARP cleavage in the absence of caspase-3 has also been 
documented in earlier publications by other laboratories (J¨anicke et al., 1998; Woo et al., 
1998; Slee et al., 2001). As seen in the acute phase experiments, the demise of the cells 
may occur via apoptosis or other non-apoptotic pathways (Yap et al., 2006). The PARP 
cleavage observed in the contralateral cortices may be an effort of the body to prevent 
over-activation of PARP which will lead to depletion of intracellular ATP and subsequent 
cell death due to bio-energetic crisis. 
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Subsequent to ischemic insults, MCAo-runner rats were allowed to rest for one week 
before the initiation of one week familiarization and training on the treadmill (with a 
shorter distance) and eight weeks of moderate exercise regime (for a distance of 892m in 
each run). A “dose-response” correlation between exercise duration/intensity and 
beneficial effects has been reported, whereby the best outcomes were associated with 
moderate exercise. Running distances covered in the present study were well above the 
threshold level of 500m/day, was considered as moderate regime, reported to be needed 
for up-regulation of some key gene products believed to mediate valuable effects of 
exercise on the brain (Shen et al., 2001).  
 
In the present experiment, it was demonstrated that the long term post-ischemic exercise 
could decrease the caspase-3 activation remarkably from 2.84 ± 0.27 fold (seen in the 
MCAo rats) to 0.94 ± 0.04 fold in the insulted ipsilateral cortices of the MCAo-runner 
rats, indicating activated caspase activities at pathological stratum returning back to 
normal level (with reference to the sham rats), when compared with the same cortices of 
the MCAo rats. The caspase-3 activation in the contralateral cortices within the 
MCAo-runner rats was not influenced in any degree after subjected to post-ischemic 
exercise contrasting with MCAo rats. These observations showed that post-ischemic 
exercise alone could effectively reduced the pathological expression of activated 
caspase-3 in the affected region. Contrary to the level of caspase activity, TUNEL 
staining was paradoxically increased in the ipsilateral cortices MCAo-runner rats 
following post-ischemic exercise as compared to the same cortices in the MCAo rats. 
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This observation seemed to put forward an idea that post-ischemic exercise exacerbated 
cell death in the ischemia insulted cortex, but this contradiction upon further 
consideration of various cell death modes in an inevitable cell death circumstance, 
suggested that the increased in TUNEL staining seen in the MCAo-runner rats may 
ironically be beneficial to the ischemic milieu of the nervous system as apoptosis has 
been considered as “less messy” cell death mode which precludes subsequent 
inflammatory response (Patel et al., 2009). Moreover, expression of activated capase-3 
that is inversely correlated with positive TUNEL staining had also been reported in earlier 
studies which showed DNA breakage independent of caspase-3 activation (Liang et al., 
2008; Madeo et al., 2009).  
 
Post-ischemic exercise did not show any significant effect on PARP cleavage in the 
ipsilateral cortices as PARP cleavage was only observed with a marginal drop. However, 
the PARP cleavage in the MCAo-runner rats, in contrast with the MCAo rats, was 
reduced significantly to 0.73 ± 0.03 fold in the contralateral cortices. These observations 
showed that post-ischemic exercise program in the present study could down-regulate 
PARP cleavage in the contralateral cortices more effectively as opposed to PARP 
cleavage reduction in the ipsilateral cortices, therefore suggested the disparity may be due 
the continuing evolvement of the ischemic cortices. As PARP participates in the 
modulation of chromatin architecture, maintenance of genomic stability, regulation of 
transcriptional processes, and the regulation of DNA repair (Lindahl et al., 1995), the 
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reduction in PARP cleavage, in any degree, after post-ischemic exercise may suggest a 
neuroprotective and neuroregenerative role of exercise following ischemic brain insults. 
 
In conclusion, the study has shown that eight weeks of forced treadmill exercise under 
sham-operated condition did not change the level of caspase-3 activation, PARP cleavage 
and TUNEL both in the hippocampus and cortex. Eight weeks of post-ischemic exercise 
were able to lower the level of caspase-3 activation effectively but not PARP cleavage 
(which play pivotal role in caspase-dependent apoptosis) in the ipsilateral cortices from 
the MCAo-runner rats. The paradoxical increase of positive TUNEL staining seen in the 
MCAo-runner rats’ ipsilateral cortices may possibly serve to better manage unpreventable 
cell death. Future studies will be required to study the mechanisms involved in reduction 
of activated caspase-3 following post-ischemic exercise, together with combinatorial 
treatment, and quantify the infarct size using magnetic resonance tools which will have an 
important implication to further exploit physiotherapy in clinical settings. 
 
4.4 Correlation of apoptosis and TGF-β signaling pathway in both sham-operated 
and ischemic brains with or without exercise 
 
TGF-β1 is a member of super-family of multifunctional cytokines that orchestrates 
various critical physiological processes, including proliferation, differentiation, growth 
inhibition, and apoptosis (Schuster and Krieglstein, 2002). In another word, TGF-β1 plays 
a critical role in the maintenance of homeostasis between cell survival and mortality. 
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TGF-β is produced by neurons, astrocytes and microglia in the CNS, and contributes to 
the regulation of neuronal survival (Prehn et al., 1994). Each member of the TGF-β 
superfamily binds characteristically with different receptor configuration where the 
combination of ALK-5 (TGFBR-I) and TGFBR
Long term forced treadmill exercise following sham-operation illustrated in the present 
study showed increased expressions of both TGF-b1 mRNA and TGF-β1 protein by 1.40 
± 0.06 and 1.38 ± 0.05 fold respectively in the sham-operated hippocampus. Unlike in the 
hippocampus, cortices of sham-runner rats did not show any increase in neither TGF-b1 
mRNA nor TGF-β1 protein subsequent to the forced treadmill exercise program which 
remained at 1.07 ± 0.15 fold and 1.05 ± 0.05 fold respectively. On the other hand, both 
hippocampal and cortical 
-II is most common for TGF-β1. Smads 
are divided into three classifications such as receptor-activated smads (R-smads including 
smad2 and smad3), common-partner smad (Co-smad including smad4) and inhibitory 
smad (I-smad including smad6 and smad7). TGF-β1 primarily activates both smad2 and 
smad3 where smad2 and smad3 will form a heterotrimeric complex with smad4 and 
translocate into the nucleus to regulate key target gene transcription cascade (Shi and 
Massague, 2003; ten Dijke and Hill, 2004). The TGF-β1 signaling can be inhibited by 
smad7 but not by smad6 (Shi and Massague, 2003). Smad7 inhibits TGF-β1 signaling 
either by preventing the interaction between smad2 and smad3 with ALK receptor, or by 
inducing the ubiquitination or proteosomal degradation of ALK receptor (Bonni et al., 
2001). 
 
TGFBR-II mRNA did not show any significant change 
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following the forced treadmill exercise. The disproportion of TGF-β1 expression seen in 
the cortex and hippocampus subsequent to exercise suggested that the profile of TGF-β1 
expression may depend on distinct anatomical structures and their functions within these 
structures. Take for example, the immunofluorescence data showed that sham rats’ 
TGF-β1 expressions in both CA1 and DG were detected but did not co-localise with 
NeuN positive neurons. TGF-β1 expression has been shown to be an impediment for 
neurogenic activities which happen in the DG of the hippocampus (Buckwalter et al., 
2006). Interestingly, succeeding forced treadmill exercise, the sham-runner rats showed 
that TGF-β1 expressions were localised with some NeuN labeled neurons in the CA1 
region and also detected in a diffused pattern in both oriens layer and stratum radiatum. 
The TGF-β1 expression in the DG, on the other hand, was substantially reduced. With 
TGF-β1 assuming various roles, it is crucial to note that high level of endogenous 
TGF-β1 has been shown to be inhibitive on neurogenesis (Buckwalter et al., 2006). 
Therefore observations made in the DG, associated with zone of neurogenesis supporting 
learning and memory function, provided possible evidences that suggested forced 
treadmill exercise could assist in preventing inhibition of neurogenesis with reduced 
TGF-β1 expression and its anti-neurogenic properties especially in DG of hippocampus. 
All in all, results from both Western blots and immunofluorescence experiments showed 
that increased TGF-β1 expression in the hippocampus was accounted for in the CA1 
which may benefit neuronal survivability (Prehn et al., 1994). The TGF-β1 expression in 
the cortices of the sham-runner rats, shared a similar staining pattern seen in the CA1, 
with more being localised with NeuN positive neurons subsequent to forced treadmill 
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exercise in comparison with sham rats. As TGF-β1 has been shown to play a 
neuroprotective role in pathological CNS (Dhandapani and Brann, 2003), these 
observations suggested that forced treadmill exercise regime in the current 
sham-operation setting may produce exercise-induced effects comparable to those seen in 
ischemic preconditioning as reported by earlier studies (Boche et al., 2003; Ding et al., 
2006), provide neuroprotection to ensuing brain ischemia by virtue of being localised to 
neuronal cells. At the same time, some TGF-β1 immunoreactive structures that resembled 
vasculatures suggested TGF-β1 being a possible component of angiogenesis that too offer 
protection when responding to subsequent ischemic attack (Roethy et al., 2001). 
 
Smad2 mRNA level was not increased with prolonged forced treadmill exercise, but both 
smad7 mRNA and protein level was up-regulated significantly by 2.30 ± 0.45 fold and 
1.54 ± 0.07 fold respectively in the hippocampi of sham-runner rats. As in the case of the 
hippocampus, forced treadmill exercise did not induce any significant increase in cortical 
smad2 mRNA level. Conversely, cortical expression of both smad7 mRNA and protein, 
differing from the hippocampus, did not register any significant increase following the 
exercise program. Smad7 is an inhibitory smad which interrupts the downstream 
signaling pathway of TGF-β1, therefore its concomitant increase expression alongside 
with up-regulated TGF-β1 level in the hippocampus may play an essential role in 
regulating TGF-β1 signals. The sham rats’ immunofluorescence data showed that smad7 
expression was detected in the oriens layer, stratum radiatum and DG. The sham-runner 
rats seemed to have more smad7 being expressed by NeuN positive neurons in both CA1 
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and DG. These observations suggested that the localisation of smad7 to CA1’s neurons 
may be due to the concomitant increase in TGF-β1 expression to moderate TGF-β1 
signaling in sham-runner rats’ CA1’s neurons. Although TGF-β1 staining profile may 
have been reduced in the DG, the detection of smad7 in neurons resided in the DG were 
possibly regulated by factors found in other pathways that also has been noted with the 
same capacity to illicit TGF-β1 signaling (Ulloa et al., 1999; Bitzer et al., 2000). And this 
detection of smad7 in the DG may further suppressed the already reduced TGF-β1’s 
action and accentuate its condition for neurogenesis. Sharing a similar staining pattern as 
the hippocampus, the smad7 expressions in the cortices of the sham-runner rats appeared 
to be localised more with the NeuN labeled neurons after forced treadmill exercise in 
comparison with the sham rats. This staining pattern of smad7 when mirrored that of the 
cortical TGF-β1 staining profile suggested co-expression of smad7 and TGF-β1 in 
neurons may indicate likelihood of moderated TGF-β1 signaling subsequent to forced 
treadmill exercise. 
 
MCAo rats’ cortical TGF-b1 and TGFBR-II mRNAs expressions did not register any 
significant change following prolonged permanent MCAo in both ipsilateral and 
contralateral cortices. The cortical TGF-β1 protein expression was observed at 1.28 ± 
0.05 fold in the ipsilateral cortices but the marginal change was also not statistically 
significant when compared with the sham rats. The contralateral cortices, on the other 
hand, registered a significant up-regulation of the cortical TGF-β1 protein expression 
which was calculated at 1.71 ± 0.08 fold. The reasons for the differences seen in the 
169 
 
TGF-b1 mRNA and TGF-β1 protein levels in the contralateral cortices may be attributed 
to the involvement of ill defined post-transcriptional mechanisms and in vivo half lives 
(Greenbaum et al., 2003). TGF-β1 protein expression in earlier studies have been shown 
to be up-regulated in the acute phase subsequent to brain ischemia and asserted 
neuroprotective functions (Ata et al., 1999; Boche et al., 2003). In the present study, 
TGF-β1 protein expressions in the chronic phase were considerably up-regulated only 
within the contralateral cortices. With reference to the expression profile of activated 
caspase-3 at 2.84 ± 0.27 and the detected positive TUNEL, the marginal increase of 
TGF-β1 protein in the ipsilateral cortices was not sufficient to reduce activation of the 
executioner caspase and subsequent caspase-3 dependent apoptosis, therefore showing 
that TGF-β1 protein expression were not able to retain its expression level that could 
provide effective neuroprotective threshold in the chronic phase of experimental MCAo. 
At the other end of the spectrum, persistent elevation seen in its contralateral cortices may 
be accountable for ischemic preconditioning (Boche et al., 2003; Ding et al., 2006). The 
immunofluorescence data of the MCAo rats showed that cortical TGF-β1 proteins were 
highly immunostained and appeared to be more localised with NeuN positive neurons in 
both ipsilateral and contralateral cortices analogous to the observations made in the CA1s. 
TGF-β1 has been reported to have neuroprotective functions and thus these observations 
seen in the MCAo rats suggested that the localisation of TGF-β1 to neurons in the 
immediate periphery of injury may prevent neuronal cell damage and assist cellular repair 
(Ata et al., 1999; Boche et al., 2003). However the present TUNEL data showed some 
cortical neurons with positive TUNEL staining thus suggested that neuroprotection via 
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the TGF-β1 was possible to protect but not able to prevent the entire population of 
neurons from imminent (apoptotic) cell death when cross referenced with the activated 
caspase-3 protein level in the ipsilateral cortices. The detection of TGF-β1 protein, in 
both NeuN labeled neurons and other cell structures, further away from the injury site 
suggested that non-neuronal type cells also produced TGF-β1 protein following ischemic 
insults and contributed to the extracellular level of TGF-β1 spotted in the interstitium of 
the cortex and hippocampus (Prehn et al., 1994). 
 
Cortical smad2 and smad7 mRNAs, following experimental brain ischemia, were not 
significantly altered in both ipsilateral and contralateral cortices of MCAo rats. However, 
cortical smad7 protein expressions were increased significantly in both cortices of the 
MCAo rats at 1.50 ± 0.09 fold (ipsilateral cortices) and 1.43 ± 0.10 (contralateral cortices) 
fold. These differences seen in the smad7 mRNA and protein levels, like in the case of 
TGF-β1, may be attributed to the involvement of ill defined post-transcriptional 
mechanisms and in vivo half lives (Greenbaum et al., 2003). Smad7 expression increases 
in response to both TGF-β1 and factors regulating TGF-β1 (Ulloa et al., 1999; Bitzer et 
al., 2000), however the increased in smad7 protein expression in the ipsilateral cortices 
may further undermined the marginal elevation of TGF-β1 proteins for neuroprotective 
functions thus exacerbating the harsh ischemic pathology. The immunofluorescence data 
showed that cortical smad7 proteins of the MCAo rats were expressed in both NeuN 
labeled neurons and other cell structures in the two cortices. Therefore the observed 
increment and co-localisation of smad7 to neurons, in addition to the expressions of 
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TGF-β1, in the ailing ipsilateral cortices suggested that neuroprotective domain of 
TGF-β1 activities, not only were unsustainable, but were further challenged and 
handicapped by inhibitory smad during the chronic phase of experimental MCAo (Park, 
2005; Hong et al., 2007). With reference to the TUNEL data, the neurons of the ipsilateral 
cortices with positive TUNEL staining reiterated that TGF-β1 signals, which can be 
moderated by inhibitory smads, were compromised for neuroprotection following 
prolonged experimental brain ischemia. In the same experimental group, hippocampal 
smad7 proteins appeared to be marginally increased and were co-localised with the 
neurons and other cell structures in both CA1s and DGs of ipsilateral and contralateral 
hippocampi when compared with the sham rats. These observations made on smad7 
staining patterns in the MCAo rats suggested that the inhibitory smad may follow the 
staining patterns of the TGF-β1 in an attempt to moderate actions of TGF-β1 signaling. 
However, since TGF-β1 has been shown to suppress neurogenesis, the presence of 
smad7, which inhibited TGF-β1 activity, in neurons located in the DGs perhaps could be 
regarded as a favorable response to regain learning and memory functions (Buckwalter et 
al., 2006). 
 
MCAo-runner rats’ cortical TGF-b1 mRNA levels in the ipsilateral cortices were further 
increased when compared with the sedentary MCAo rats and were considered 
significantly increased following post-ischemic exercise when compared with the sham 
rats. On the other hand, the cortical TGF-b1 mRNA level in the contralateral cortices of 
the same experimental group remained up-regulated as was in the MCAo rats. The 
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cortical TGF-β1 protein expressions of the MCAo-runner rats were recorded with 
statistically significant increase of 1.55 ± 0.05 fold in ipsilateral cortices while the 
TGF-β1 protein in contralateral cortices remained at an elevated level as compared with 
the MCAo rats at 1.73 ± 0.12 fold. Cortical TGFBR-II mRNA registered a significant 
down-regulation in the ipsilateral cortices of the MCAo-runner rats by 0.59 ± 0.06 fold, 
and the cortical TGFBR-II mRNA in the contralateral cortices remained comparable to 
the level similar with sham rats. With up-regulated TGF-β1 protein level in the ipsilateral 
cortices, these changes in the TGFBR-II mRNA did not influence the reduction of 
activated caspase-3. In comparison with the MCAo rats, post-ischemic exercise was able 
to elevate the TGF-β1 protein to a significant level which was effective and correlated 
with considerable reduction in the activation of executioner caspases (Zhu et al., 2001). 
TUNEL stainings on the other hand showed a conflicting trend of increased apoptosis in 
neurons (with more positive TUNEL immunoreactivities) in the ipsilateral cortices 
following post ischemic exercise, even when the immunofluorescence data of the 
MCAo-runner rats showed that cortical TGF-β1 proteins in the ipsilateral cortices were 
localised to both NeuN labeled neurons and other cells. In the contralateral cortices of the 
MCAo-runner rats, cortical TGF-β1 proteins were expressed mainly in non-neuronal 
cells. These observations in the MCAo-runner rats showed that post-ischemic exercise in 
the present study was able to further increase the cortical TGF-β1 protein level in the 
ischemia-insulted ipsilateral cortices. Following post-ischemic exercise, TGF-β1 proteins 
were localised with more non-NeuN positive cells than NeuN labeled neurons in both 
cortices suggested that TGF-β1 protein production under such circumstances involved 
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more non-neuronal type of cells, and TGF-β1 localised to neurons in the ipsilateral 
cortices may imply cellular protection for the vulnerable neurons or merely swaying the 
cell death mode to less “messy” apoptotic course. Therefore, the increase in TUNEL 
detection in the ipsilateral cortices following post-ischemic running may not necessarily 
be taken as a failed attempt in improving the outcome after experimental stroke. In the 
same experimental group, the hippocampal TGF-β1 protein in the CA1 region was 
localised to both NeuN labeled neurons and other cell structures in both ipsilateral and 
contralateral hippocampi. Sharing a similar trend seen in the sham-runner rats, the 
hippocampal TGF-β1 staining patterns in the DG were substantially reduced in intensity 
subsequent to post-ischemic exercise. The detection of persistent expression of TGF-β1 
protein in the CA1 region and the lowered staining TGF-β1 intensity in the DG suggested 
that the beneficial effects of post-ischemic exercise may be moderated for 
neuroprotection in the CA1 region and neuroregenerative potential in the DG. 
 
MCAo-runner rats, as compared with the MCAo rats, registered slight drop in cortical 
smad2 mRNA level at 1.24 ± 0.14 and 1.10 ± 0.04 fold and smad7 mRNA level at 0.73 ± 
0.04 and 1.01 ± 0.10 fold in both ipsilateral and contralateral cortices respectively albeit 
not statistically significant following post-ischemic exercise when compared with the 
sedentary MCAo rats. Cortical smad7 protein expression in the ipsilateral cortices was 
significantly brought down to 1.03 ± 0.07 fold in the MCAo-runner rats, comparable to 
sham rats, in contrast with the same cortices of the MCAo rats. On the other hand, no 
alteration to the cortical smad7 protein expression was observed in the contralateral 
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cortices following post-ischemic exercise which remained at 1.36 ± 0.08 fold when 
compared with MCAo rats. This significant reduction in the smad7 protein, in addition to 
increased TGF-β1 polypeptide, presented permissive conditions in the ipsilateral cortices 
which were correlated with down-regulation of activated caspase-3 therefore reinforced 
the neuroprotective role of TGF-β1 signaling following post-ischemic exercise. Even with 
the background of paradoxical increased apoptosis in neurons depicted in the TUNEL 
data, the outcome may not necessary be viewed with negative connotation and instead 
offered a more favorable condition for the body to manage inevitable cellular death by 
going down a route which will less likely to induce inflammatory responses. The 
immunofluorescence data of MCAo-runner rats showed that cortical smad7 protein 
expressions were restricted to neurons in the ipsilateral cortices and highlighted the 
influence of smad7 within NeuN neurons being more widespread following post-ischemic 
exercise, reversing the hopes hinged on the anti-apoptotic functions of TGF-β1. The 
staining patterns of the cortical smad7 protein in the contralateral cortices of the 
MCAo-runner rats did not differ much as compared to the same cortices of the MCAo 
rats. Even with smad7 protein level being greatly reduced in the ipsilateral cortices, the 
localisation of smad7 to neurons may still have an inhibitive grip on the TGF-β1’s 
neuroprotective function to a certain degree therefore impeded the prevention of cell 
death to individual neurons. Several studies had been conducted and showed 
up-regulation of TGF-β1 in other types of tissue following exercise (Hering et al., 2002; 
Heinemeier et al., 2003); however this is the first study to document the beneficial effects 
of forced exercise and post-ischemic exercise on TGF-β1 expression profile in (rat) brain 
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tissues. In ipsilateral hippocampi of the same experimental group, the hippocampal smad7 
protein expressions at both CA1 region and DG were detected with lower staining 
intensity subsequent to post-ischemic exercise. Following the same discussion thread 
earlier, the reduced intensity of smad7 may enhance the neuroprotective role of TGF-β1 
in the CA1 region, but on the other hand, may undermined neuroregenerative potential in 
the DG. The hippocampal smad7 protein expression at both CA1 region and DG in the 
contralateral hippocampi of the MCAo-runner rats did not show any contrasting 
difference in the staining profile as compared with the MCAo rats. 
 
In conclusion, the study has shown that eight weeks of forced treadmill exercise may be 
able to induce preconditioning-like effects and enhance neurogenic potential via TGF-β 
signaling in hippocampus, but not cortex, with increased TGF-β1 and smad7 under 
non-ischemic condition. And eight weeks of post-ischemic exercise were reported to be 
able to bring about neuroprotection via enhanced TGF-β signaling (cross reference to the 
reduction in activated caspase-3) with elevated TGF-β1 and down-regulated smad7 
protein expressions. More studies will be needed to study the effects of exercise, together 
with combinatorial treatment, on regulation TGF-β signaling in permanent focal brain 






4.5 Impact of exercise on angiogenesis in brain with or without ischemia in 
reference to PDGFB level 
 
Hypoxia-inducible factor 1 (HIF-1) is a wide spectrum transcription factor that encodes 
for various proteins that mediate molecular responses to reduced oxygen availability 
(Stroka et al., 2001; Shao et al., 2005). During hypoxia, HIF-1α subunit is protected from 
ubiquitination and proteasomal degradation thus allowing accumulation of HIF-1α 
subunit which is then translocated into the nucleus from the cytoplasm to form 
heterodimerization of the HIF-1α and HIF-1β subunits (Semenza, 1999; Wenger, 2000). 
This complex, together with its transcriptional co-activators, will then bind to the hypoxia 
response elements of various HIF-1 target genes such as VEGF and PDGF (Fandrey et 
al., 2006; Yoshida et al., 2006) to elicit an appropriate response. Vascular endothelial 
growth factor (VEGF) is a major family of angiogenic growth factor that induces 
vascularisation (Carmeliet and Storkebaum, 2002). VEGF ligand binds to the vascular 
endothelial growth factor receptors (VEGFR), a tyrosine kinase receptor, other than to 
induce vascularisation, also elicit several intracellular signaling pathways to promotes cell 
proliferation and induce cell survival (Takahashi et al. 1999; Kilic et al. 2006). VEGFR 
are dichotomized into VEGFR-1 and VEGFR-2 with VEGFR-2 being the primary 
transducer of VEGF signals. VEGF expression level is increased following a variety of 
brain insults. On top of its angiogenic property, VEGF signals have been documented to 
play a neuroprotective and neurotrophic roles (Carmeliet and Storkebaum 2002) and exert 
direct effects on different cell types such as neurons, astrocytes, and microglia. Under 
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hypoxia, VEGFR-2 expression was found to co-localise with the endothelial cells of 
blood vessels, astrocytes, and neurons (Kovacs et al., 1996; Kilic et al., 2006) at 48hr 
post-stroke and persist up to ten days. Platelet-derived growth factor (PDGF) is expressed 
as an inactive monomeric form is then activated proteolytically to form homodimeric or 
heterodimeric complexes. Active PDGF ligands interact with two distinct, but structurally 
related, membrane bound receptor tyrosine kinases, PDGF receptor-A (PDGFRA) and 
PDGF receptor-B (PDGFRB) (Fredriksson et al., 2004; Reigstad et al., 2005). Each 
PDGFR has been shown to have different affinity with different PDGF ligands (Heldin 
and Westermark, 1999; Li et al., 2000; Bergsten et al., 2001; LaRochelle et al., 2001), 
where PDGF-BB has a greater binding affinity for PDGFRB. In congruence of VEGF and 
VEGFR roles in vascularisation, PDGFB and its receptor PDGFRB displayed a 
complementary role in the maturation process (Folkman and D’Amore, 1996; Lindahl et 
al., 1997; Yancopoulos et al., 2000).
In the present study, it was demonstrated that hippocampal HIF-1α protein was increased 
significantly by 1.82 ± 0.24 fold subsequent to long term forced treadmill exercise. The 
 In the CNS, PDGFB and its receptor PDGFRB were 
found to be expressed strongly in neurons (Sasahara et al., 1991; Smits et al., 1991). 
Following cerebral ischemia, expression of the ligand has been up-regulated in neurons 
and macrophages, and expression of its receptor has been observed in neurons, astrocytes 
and macrophages which suggest possibly neuroprotective function in addition to the role 
of angiogenic maturation (Iihara et al., 1994; Cheng and Mattson, 1995; Iihara et al., 




hippocampal HIF-1α mRNA on the other hand was also evaluated with an upward trend 
at 1.67 ± 0.42 fold albeit not statistically significant. Both hippocampal VEGF mRNA 
and hippocampal VEGFR2 mRNA were observed with up-regulation at 1.38 ± 0.38 and 
2.07 ± 0.91 folds respectively following forced treadmill exercise but were not 
statistically significant due to wide ranging standard error. The VEGF protein expression 
level in an earlier work had shown that VEGF was up-regulated significantly following 
long term exercise (Ding et al., 2004). And this increase in the VEGF protein level may 
have been influenced by the exercise induced up-regulation of HIF-1α proteins, 
transcription factor of VEGF, seen in the hippocampus in the current study (Fandrey et 
al., 2006). Both hippocampal PDGFB mRNA and hippocampal PDGFRB mRNA were 
significantly increased by 1.53 ± 0.16 and 2.58 ± 0.35 folds respectively following forced 
treadmill exercise. Accordingly, the PDGFB protein level was also calculated with a 
significant increment at 1.30 ± 0.03 fold after forced treadmill exercise. The increase in 
PDGFB, like in the case of VEGF, may have been influenced by the exercise induced 
up-regulation of HIF-1α which is also a transcription factor of PDGF (Yoshida et al., 
2006). Studies have shown that hypoxic preconditioning can enhance ischemic tolerance 
and prevent exacerbation of neurodegeneration via increase in HIF-1α (Baranova et al., 
2007; Gu et al., 2008; Peng et al., 2008). And in separate studies, exercise 
preconditioning has been described to emulate hypoxic preconditioning in ameliorating 
neurodegeneration (Ding et al., 2005; Ding et al., 2006). The present study is the first 
report to show up-regulation of hippocampal HIF-1α following eight weeks of forced 
treadmill exercise. Thus, apart from regulating the angiogenic factors, this increased in 
179 
 
hippocampal HIF-1α may also contribute directly to the neuroprotective properties seen 
in studies looking at preconditioning effects. Studies using animal model have also 
reported that increased physical exercise can induce neurogenesis and improve spatial 
memory (Clark et al., 2008; Naylor et al., 2008). PGDFB, has been implicated in the 
maturation process of neo-vascularisation in earlier studies, was shown to be increased in 
the hippocampi after forced treadmill exercise under sham-operated condition in the 
current settings (Folkman and D’Amore, 1996; Lindahl et al., 1997; Yancopoulos et al., 
2000). Similarly, up-regulation of PGDFB, like VEGF, may have been under the 
influenced of increased level of HIF-1α. Taken together with increased VEGF following 
exercise shown in earlier studies, the PDGF/VEGF system may play an important role of 
stabilizing angiogenesis in support of the neurogenesis and enhanced learning and 
memory properties seen in other studies (Clark et al., 2008; Naylor et al., 2008). 
 
The cortices presented different expressional profiles as compared with the hippocampi, 
the study demonstrated that both cortical HIF-1α mRNA and cortical HIF-1α protein were 
increased marginally by 1.23 ± 0.08 and 1.17 ± 0.05 folds respectively subsequent to long 
term forced treadmill exercise, but the changes were not statistically significant in 
contrast to the sham rats. The cortical VEGF mRNA did not register any significant 
difference after forced treadmill exercise. Although the cortical VEGFR2 mRNA was 
observed with up-regulation at 1.77 ± 0.35 fold following forced treadmill exercise, the 
change was also not statistically significant due to wide standard error. However, the 
up-regulation of cortical VEGF recorded in earlier exercise studies, in contrast with the 
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absence of concomitant increase in HIF-1α observed in the present study, suggested that 
regulation of VEGF protein level may involve other transcription factors in brain cortices 
thus different means of regulations may be used in various brain regions (Ding et al., 
2004; Birk et al., 2008). While the cortical PGDFB mRNA level was increased 
significantly by 1.46 ± 0.10 fold after forced treadmill exercise, the cortical PGDFB 
protein and PDGFRB mRNA did not show any significant alteration when compared with 
the sham rats. In contrast with the hippocampal region, the cortical expressions of both 
HIF-1α and PGDFB protein were noted with increment that was not significant. Although 
the increment of PDGFB in this group was marginal, angiogenesis as represented by 
Pecam-1 was detected in the cortices. These observations suggested that even marginal 
increase in PDGFB, together with the expected VEGF increment shown in earlier studies, 
played a maintenance role important for sustaining the integrity of new vascular structure 
produced following long term forced treadmill exercise (Ding et al., 2004). These new 
blood vessels formed would be able to meet the demand of increased brain metabolism 
and its presence also offered physical evidence to support preconditioning-like effects. 
Taken together, the data from both hippocampus and cortex showed a consistent 
correlative trend between HIF-1α and PGDFB which highlighted the possibility that 
HIF-1α play a major role in regulating PGDFB’s expressions in sham-operated brain. 
 
The MCAo rats’ cortical HIF-1α proteins were significantly up-regulated by 1.51 ± 0.09 
fold in the ipsilateral cortices but not in the contralateral cortices which was evaluated at 
1.22 ± 0.05 fold in contrast with the sham rats. These results implied that the ischemic 
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brain pathology was still evolving at the chronic phase following experimental MCAo 
and the ipsilateral cortices of the MCAo rats were able to adapt to the unremitting 
ischemic insult by increasing the cortical HIF-1α protein appreciably. This increase in 
HIF-1α protein also reflected the tissue’s localised adaptation to ischemic insults (Ratan 
et al., 2007). However, the cortical HIF-1α mRNA registered an opposite expression 
profile with a significant down-regulation in both ipsilateral and contralateral cortices at 
0.46 ± 0.02 and 0.50 ± 0.05 respectively. Although both cortical VEGF mRNA and 
cortical VEGFR2 mRNA in the two cortices were not observed with any significant 
change in the chronic phase of experimental brain ischemia, increased VEGF protein 
expression was reported in earlier study during chronic phase of brain ischemia (Zhang et 
al., 2002). On the other hand, both ipsilateral and contralateral cortices of the MCAo rats 
recorded significant increase of cortical PGDFB mRNA recorded at 1.59 ± 0.08 and 1.51 
± 0.06 fold respectively. However this significant genomic expression did not translate 
into similar protein profile. The cortical PGDFB proteins in the two cortices were not 
noted with any significant change. At the same time, cortical PDGFRB mRNA 
expressions managed apparent but not statistically significant upward trends in both 
ipsilateral and contralateral cortices recorded at 1.60 ± 0.15 and 1.75 ± 0.27 respectively. 
The reasons for the contradicting phenomenon seen in mRNA and protein levels of the 
ischemic cortices during the chronic phase of experimental MCAo may be attributed to 
the involvement of under defined post-transcriptional mechanisms and in vivo half lives 
(Greenbaum et al., 2003). As HIF-1α is one of the various transcription factors for PGDF, 
it was surprising to see absence of reciprocal increment of cortical PGDFB protein in 
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tangent with the increased HIF-1α protein in the ipsilateral cortices of the MCAo rats 
(Yoshida et al., 2006). This phenomenon of PGDFB protein repression in chronic phase 
of hypoxia/ischemia had also been reported by Ullerås and coworkers who suggested the 
involvement of a biphasic regulation of PGDFB (Ullerås et al., 2001). This repression of 
PDGFB in the late phase of chronic experimental stroke was correlated with 
compromised angiogenesis depicted by Pecam-1 immunoreactivities, thus PDGFB may 
have been highlighted for its importance in maintenance of stable neo-vasculature 
following brain ischemia. 
 
Similarly with MCAo rats, cortical HIF-1α proteins in the MCAo-runner rats were 
significantly up-regulated in the ipsilateral cortices but not in the contralateral cortices. 
And the cortical HIF-1α mRNAs remained in the opposite expressional profiles noted 
with significant down-regulation in both cortices. Taken together with the sham-runner 
rats, these results showed that long term forced treadmill exercise did not have any effect 
on HIF-1α protein expressions in the cortical regions under both sham-operated and 
ischemic conditions. Both cortical VEGF and VEGFR2 mRNAs, in the two cortices of 
MCAo-runner rats similar to MCAo rats, were also not observed with significant change 
in the late phase of experimental brain ischemia. Subsequent to post-ischemic exercise, 
cortical PGDFB mRNA levels in the ipsilateral cortices of the MCAo-runner rats were 
significantly down-regulated to 0.79 ± 0.09 fold as compared with the same cortices of 
the MCAo rats at 1.59 ± 0.08 fold. Although the cortical PGDFB mRNA levels in the 
contralateral cortices were also observed with reduction following post-ischemic exercise 
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when compared with the MCAo rats, the change was not statistically significant. 
Interestingly, the cortical PGDFB proteins in the ipsilateral cortices of the MCAo-runner 
rats, showed an opposite trend to its genomic profile, were significantly up-regulated to 
1.43 ± 0.11 fold as compared with the same cortices of the MCAo rats (and also 
sham-operated rats). PGDFB proteins in the contralateral cortices of the MCAo-runner 
rats also showed increment by 1.30 ± 0.12 fold albeit not statistically significant in 
contrast to the MCAo rats. At the same time, cortical PDGFRB mRNA in the ipsilateral 
was significantly increased by 2.82 ± 0.75 fold following post-ischemic exercise when 
compared with the sham rats but not the MCAo rats. The strong up-regulation of the 
cortical PGDFB proteins, following post-ischemic exercise, observed in the ipsilateral 
cortices of MCAo-runner rats were not accompanied by any further change in HIF-1α 
expressions, suggested that increased cortical PGDFB protein under ischemic condition 
was not due to HIF-1α alone but may involved other transcription factors and regulation 
as well (Dirks and Bloemers, 1996). The further increase of PGDFB protein seen in the 
MCAo-runner rats, in comparison with the sham-runner rats, suggested that ischemic 
insults and exercise could be regarded as two separate factors which allowed mutual 
potentiation in regulating the expressions of angiogenic factors. The increased of Pecam-1 
staining intensity noted in MCAo-runner rats as compared to that of MCAo rats suggested 
that enhanced expressions of PDGFB protein following post-ischemic exercise were able 
to reverse compromised angiogenesis by a limited degree as angiogenic potential could 
have been thwarted by the harsh ischemic milieu. And cross referencing to the data on 
cleaved caspase-3 protein expression, post-ischemic exercise mediated increase in 
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PDGFB, other than in angiogenesis, was also correlated to the reduced activation of 
executioner caspase thus possibly serving neuroprotective function in addition to 
maturation of neo-vasculature. 
 
In conclusion, the study has shown that eight weeks of forced treadmill exercise may 
induce preconditioning-like effects and enhance maturation of angiogenesis with 
marginal increase of HIF-1α and PDGFB under sham-operated condition. And eight 
weeks of post-ischemic exercise has shown to be able to up-regulate HIF-1α and 
especially PDGFB, as compared with sedentary rats with experimental brain ischemia, 
thus contributed to neuroprotection and maturation of newly formed blood vessels under 
ischemic condition. Future studies will be required to study the effects of exercise 
together with combinatorial treatment on HIF-1α and PDGFB in permanent MCAo at 
varying temporal profile which will have an important implication in clinical settings. 
 
4.6 Effects of exercise on erythropoietic factors in brain under either 
sham-operation or ischemia 
 
EPO is produced mainly in the adult kidney and the foetal liver (Fisher, 2003). However, 
both EPO and its receptor (EPOR) are also expressed in the CNS (Bernaudin et al., 1999; 
Bernaudin et al., 2000; Sirén et al., 2001b). As EPO is a target gene of transcription factor 
HIF-1α, during hypoxia and ischemia, expressions of erythropoietin (EPO) and its 
receptor (EPOR) are enhanced as a result of HIF-1α accumulation (Semenza and Wang, 
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1992; Wenger, 2000). In several in vitro and in vivo experiments, endogenous EPO has 
shown neuroprotective effects against neurological injury (Grasso et al., 2001; Junk et al., 
2002) and neurotrophic effects to support neurogenesis (Shingo et al., 2001), in addition 
to its role in erythropoiesis (Yamaji et al., 1996). Treatment with rHuEPO in hypoxic and 
ischemic animal experiments have shown significant reduction in delayed neuronal cell 
death in the CA1 area of the hippocampus and prevented cognition impairment in the 
passive avoidance test (Sakanaka et al., 1998; Catania et al., 2002; Zhang et al., 2006). 
Taken together, EPO can exert both direct and indirect effects to improve sensory, 
cognitive and endocrine functions of the CNS following brain insults. The direct effects 
of EPO are independent of erythropoiesis but acting as a neurotrophic or neuroprotective 
factor (Marti et al., 2000). EPO prevents hypoxia- and glutamate-induced neuronal cell 
death by activation of calcium channels, increasing the activity of antioxidant enzymes in 
neurons, modulation of angiogenesis in the ischemic brain, and by anti-apoptotic effects 
via the activation of janus kinase-2 (JAK2) and nuclear factor κB (NF-κB) signaling 
pathways (Digicaylioglu and Lipton, 2001; Chong et al., 2002). Whereas indirectly, the 
EPO act through its erythropoiesis-stimulating effect to increase the oxygen supply to the 
brain thus counteracts the detrimental effects of hypoxia 
In the present study, the hippocampal EPO and EPOR proteins were demonstrated to 
increase significantly by 1.97 ± 0.30 and 1.63 ± 0.19 folds respectively subsequent to 
long term forced treadmill exercise. This statistically significant up-regulation of EPO 





and EPOR proteins were repeated in the cortex at 1.42 ± 0.04 and 1.28 ± 0.04 folds 
respectively in the sham-runner rats in contrast with the sham rats. In the 
immunofluorescence experiment, EPO proteins were hardly detected in the CA1s and 
DGs but were mildly detected in the cortices of the sham rats. Subsequent to forced 
treadmill exercise, EPO proteins not only were detected but were also co-localised with 
the NeuN labeled neurons in all the three regions stated above. As DG has been regarded 
as the high plasticity region in adult brain, the detection of EPO in the DGs may suggest 
plausible neurotrophic role in inducing neurogenesis leading to improved learning and 
memory properties with moderate exercise (Marti et al., 2000; Zhang et al., 2006). EPOR 
proteins on the other hand were constitutively expressed in the CA1s, DGs and cortices. 
While the staining intensities of EPOR proteins remained relatively similar following 
forced treadmill exercise in the CA1s and cortices, the EPOR immunoreactivity in the 
DGs seemed to be slightly reduced. These results showed that exercise under 
sham-operated condition not only increased but also redistributed the EPO protein mainly 
to the neurons found in CA1s, DGs and cortices. Because EPO can exert both direct and 
indirect effects, the localisation of EPO to neurons after exercise suggested that the 
exercise regime used for the present experiment could bring about the direct effects of 
EPO possibly with a neuroprotective and neurotrophic functions (Grasso et al., 2001; 
Shingo et al., 2001; Junk et al., 2002). EPOR had been shown in other study to play an 
essential role in neurogenesis, therefore the elevation of EPOR protein measured in the 
present study suggested that long term forced exercise may permit EPO-EPOR mediated 
neuroprotection and neurogenesis (Tsai et al., 2006). Although earlier studies had 
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reported EPO production could be induced by increased physical activity, this is the first 
work to show the effects of forced treadmill exercise enhancing expression of EPO 
together with its receptor in the CNS that may form one of the underlying mechanism for 
preconditioning-like effects as well as improved learning and memory properties 
following exercise seen in other studies (Robert and Smith, 1999; Marti 
In the MCAo rats, cortical EPO proteins were registered with a statistically significant 
increase of 1.36 ± 0.05 fold in the ipsilateral cortices. However, the cortical EPOR protein 
was up-regulated significantly by 1.49 ± 0.04 fold only in the contralateral cortices. 
Although EPOR protein in the ipsilateral cortices was also increased by 1.21 ± 0.04 fold, 
the adjustment was not statistically significant. In the immunofluorescence experiment, 
subsequent to prolonged ischemic insult in the MCAo rats, cortical EPO and EPOR 
proteins were localised to both neurons and other cells in both cortices. Interestingly, in 
the immediate periphery of the injury site, resembling astrocytic-like processes were 
distinctively outlined by strong EPOR immunoreactivities where EPOR was shown to be 
expressed by neurons, astrocytes and endothelial cells, especially astrocytic processes 
surrounding the capillaries (Yamaji et al., 1996; Bernaudin et al., 1999; Bernaudin et al., 
2000; Brines et al., 2000; Sirén et al., 2001b). Therefore, this phenomenon in the present 
study showed that the astrocytic-like processes could be the astrocytes cells that were 
expressing EPOR to receive EPO ligands to modulate angiogenesis (via the EPO-EPOR 
system) or barriergenesis in the penumbra responding to compromised neurovasculature 
et al., 2000; 




following ischemic insult (Wu et al, 1999; Kertesz et al, 2004; Lee et al., 2009a). 
However, with reference to the present data on cortical caspase-3 activation in the 
ipsilateral cortices of the MCAo rats, the increased endogenous cortical EPO following 
ischemic insult may not have been sufficient to moderate the apoptotic process. In CA1s, 
EPO and EPOR proteins in the ipsilateral hippocampi were localised mainly to neurons, 
with EPOR being seen with a reduced staining intensity. Hippocampal EPO and EPOR 
proteins in the contralateral CA1s, in addition to neuronal cells, were also detected in the 
oriens layer and stratum radiatum. In DGs, hippocampal EPO and EPOR proteins were 
co-localised with NeuN positive neurons and other cells, with EPOR again seen in mildly 
reduced staining intensity. The MCAo rats involved other cells for the production of EPO 
protein in both DG and cortex (Masuda et al., 1994). The data from the rats with 
experimental MCAo showed that EPO and EPOR proteins in the ipsilateral CA1s were 
expressed in neurons following brain ischemia possibly fulfilling neuroprotective 
function, while the expression of EPO and EPOR proteins in the DG involved both NeuN 
positive neurons and non NeuN labeled cells which may serve to mediate 
neuroregeneration in addition to neuroprotection as discussed earlier (Shingo 
In the MCAo-runner rats, cortical EPO protein was recorded with a statistically 
significant increment at 1.76 ± 0.08 fold in ipsilateral cortices and 1.57 ± 0.11 fold in 
contralateral cortices following post-ischemic exercise when compared with the sham rats 
(and additionally, ipsilateral cortices of MCAo rats). Cortical EPOR proteins in the 
MCAo-runner rats were also registered with statistically significant increase by 2.19 ± 




0.06 fold and 2.00 ± 0.11 fold in the ipsilateral cortices and contralateral cortices 
respectively after post-ischemic exercise in contrast to the sham rats (again additionally, 
ipsilateral cortices of MCAo rats). At the same time, In contrast with the sham-runner 
rats, the further increase in the expression of EPO and EPOR proteins for the 
MCAo-runner rats showed that ischemic insults (Wen et al., 2004; Gu et al., 2008) and 
exercise (Robert and Smith, 1999; Schobersberger et al., 2000) could be regarded as two 
separate realms which allowed mutual potentiation in regulating the expression of 
erythropoietic factors. With reference to the data on reduced cortical cleaved caspase-3 
protein expression seen in the ipsilateral cortices of the MCAo-runner rats, post-ischemic 
exercise mediated increase in EPO and EPOR signaling may be correlated with reduced 
apoptotic process. In the immunofluorescence experiment, MCAo-runner rats displayed 
immunoreactivities of cortical EPO proteins in the two cortices that were comparable to 
the distribution trend seen in the MCAo rats where the EPO proteins were localised to 
both NeuN positive neurons and other cells. The cortical EPOR staining profiles in the 
ipsilateral cortices of MCAo-runner rats shared similar but slightly less intense staining 
for the astrocytic-like processes as compared with the MCAo rats. Taken together, 
post-ischemic exercise increased overall expression (based on Western blot analysis) but 
did not alter the distribution of cortical EPO and EPOR proteins under ischemic 
conditions. In the CA1s of the MCAo-runner rats, higher staining intensity of both 
hippocampal EPO and EPOR proteins were observed in the ipsilateral hippocampi’s 
neurons when compared with the MCAo rats. In the DGs, similar staining profiles of 
hippocampal EPOR proteins were observed between the MCAo-runner rats and MCAo 
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rats but hippocampal EPO proteins were more prominent following post-ischemic 
exercise. The localisation of EPO and EPOR proteins to neurons following either 
ischemic insult or exercise suggested that both events could act separately or come 
together in triggering neuroprotection of the neurons. 
 
In conclusion, the study has shown that eight weeks of forced treadmill exercise were 
able to enhance neuroprotection and erythropoietic potential in both hippocampus and 
cortex, with increased EPO and EPOR under sham-operated condition. And eight weeks 
of post-ischemic exercise has shown to be able to up-regulate EPO and EPOR further, as 
compared with sedentary rats with experimental MCAo, thus provided support possibly 
for both neuroprotection and anigiogenesis/barriergenesis. More studies are needed at 
different temporal profile to study the effects of exercise, together with combinatorial 
treatment, on EPO and EPOR in permanent MCAo. 
 
4.7 Changes in antioxidants’ profile for both sham-operated and ischemic brain 
with or without exercise 
 
Reactive oxygen species (ROS) or free radicals, e.g. superoxide and hydrogen peroxide, 
are generated physiologically via aerobic metabolism, although with short half-life, when 
produced in excess ROS will lead to oxidative stress which are implicated in the 
pathophysiology of many neurologic disorders and brain dysfunctions such as stroke 
(Kontos, 1985; Siesjö et al., 1989; Chan, 1994). This malice against the individual cell by 
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the ROS are capable of damaging lipids, proteins and DNA, and are scavenged and 
mediated by a variety of antioxidant enzymes such as superoxide dismutase (SOD), 
catalase and glutathione peroxidase (GPx) (Crack et al., 2003). Superoxide anions can be 
readily dismuted enzymatically from superoxide to hydrogen peroxide by SOD, which is 
subsequently converted to water by GPx or neutralized to water and oxygen by catalase 
(Fujimura et al., 2005). Expressions of endogenous antioxidants are up-regulated 
following ischemic attack, however can be insufficient when the brain ischemia episode 
proved too challenging (Fukui et al., 2002). Although studies have shown that increased 
physical activities can enhance antioxidants enzyme activities in the brain, most of the 
studies used normal animals in the experimental settings (Somani et al., 1995; Devi et al., 
2004; Cechetti et al., 2007; Cechetti et al., 2008; Lappalainen et al., 2009). Currently, this 
is the first experiment that attempted to study the effects of long term forced treadmill 
exercise in modulation of antioxidants enzyme activities under sham-operated and 
ischemic conditions. 
 
In the present study, it was demonstrated that both cortical and hippocampal GPx1 
proteins were increased significantly by 1.38 ± 0.03 and 1.26 ± 0.02 folds respectively 
subsequent to long term forced treadmill exercise. This up-regulation seen in the current 
experiment reaffirmed observations made in earlier study which used older rats (at 14 
weeks) (Lappalainen et al., 2009). As superoxide is the key constituent of oxidative 
stress, up-regulation of SOD will play a critical role in antioxidation. However, the 
exercise regime in the current study did induce any significant change to the enzyme 
192 
 
activity of the Cu/ZnSOD in both cortex and hippocampus (Lappalainen et al., 2009). 
This could be attributed to the Cu/ZnSOD’s short half lives of about six to ten minutes 
and also the enzyme’s activity being already in abundance in neural tissues rendering the 
current exercise regime not able to effect further changes (Fujimura et al., 2005). 
Interestingly, expression of catalase was only up-regulated significantly in the cortex but 
not in the hippocampus under sham-operated condition. This observation suggested that 
catalase’s enzymatic activity may be dependent on the anatomical location in the brain 
subsequent to long term forced treadmill exercise. All in all, the changes to various 
antioxidant enzymes evaluated in the study suggested that the current exercise program 
was able to induce adaptation to possibly increased oxygen consumption in the brain 
(Somani et al., 1994; Servais et al., 2003). The results also suggested that both “second 
line” of antioxidants, GPx1 and catalase, were essential for adapting to changes in 
increased metabolism. However, the effect of forced treadmill exercise on enzymatic 
activity level of Cu/ZnSOD may have to be relooked upon at an earlier timing due to its 
short half lives. 
 
In the MCAo rats, cortical GPx1 enzyme activities were significantly increased in the 
ipsilateral and contralateral cortices by 2.87 ± 0.06 and 2.75 ± 0.08 folds respectively 
following ischemic insults. In the same group, Cu/ZnSOD enzyme activities were also 
significantly increased in the ipsilateral and contralateral cortices by 1.65 ± 0.03 and 1.76 
± 0.05 folds respectively following ischemic insults. These observations suggested that 
Cu/ZnSOD were constantly expressed under the evolving ischemic milieu, otherwise 
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detection of its increase would be difficult to accomplish due to its short half lives. 
Overexpression of Cu/ZnSOD has been shown to reduce ischemic damage only in 
transient focal cerebral ischemia (Kinouchi et al., 1991; Yang et al., 1994; Kondo et al., 
1997), but neither Cu/ZnSOD overexpression nor Cu/ZnSOD targeted deletion has shown 
any beneficial effect in permanent focal ischemia, thus pointing out Cu/ZnSOD’s 
requirement for reperfusion to happen in order to serve its function (Chan et al., 1993; 
Fujimura et al., 2001). Although the present study employed a permanent MCAo model, 
the up-regulation in Cu/ZnSOD enzymatic activities could be relevant when collateral 
arteries were formed. However, catalase expression level was only elevated significantly 
by 1.32 ± 0.11 fold in the contralateral cortices. These results showed that the level of 
enzymatic activities of both GPx1 and Cu/ZnSOD, except catalase, remained 
up-regulated in the ipsilateral cortices thus suggested their importance in a continuously 
evolving pathology in the chronic phase following brain ischemia. 
 
In the MCAo-runner rats, post-ischemic exercise significantly down-regulated cortical 
GPx1 enzyme activity to 1.36 ± 0.02 and 1.33 ± 0.07 folds in both ipsilateral and 
contralateral cortices respectively as compared with the MCAo rats. However, the GPx1 
enzyme activity remained significantly elevated when compared with the sham rats. 
These downward trends were also noted for Cu/ZnSOD with a smaller margin to 1.53 ± 
0.06 and 1.36 ± 0.03 folds in both ipsilateral and contralateral cortices respectively as 
compared with the MCAo rats. However, the enzymatic activities of cortical Cu/ZnSOD, 
similar with GPx1, were also significantly higher than the sham rats. Catalase enzyme 
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activity in the contralateral cortices was reduced to 1.19 ± 0.04 fold following 
post-ischemic exercise which rendered its activity level comparable to the sham rats. So 
far, there has been no data reporting the effect of post-ischemic exercise on enzymatic 
activities of antioxidants. Taken together, the multi-level of enzymatic activities of the 
three antioxidants posted a drop following post-ischemic exercise. Thus with much 
consideration, the present data may suggest long term moderate post-ischemic exercise 
were able to alleviate ischemic damages thus lowering the requirements of antioxidative 
defense. However, enzyme activity level of both GPx1 and Cu/ZnSOD remained elevated 
and relevant in evolving brain ischemia following post-ischemic exercise. 
 
In conclusion, the study has shown that eight weeks of forced treadmill exercise were 
able to enhance the enzyme activities of GPx1 and catalase, and chronic phase of 
permanent MCAo has shown to be able to increase the enzyme activities of GPx1 and 
Cu/ZnSOD, thus outlining the varying repertoire of antioxidants used in different 
conditions. And in general, eight weeks of post-ischemic exercise has shown to 
down-regulate the enzyme activities of the three antioxidants which may suggest changes 
to an ischemic condition that has lower requirement for antioxidative defense and 
improved oxidative stress status. Future studies are recommended to study the effects of 
exercise, together with combinatorial treatment, on the enzyme activities of antioxidants 


























Stroke can be temporally classified into hyper-acute phase, acute phase, sub-acute phase 
and chronic phase for brain ischemia, where pharmacological intervention plays an 
important mediating role in the early phase while physiotherapy in addition to medication 
are proven clinical approach for managing the late phases of brain ischemia. The present 
study in the acute phase has shown that treatment with combined inhibitors using 
z-VAD-fmk and 3-AB can achieve better infarct size reduction as compared to single 
modality treatment with the same chemical compounds when delivered at the same 
timing. Though the combined inhibitors treatment can also further reduce infarct size with 
pharmacological intervention at 24hr post MCAo, it is the earlier intervention that gave 
the largest reduction in infarct size. Although intracellular ATP level was not correlated 
to infarct size, treatment with PARP inhibitor showed that intracellular ATP level was 
inversely related to the size of infarct. This limited observation in the PARP inhibitor 
treatment group may be consistent with the prevention of energy utilization by the PARP. 
 
Earlier studies have shown that exercise, prior to ischemic insult, can induce neurotrophic 
factors that are beneficial to the brain. Physiotherapy, in the form of forced physical 
activities, prescribed as a complementary therapeutic program in addition to 
pharmacological intervention happen after stroke. The present study looked at the effects 
of forced exercise following experimental brain ischemia and showed that eight weeks 
post-ischemic exercise were able to lower the level of caspase-3 activation and PARP 
cleavage in the ipsilateral cortices from the MCAo-runner rats. In addition, present study 
showed that eight weeks of forced treadmill exercise under sham-operated condition did 
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not change the level of caspase-3 activation and PARP cleavage both in the hippocampus 
and cortex, and also did not induce any DNA damage or apoptosis. Although, the present 
study showed the paradoxical increase of positive TUNEL staining in the MCAo-runner 
rats, this may be a caspase independent apoptosis in which the body positioned to better 
manage the unpreventable cell death. 
 
TGF-β1 is a cytokine which orchestrates various critical physiological processes, 
including proliferation, differentiation, growth inhibition, and apoptosis. Eight weeks of 
forced treadmill exercise increased TGF-β signaling in hippocampus with increased 
TGF-β1 and smad7 under sham-operated condition which may account for 
preconditioning-like effects and enhance neurogenic potential seen in earlier studies. The 
moderate increase in TGF-β1 accompanied by significant increase in smad7 was 
correlated to persistent high expression of caspase-3 activation and PARP cleavage in the 
ipsilateral cortices of the sedentary rats with MCAo. This high level of caspase activation 
was turned around with elevated TGF-β1 expression and down-regulated smad7 level 
following post-ischemic exercise, thus suggesting an anti-caspase-dependent-apoptosis 
property of TGF-β1’s role in neuroprotection. 
 
In addition to neuroprotection, neuroregeneration after ischemic insults is pivotal for a 
more favorable prognosis. In order for neuroregeneration to happen, it is necessary for 
complementing increase in angiogenic and erythropoietic activities to form new and 
effective oxygen delivery vascular structures. HIF-1 is a wide spectrum transcription 
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factor that encodes for various proteins (such as EPO and PDGFB) that mediate 
molecular responses to reduced oxygen availability. In the sham-operated hippocampus, 
eight weeks of forced treadmill exercise increased HIF-1α level which may have led to 
the up-regulation of both EPO and PDGFB. At the same time, expression of EPOR was 
also increased following prolonged exercise. Similarly in the sham-operated cortex, long 
term forced exercise was able to bring about an upward trend in both HIF-1α and PDGFB 
expression, albeit not significant. Fortunately, EPO and EPOR were significantly 
increased, thus these observations suggested that exercise could induce the angiogenic 
and erythropoeitic potential to condition the brain to be less susceptible to subsequent 
ischemia via formation of new blood vessels as illustrated by the Pecam-1 expression. 
 
PDGFB seem to have a significant bearing on the Pecam-1 expression, as neo-vasculature 
was not evident in the cortices of MCAo rats even when HIF-1α was significantly 
up-regulated. As a consolation, both EPO and EPOR were increased by varying degree in 
the ipsilateral cortices of the MCAo rats. These observations suggested that brain 
ischemia could induce angiogenesis; however, lacking in concomitant increase of PDGFB 
may impede the maturation process of neo-vascularisation resulting in poorly formed 
blood vessels. Post-ischemic exercise was able to further increase the HIF-1α, EPO and 
EPOR expression in the MCAo-runner when compared with MCAo rats. Moreover, 
exercise under permanent ischemia was also able to build up PDGFB level. However, 
even in the presence of increased PDGFB, neo-vascularisation was unimpressive. Thus 
suggested that brain ischemia may produce or remove another unidentified factor that 
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may form either inhibitive or necessary conditions for the angiogenic property of PDGFB 
to work. These observations postulated that post-ischemic exercise although was able to 
increase endogenous neuroprotective and angiogenic activities in the MCAo-runner rats, 
but the increment was incapable of fully overcoming the limitation set by the ischemic 
milieu. 
 
In the late phase of brain ischemia, collateral arteries may be formed to resupply oxygen 
and glucose to the insulted region. During these times, reperfusion to the affected area 
may result in oxidative stress thus generate changes in the antioxidants profile. The study 
has shown that eight weeks of forced treadmill exercise under sham-operated condition 
were able to enhance the enzyme activities of GPx1 and catalase, and chronic phase of 
permanent MCAo has shown to be able to increase the enzyme activities of GPx1 and 
Cu/ZnSOD, thus outlining the varying repertoire of antioxidants used in different 
conditions. And in general, eight weeks of post-ischemic exercise has shown to 
down-regulate the enzyme activities of the three antioxidants which suggest changes to an 
ischemic condition that has lower requirement for antioxidative defense and may be a 
reflection of the oxidative stress status. Therefore, the present chronic phase study 
showed that eight weeks of moderate forced treadmill post-ischemic exercise may be able 
to reduce secondary damages, and achieve better clinical outcome following brain 





In conclusion, treatment of stroke requires understanding of its molecular mechanisms at 
different temporal profiles. While waiting for the conditions to stabilize, during the acute 
phase of stroke, primary goals of achieving arterial thrombus degradation and restoration 
of vessel patency and blood flow may also need to involve neuroprotective compounds 
that can minimize tissue damage to further improve clinical prognosis. Due to the 
complexity nature of progression in cellular damage after ischemia, combinatorial 
treatment has offered a glimpse of how it can work better than single modality approach 
in the acute phase experiment. Together with strategies to minimize tissue damaged 
during the acute phase of stroke and along with the principle of poly-sequences cellular 
damage, prolonged moderate forced treadmill exercises following experimental stroke 
have shown to induce the body to endogenously respond to challenges posed by ischemic 
insults via neuroprotective and angiogenic potentials improving gait functions and overall 
outcomes. Further experiments will be needed to look at the studying both acute and 
chronic phases together as a single model. Philosophically, these observations can be 
compared to city planning where formation of new blood vessels are likened to laying 
down new infrastructures such as roads and railway tracks. These neo-vasculature formed 
will enhance transport of neuroprotective and neuroregenerative factors more efficiently 
to the affected regions to restore devastations done and achieve improved clinical 
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Equipment and anesthesia needed for MCAO surgery 
 
• Shaver for general use  
• Thermal blanket coupled with a rectal probe for temperature read-out  
• Forceps for general use  
• Micro-scissor  
• Blade holder with Blade  
• Skin retractor  
• Hooks  
• Dissecting microscope  
• Illuminating lights  
• Irrigation and suction set-up  
• Needle and sutures  














A stock solution of 0.4% TTC was prepared by dissolving 0.4g of TTC powder in 5ml 
dimethy sulphoxide (DMSO) and 95ml of distilled water. The suspension was sonicated 
thereafter for an hr to facilitate solution. 
 
0.1%TTC 
0.1% TTC was prepared by adding 10ml of the 0.4% TTC stock solution to 16ml 0.2M 
Na2HPO4, 4ml 0.2M NaH2PO4 and 10ml 8mM MgCl2 (pH7.4). This solution should be 
protected from light. 
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Appendix 3  
 
Real Time - PCR 
 
Kit/ solutions : 
Chloroform 
 
70% and 96-100% Ethanol  
 
Qiagen RNeasy Lipid Tissue Midi Kit (QIAzol® Lysis Reagent, Buffer RW1, Buffer 
RPE, RNase-free water)  
 
Promega Reverse Transcription System (AMV Reverse Transcriptase (HC), Recombinant 
RNasin® Ribonuclease Inhibitor, Oligo(dT)15 Primer, Random Primers, 1.2kb Kanamycin 
Positive Control RNA, dNTP Mix, Reverse Transcription 10X Buffer, MgCl2, 
Qiagen QuantiTect® SYBR® Green RT-PCR [QuantiTect SYBR Green RT-PCR Master 
Mix (HotStarTaq® DNA Polymerase, QuantiTect SYBR Green RT-PCR Buffer, dNTP 
mix, including dUTP, SYBR Green I, ROX passive reference dye, 5 mM MgCl2), 
QuantiTect RT Mix, a mixture of the QIAGEN® (Omniscript® Reverse Transcriptase, 
Omniscript® Reverse Transcriptase), RNase-Free Water] 









4.5 ml of 1x PBS (pH 7.4; 4ºC) containing aprotinin (1μg/ml)  
45μl of Triton-X 100  
 
SDS-PAGE 
10%, 12% or 15% Pre-casted Gel (BioRad) was used throughout the experiments.  
 
Solutions: 
Running buffer (1x) 
1.51g/litre Tris base 
5g/litre SDS 
7.2g/litre Glycine  
 








PBS (10x) 100ml  
0.1% Tween 20 1ml  
5% non fat milk powder 50g  
Distilled water to 1 Liter  
 
Washing buffer 
PBS (10x) 100ml  
Distilled water to 1 Liter  
 
Incubation reagents and time 
Block with milk buffer for 1hr  
Incubate with primary antibody overnight on a shaker  
Incubate with biotinylated anti-rabbit or anti-goat secondary antibody (1:5000) (1hr) 
Wash with PBS  
 
Immunodetection of protein 
ECL Plus™ Western Blotting Reagents from GE Healthcare (formerly Amersham 







Solutions for transcardial perfusion 
Ringers solutions  
4% paraformaldehyde (4g/100ml of PB)  
15% sucrose (15g/10ml of PB)  
 
Gelatinized slides 
Acid-cleaned slides  
1.5% gelatin and 0.15% Chrome alum solution  
 
Buffers 
PBS (pH 7.4) 
Distilled water 1 Liter  
Disodium Hydrogen Phosphate, Heptahydrate 13.4g  
Sodium chloride 8g  
 
PBS-TX (pH 7.4) 
Distilled water 1 Liter  
Disodium Hydrogen Phosphate, Heptahydrate 13.4g  
246 
 
Sodium chloride 8g  
Triton-X 100 1ml  
 
0.1M Acetate Buffer 
1M acetate buffer 10ml  
Distilled water 90ml  
 
1M Acetate Buffer (pH 4.8) 
Sodium acetate 24.6g  
Distilled water 300ml 
